<?xml version="1.0" encoding="utf-8"?>
<ead xmlns="urn:isbn:1-931666-22-9" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:isbn:1-931666-22-9 http://www.loc.gov/ead/ead.xsd"><eadheader countryencoding="iso3166-1" dateencoding="iso8601" langencoding="iso639-2b" repositoryencoding="iso15511"><eadid>FA1103A.xml</eadid><filedesc><titlestmt><titleproper type="filing">Rockefeller University collection of The Medical Letter publication, 1996-2004</titleproper><titleproper>A Guide to the Rockefeller University collection of The Medical Letter publication, 1996-2004 <num>FA1103A</num></titleproper></titlestmt><publicationstmt><publisher>Rockefeller Archive Center</publisher><address><addressline>15 Dayton Avenue</addressline><addressline>Sleepy Hollow 10591</addressline><addressline>archive@rockarch.org</addressline><addressline>URL: <extptr xlink:href="http://www.rockarch.org" xlink:show="new" xlink:title="http://www.rockarch.org" xlink:type="simple"/></addressline></address></publicationstmt></filedesc><profiledesc><creation>This finding aid was produced using ArchivesSpace on <date>2019-11-01 00:33:06 -0400</date>.</creation><descrules>Describing Archives: A Content Standard</descrules></profiledesc></eadheader><archdesc level="collection">
  <did>
    <langmaterial>
      <language langcode="eng">English</language>
    </langmaterial>
    <repository>
      <corpname>Rockefeller Archive Center</corpname>
    </repository>
    <unittitle>Rockefeller University collection of The Medical Letter publication</unittitle>
    <origination label="Creator">
      <corpname role="aut" source="naf">Rockefeller University</corpname>
    </origination>
    <origination label="Creator">
      <corpname role="aut" source="naf">Medical Letter, Inc</corpname>
    </origination>
    <unitid>FA1103A</unitid>
    <physdesc altrender="whole">
      <extent altrender="materialtype spaceoccupied">131.21 Cubic Feet</extent>
    </physdesc>
    <unitdate normal="1996/2004" type="inclusive">1996-2004</unitdate>
  </did>
  <processinfo id="4f6518ea8bae3b64eb48a7b6e5a4ac82">
    <head>Processing Information</head>
<p>Minimal processing</p>  </processinfo>
  <prefercite id="08d6bd5a3343d88ae174562240e1c48c">
    <head>Preferred Citation</head>
<p>Information regarding the Rockefeller Archive Center's preferred elements and forms of citation can be found at <extref href="http://www.rockarch.org/research/citations.php">http://www.rockarch.org/research/citations.php</extref></p>  </prefercite>
  <accessrestrict id="8e22992d16c1acad66ec2350a423e469">
    <head>Conditions Governing Access</head>
<p>Records more than 25 years old are open for research with select materials restricted as noted. Brittle or damaged items are available at the discretion of RAC.</p>  </accessrestrict>
  <fileplan id="b18026630ad0911a346cf5ce064ebdd5">
    <head>File Plan</head>
<p>Former Classification: I 891-U</p>  </fileplan>
  <otherfindaid id="80d67a066600f6ef1d33e75468f27af6">
    <head>Other Finding Aids</head>
<p>For additional Medical Letter materials open for research see:</p><p>FA241 Rockefeller University collection of the Medical Lettter publication</p>  </otherfindaid>
  <scopecontent id="96fc3f4b0ecc38c530137eb411f39ada">
    <head>Scope and Contents</head>
<p>Contents includes: original manuscripts, reprints, advertising and package inserts, sources check, consultatnts drafts, manufacturers replies, and bibliography.</p>  </scopecontent>
  <bioghist id="6c159867ba2a2151b8b7399752c3890b">
    <head>Biographical / Historical</head>
<p>The Medical Letter on Drugs and Therapeutics is an independent, non-profit publication providing unbiased critical evaluation of drugs in terms of their effectiveness, adverse effects and possible alternative medications.</p>  </bioghist>
  <userestrict id="37e428481bbdbecee9f5c722527c7cfc">
    <head>Conditions Governing Use</head>
<p>Use agreement is required prior to providing access. See RAC Head of Reference for assistance.</p>  </userestrict>
  <dsc><c id="722d135ab2e6b9a0415068e6118db069" level="file"><did><unittitle>TML, 38-9 - Acarbose for diabetes mellitus</unittitle><unitdate type="inclusive">1996 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="2bffad65d8b376ef5e4fc0cd7ebb5253" label="mixed materials [A0000000075844]" type="box">1</container><container id="2051e04b8a36a2a8518893ac0f99a6fc" parent="2bffad65d8b376ef5e4fc0cd7ebb5253" type="folder">1-4</container></did><accessrestrict id="6413d819e0f61297a55139d343bc6b2f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="8e0dd5900ff39bfca71872aabc11f428" level="file"><did><unittitle>TML, 38-55 - Acetaminophen, NSAIDs and Alcohol</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="53584eb4597fb46d4479c448512388ab" label="mixed materials [A0000000075844]" type="box">1</container><container id="a8e64efd4194347074169029c9225290" parent="53584eb4597fb46d4479c448512388ab" type="folder">5-7</container></did><accessrestrict id="656f8049cade326890b44a882a172390"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="92bb9fbbd017dace4f8bbbdfdcec0a7a" level="file"><did><unittitle>TML, 38-43 - Acute reactions to Drugs of Abuse</unittitle><unitdate type="inclusive">1996 May 10</unitdate><container altrender="Record Storage Box (Paige)" id="5e30b476cf18e59d0b7735ce039ad7a8" label="mixed materials [A0000000075844]" type="box">1</container><container id="68ba4d26eb83108d68d7619dac68a39c" parent="5e30b476cf18e59d0b7735ce039ad7a8" type="folder">8-12</container></did><accessrestrict id="ca3616172a78ef218806617937be4ae3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="299c68349552c9c16b93a8a4762f739e" level="file"><did><unittitle>TML, 38-35 - New drugs for HIV</unittitle><unitdate type="inclusive">1996 April 12</unitdate><container altrender="Record Storage Box (Paige)" id="979c713aa5fceaaa0447d15361d3b20d" label="mixed materials [A0000000075844]" type="box">1</container><container id="8e89e21ecd50a1144487b6e8164b4faf" parent="979c713aa5fceaaa0447d15361d3b20d" type="folder">13-17</container></did><accessrestrict id="86a00cb09aea1b9f00fe35947afa8c0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c5fa85f3bd2884f1a9dfd36830a4fb4d" level="file"><did><unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="51a3ec5b5f1138a76a7c3d9e20037d30" label="mixed materials [A0000000075844]" type="box">1</container><container id="066cc538ced4c69fa2384719a474d827" parent="51a3ec5b5f1138a76a7c3d9e20037d30" type="folder">18</container></did><accessrestrict id="6490910db6cb9773d516babe0e3ba2c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="25c672276d8de231f00bfa483bb42cb2" level="file"><did><unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="e22556d942ba015e545ffc033f69e7ae" label="mixed materials [A0000000075845]" type="box">2</container><container id="1f4d4e183bd8e319d740cd72a1150db6" parent="e22556d942ba015e545ffc033f69e7ae" type="folder">1-3</container></did><accessrestrict id="2d841e9b213eca4386b5020a0f960ab2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="520cba0819f4d1a661ffbae9d84a72d2" level="file"><did><unittitle>TML, 38-61 - Anatrozle for metastatic breast cancer</unittitle><unitdate type="inclusive">1996 July 5</unitdate><container altrender="Record Storage Box (Paige)" id="83a718dd1668be007e4b4b70cf9aa5f1" label="mixed materials [A0000000075845]" type="box">2</container><container id="b268ccb3cbe7ab9d214115063c24a5d1" parent="83a718dd1668be007e4b4b70cf9aa5f1" type="folder">4-6</container></did><accessrestrict id="391e7265783eb309c372f58724caf420"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="b466c2ae20545eb902a029aabfadd4a2" level="file"><did><unittitle>TML, 38-25 - Choice of Antimicrobial Drugs</unittitle><unitdate type="inclusive">1996 March 29</unitdate><container altrender="Record Storage Box (Paige)" id="3f36aebb7b8e87a46a3f94367a0a207e" label="mixed materials [A0000000075845]" type="box">2</container><container id="92fe21d515389de1a74d2cb217ad2394" parent="3f36aebb7b8e87a46a3f94367a0a207e" type="folder">7-9</container></did><accessrestrict id="abc8cefbfb0e5ceded73db45b93e2776"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="ef71891079fc8afb056a13746e052f75" level="file"><did><unittitle>TML, 38-52 - Drugs for Cardiac Arrythmias</unittitle><unitdate type="inclusive">1996 August 30</unitdate><container altrender="Record Storage Box (Paige)" id="cc411191dca020b618a78bc99e8cd3fe" label="mixed materials [A0000000075845]" type="box">2</container><container id="14ef3742707e690f0413c83c18b7ef1d" parent="cc411191dca020b618a78bc99e8cd3fe" type="folder">10-16</container></did><accessrestrict id="e9ba90f8f6e01a82041a2cb46e749402"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="630284f8fa9310d4604f35f82942ec99" level="file"><did><unittitle>TML, 38-52 - Azelaic acid a new topical drug for acne</unittitle><unitdate type="inclusive">1996 June 7</unitdate><container altrender="Record Storage Box (Paige)" id="17b1933bb9db260a0df544b5c7a1a906" label="mixed materials [A0000000075845]" type="box">2</container><container id="0bfe0aa40bfafe0cef736de77539cc96" parent="17b1933bb9db260a0df544b5c7a1a906" type="folder">17-18</container></did><accessrestrict id="7d350d2c114c77a5007cc5bd6bef48d0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="4b06c4e94eeae1bbd7e893099db3bb23" level="file"><did><unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="2f6afb6931f8d347d550f40b64c6bb98" label="mixed materials [A0000000075845]" type="box">2</container><container id="d1e707b517f67945c79329452fe53606" parent="2f6afb6931f8d347d550f40b64c6bb98" type="folder">19-20</container></did><accessrestrict id="c9d5e1a415d2921805aa74b729504b02"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="cdf8cc07b4cfdaccc7c2d14cfe460d41" level="file"><did><unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="397b4899ad460e99f7a9808e99f67652" label="mixed materials [A0000000075846]" type="box">3</container><container id="5c6b315e591e88d713aafe2414afa9b4" parent="397b4899ad460e99f7a9808e99f67652" type="folder">1</container></did><accessrestrict id="bc8ec69f68ddfbb05692b444a9d33f73"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="8e8440ccfa5de303b70df4a8556b7da1" level="file"><did><unittitle>TML, 38-103 - Bone Density Testing</unittitle><unitdate type="inclusive">1996 November 26</unitdate><container altrender="Record Storage Box (Paige)" id="65819e813da576ecce2092687d9af8ac" label="mixed materials [A0000000075846]" type="box">3</container><container id="b780f0500d756fa72858ac5560e57e53" parent="65819e813da576ecce2092687d9af8ac" type="folder">2-3</container></did><accessrestrict id="9371d9820f979006c113e8341494696d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="2bc3e056d1f8fa2492e7303d95310131" level="file"><did><unittitle>TML, 37-109 - Dirithromycin</unittitle><unitdate type="inclusive">1995 November 24</unitdate><container altrender="Record Storage Box (Paige)" id="817def1626c88ba9698fd44904b90d39" label="mixed materials [A0000000075846]" type="box">3</container><container id="ddd11fac0d2ea73af558f324ee3e5702" parent="817def1626c88ba9698fd44904b90d39" type="folder">4-7</container></did><accessrestrict id="70e63df474c05d465a52ed6834a63c2e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="404e68490aeea4bc03276bd2e1972297" level="file"><did><unittitle>TML, 38-108 - Calcium Supplements</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="bdd063c4ce998ea8ce506e0c61098ab4" label="mixed materials [A0000000075846]" type="box">3</container><container id="733da26ff96b1ac730ae3f3ef88197a8" parent="bdd063c4ce998ea8ce506e0c61098ab4" type="folder">8-12</container></did><accessrestrict id="6397bcfd119b8dee01530ad0c01d2fe0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="787f855d64193a39aa5fa640c29b09f9" level="file"><did><unittitle>TML, 38-40 - Radiofrequency cather abilation for treatment of cardiac arrhythmias</unittitle><unitdate type="inclusive">1996 April 26</unitdate><container altrender="Record Storage Box (Paige)" id="0dcfdd8b1162d57dfe7c04f95f23d2e7" label="mixed materials [A0000000075846]" type="box">3</container><container id="f2bea1250b89bc37126ff8780836ec13" parent="0dcfdd8b1162d57dfe7c04f95f23d2e7" type="folder">13-16</container></did><accessrestrict id="9407b24c4bbb8b9a8280fd95b434f402"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="6ee9fed32bd765fba31910157fc457da" level="file"><did><unittitle>TML, 38-23 - Cetibuten - a new oral cephalosporin</unittitle><unitdate type="inclusive">1996 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="b27a93ab6516ccc13ae37e32a4cd89a4" label="mixed materials [A0000000075846]" type="box">3</container><container id="3382f79f2b3786e975d596daca95a5cb" parent="b27a93ab6516ccc13ae37e32a4cd89a4" type="folder">17-19</container></did><accessrestrict id="fe428baa314a27bf86569a7a685bf75c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="cf9669d33a59dba3ffbe8f50f22fca78" level="file"><did><unittitle>TML, 38-84 - Cefepime (Maxime) - a new parenteral cephalosporin</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="793727476c7a9dac559f099bee429844" label="mixed materials [A0000000075847]" type="box">4</container><container id="8930a96b130789bd5f52f3005165bf64" parent="793727476c7a9dac559f099bee429844" type="folder">1-4</container></did><accessrestrict id="cd47248ae2cfc55d2fb4424654263054"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="7dd0747a03e955ecdd43cb4fc77cc296" level="file"><did><unittitle>TML, 38-46 - Chlorzoxazone hepatotoxsicity</unittitle><unitdate type="inclusive">1996 May 10</unitdate><container altrender="Record Storage Box (Paige)" id="0f83b1b3047d333a63c413dc9dbfcef5" label="mixed materials [A0000000075847]" type="box">4</container><container id="3552122e1c2ef70baada21c7d98d79ab" parent="0f83b1b3047d333a63c413dc9dbfcef5" type="folder">5</container></did><accessrestrict id="2fb3ed462271aeec0fb14801053de435"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9050bc8c28970ad791e377582e9c079c" level="file"><did><unittitle>TML, 38-67 - Choice of Lipid-Lowering drugs</unittitle><unitdate type="inclusive">1996 August 2</unitdate><container altrender="Record Storage Box (Paige)" id="cb4bdc696f7b3e713b9b65840d6f83fc" label="mixed materials [A0000000075847]" type="box">4</container><container id="a5b3d651b283e02c3f9754586e79bc0d" parent="cb4bdc696f7b3e713b9b65840d6f83fc" type="folder">6-13</container></did><accessrestrict id="88da501863cd117b47bcae321e4b3b00"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="5c5e7299af1de05e46453f0fea0e1720" level="file"><did><unittitle>TML, 38-21 - Cetirizine - a new antihistamine</unittitle><unitdate type="inclusive">1996 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="d2a6ff13842a085851532582e3850259" label="mixed materials [A0000000075847]" type="box">4</container><container id="36c6e616494e7457c788cfc4237e035c" parent="d2a6ff13842a085851532582e3850259" type="folder">14-18</container></did><accessrestrict id="0f7c6d142759503d2196573bb0b89f9a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="0f91362447d7a3cdff68d7ebac520b38" level="file"><did><unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="78fc157a4e91deb2304aa25b43dd0c75" label="mixed materials [A0000000075847]" type="box">4</container><container id="ae8fd0be3a63b85b3614f89c369b358d" parent="78fc157a4e91deb2304aa25b43dd0c75" type="folder">19-20</container></did><accessrestrict id="4e5c9545497b1cea799d01d6d8e16965"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c714362a04b8f852b521155e586e0af2" level="file"><did><unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="0e779dce7f04b4c6a1080348ab3af355" label="mixed materials [A0000000075848]" type="box">5</container><container id="133dc6e0e703a62db45288f6a97be18c" parent="0e779dce7f04b4c6a1080348ab3af355" type="folder">1</container></did><accessrestrict id="a545b57ddc41b86449988949e310c707"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="484f5bda82347b92c1fd763adae1bf8a" level="file"><did><unittitle>TML, 38-64 - Dexfenfluramine for obesity</unittitle><unitdate type="inclusive">1996 July 19</unitdate><container altrender="Record Storage Box (Paige)" id="0cfedaaab3df278f9b0033def9f641e7" label="mixed materials [A0000000075848]" type="box">5</container><container id="ce8c6e50e82e80c4e4f8a0ecf5c8557f" parent="0cfedaaab3df278f9b0033def9f641e7" type="folder">2-5</container></did><accessrestrict id="0ae4223f8a683f538d4cd77c366f1250"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="8d0423127d33593f9f53a6262dc9f97c" level="file"><did><unittitle>TML, 38-87 - Docetaxel (Taxotere) for advanced breast cancer</unittitle><unitdate type="inclusive">1996 September 27</unitdate><container altrender="Record Storage Box (Paige)" id="f54929a09467429ab06ec0bd15c6bd42" label="mixed materials [A0000000075848]" type="box">5</container><container id="dcda6058ea29e3cd68296797f7b7b10d" parent="f54929a09467429ab06ec0bd15c6bd42" type="folder">6-8</container></did><accessrestrict id="ed7cc80f5cac6080418667469e63fcc5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="a348057f4e83121c70f8e63e18862273" level="file"><did><unittitle>TML, 38-14 - Epoprostenol for primary pulmonary hypertension</unittitle><unitdate type="inclusive">1996 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="32fe9fda449408451714550cebb7404a" label="mixed materials [A0000000075848]" type="box">5</container><container id="8e099f297b7486232cc54aba78813a95" parent="32fe9fda449408451714550cebb7404a" type="folder">9-10</container></did><accessrestrict id="9060f4c1941e62cde507283711c42123"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="4fb37dc500fa2658eede9f802e9df8f8" level="file"><did><unittitle>TML, 38-95 - Fexofenadine</unittitle><unitdate type="inclusive">1996 October 25</unitdate><container altrender="Record Storage Box (Paige)" id="a5807289acad21d53cdad45e7cd2304d" label="mixed materials [A0000000075848]" type="box">5</container><container id="48e4e964ac7bfcef870a37552d982ce6" parent="a5807289acad21d53cdad45e7cd2304d" type="folder">11-12</container></did><accessrestrict id="a8ff5bd8f8c9a8beb936876d0ab13404"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="64be8e3eb6b9a7f019087998bc44abd8" level="file"><did><unittitle>TML, 37-13 - Fluvoxamine for obsessive compulsive disorder</unittitle><unitdate type="inclusive">1995 February 17</unitdate><container altrender="Record Storage Box (Paige)" id="884f9d70acb06aa13b7f480934af5950" label="mixed materials [A0000000075848]" type="box">5</container><container id="5f73855fa681d9a5018b00e69c6e078b" parent="884f9d70acb06aa13b7f480934af5950" type="folder">13-16</container></did><accessrestrict id="695bcbd1bf632b907b932d7960966f9f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="892b6eca462f2e15ad9ec8aa8eca30aa" level="file"><did><unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="7ef9d394001d415a6b76a21359f8e4c1" label="mixed materials [A0000000075848]" type="box">5</container><container id="788e3e3c1ec8a3c2c6f7cde0a1fc0fa5" parent="7ef9d394001d415a6b76a21359f8e4c1" type="folder">17-21</container></did><accessrestrict id="beb3673044e9a99bc1e5e6f80a600a9c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="35c106caf84841f600db741ede502382" level="file"><did><unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="37d1bcca625d36299e107cae36677295" label="mixed materials [A0000000075849]" type="box">6</container><container id="1a2844a328bac4e28626eda70b723fef" parent="37d1bcca625d36299e107cae36677295" type="folder">1</container></did><accessrestrict id="f54d8351e9c7683733c760ddc9c6386f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9c02c90545e46d220940cf2a507e0a28" level="file"><did><unittitle>TML, 38-10 - Systematic antifungal drugs</unittitle><unitdate type="inclusive">1996 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="fa1e0bcb75e5bd3eca436a7089023e27" label="mixed materials [A0000000075849]" type="box">6</container><container id="843ed9d8a30faac398aff35013550719" parent="fa1e0bcb75e5bd3eca436a7089023e27" type="folder">2-3</container></did><accessrestrict id="24650d75f7a4fe5ddaf748532b77d1c8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="af3d9dfc1b1412c493e47fcf1216a75b" level="file"><did><unittitle>TML, 38-102 - Gemcitabine for treatment of pancreatic cancer</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="cd7bae00798646194ef2b29679a0cf06" label="mixed materials [A0000000075849]" type="box">6</container><container id="640b1ba7b851a545a4eeceeb0fd6762c" parent="cd7bae00798646194ef2b29679a0cf06" type="folder">4-6</container></did><accessrestrict id="7105d2dd194378e7c1b806e1786142c0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="237f462175824d3b36e04281c83344ac" level="file"><did><unittitle>TML, 38-47 - Glimepiride for NIDDM</unittitle><unitdate type="inclusive">1996 May 24</unitdate><container altrender="Record Storage Box (Paige)" id="4834b7f51f1908b695640506a070d538" label="mixed materials [A0000000075849]" type="box">6</container><container id="b3dfcf36a0b1d242f279ab7c925d8a8a" parent="4834b7f51f1908b695640506a070d538" type="folder">7-8</container></did><accessrestrict id="d0c68415f609b87b8e322217b54f482b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="f5f43d18d02fa3b8ac7f25b5d2f4bf4e" level="file"><did><unittitle>TML, 38-92 - Drugs for chronic heart failure</unittitle><unitdate type="inclusive">1996 October 11</unitdate><container altrender="Record Storage Box (Paige)" id="7a213026e2095c2599cf997edf17cf74" label="mixed materials [A0000000075849]" type="box">6</container><container id="12382a30dd792de4661333dab002cd62" parent="7a213026e2095c2599cf997edf17cf74" type="folder">9-13</container></did><accessrestrict id="a3631f3ddc4c9deaa183f2128f324ec8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="df185de80953b9ba72734fc53563026f" level="file"><did><unittitle>TML, 37-73 - Grapefruit juice interactions with drugs</unittitle><unitdate type="inclusive">1995 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="c04cfbab12d78cdbfc30b8e8e1873f13" label="mixed materials [A0000000075849]" type="box">6</container><container id="03611140b7daed398cc2fe74bdbfb4f2" parent="c04cfbab12d78cdbfc30b8e8e1873f13" type="folder">14-16</container></did><accessrestrict id="ee2185b1e98265927be53db9e0fa2dda"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9ea393808d7941a34a9237ff7d3e21d0" level="file"><did><unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle><unitdate type="inclusive">1995</unitdate><container altrender="Record Storage Box (Paige)" id="971cb13f809344ea300c9d9f4cffe541" label="mixed materials [A0000000075849]" type="box">6</container><container id="52230420b7a0a76cd15866adc5a0bec5" parent="971cb13f809344ea300c9d9f4cffe541" type="folder">17-20</container></did><accessrestrict id="052ebcc34a91845237e97c0df53775e3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="b5728f730c61991eb3d049832355c05c" level="file"><did><unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle><unitdate type="inclusive">1995</unitdate><container altrender="Record Storage Box (Paige)" id="e54ec72ec9de1ee51fd8844a75208d9c" label="mixed materials [A0000000075850]" type="box">7</container><container id="14fa59b113004d66494999f465293d0f" parent="e54ec72ec9de1ee51fd8844a75208d9c" type="folder">1-2</container></did><accessrestrict id="8725ceb0317248c73c37ce2386f5e01b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="34fded3e81407289cef7298c43db888c" level="file"><did><unittitle>TML - Drugs of Choice - Pain</unittitle><unitdate type="inclusive">1995</unitdate><container altrender="Record Storage Box (Paige)" id="aab016d6934957e6245087c83f1e2d7c" label="mixed materials [A0000000075850]" type="box">7</container><container id="1e0b4f5e26327f185fecec719a5f66ab" parent="aab016d6934957e6245087c83f1e2d7c" type="folder">3-7</container></did><accessrestrict id="fd6c1b22c3706f5ee95e16758bf6f9f6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="73f114dc6e630afb990634a443031d95" level="file"><did><unittitle>TML, 37-95 - OTC H2 Blockers for heartburn</unittitle><unitdate type="inclusive">1995 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="8c0e3109d8c8fa018cbbc185ab298df8" label="mixed materials [A0000000075850]" type="box">7</container><container id="6278e1291d1b7a75168f632d1fcad481" parent="8c0e3109d8c8fa018cbbc185ab298df8" type="folder">8-10</container></did><accessrestrict id="6f9d54ac52d448a971ae1e70ff68a5a9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e3ff759a8063b390ff0175205e40649d" level="file"><did><unittitle>TML, 38-6 - Rho (D) IV Immune Globulin</unittitle><unitdate type="inclusive">1996 January 19</unitdate><container altrender="Record Storage Box (Paige)" id="84a2551d2c0998cd9005108bd6e390f1" label="mixed materials [A0000000075850]" type="box">7</container><container id="1805cc0654194cfda932b1a43a50253a" parent="84a2551d2c0998cd9005108bd6e390f1" type="folder">11-13</container></did><accessrestrict id="ce939d07fa2fe96e5b623cff81c37a02"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="343b5e9d7ba1058f32a08341d9be9f4a" level="file"><did><unittitle>TML, 38-17 - Advice for Travelers</unittitle><unitdate type="inclusive">1996 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="388a76dc700a6b6dcfb189e790702717" label="mixed materials [A0000000075850]" type="box">7</container><container id="57d1a89317d0c6213d52d7158217ce48" parent="388a76dc700a6b6dcfb189e790702717" type="folder">14-16</container></did><accessrestrict id="c3bea7a676bd5b9981068ccf42242297"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="314ebfe0a12d0bad31002df2bbabf782" level="file"><did><unittitle>TML, 37-98 - Influenza Vaccine, 1995-1996</unittitle><unitdate type="inclusive">1995 September 1</unitdate><container altrender="Record Storage Box (Paige)" id="16b62e54fd4d2b371890f55938081d68" label="mixed materials [A0000000075850]" type="box">7</container><container id="052fc4fb1c1cbf5f1ce54f6ab0a71167" parent="16b62e54fd4d2b371890f55938081d68" type="folder">17</container></did><accessrestrict id="aaa5f55ecc1b4da36b3c2d152b9841b0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="fa30b8e25d30bd60ee7b9207731748dd" level="file"><did><unittitle>TML, 38-86 - Influenza Vaccine, 1996-1997</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="f4cb3159ddca301fba413139b2795b0d" label="mixed materials [A0000000075850]" type="box">7</container><container id="c7da7092fed28efbcbe710cec67c8f37" parent="f4cb3159ddca301fba413139b2795b0d" type="folder">18</container></did><accessrestrict id="5726a4d76a933c3152d68d2618f96f58"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="76dcb6a56a7b5f83636afb906304e3de" level="file"><did><unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle><unitdate type="inclusive">1996 July 5</unitdate><container altrender="Record Storage Box (Paige)" id="f85333d628e06d8cb8c78854885b02a0" label="mixed materials [A0000000075850]" type="box">7</container><container id="b40c1966a37bbb3e9fc606b1a7f64106" parent="f85333d628e06d8cb8c78854885b02a0" type="folder">19</container></did><accessrestrict id="c85f0b8357c82829d2a4eb5e651846cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="bcfc06fa9fa8a02872f2c29e1146f46b" level="file"><did><unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle><unitdate type="inclusive">1996 July 5</unitdate><container altrender="Record Storage Box (Paige)" id="fe17b4ee8022df53ddfb73a0ea5ccb1e" label="mixed materials [A0000000075851]" type="box">8</container><container id="be8d851589f3e712d64ec22db3e56c86" parent="fe17b4ee8022df53ddfb73a0ea5ccb1e" type="folder">1-4</container></did><accessrestrict id="5afb2bc4dd74607653137719b41bcbd1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="ca2a00af5d69b29922032ebf4abb0fa9" level="file"><did><unittitle>TML, 38-63 - Interferon beta IA for relapsing multiple sclerosis</unittitle><unitdate type="inclusive">1996 July 19</unitdate><container altrender="Record Storage Box (Paige)" id="b36ec8a6b1d8654355715b7dc8e56525" label="mixed materials [A0000000075851]" type="box">8</container><container id="d024cda51e7ee0ebc4b57a5f65a304c0" parent="b36ec8a6b1d8654355715b7dc8e56525" type="folder">5-6</container></did><accessrestrict id="03343319e99b7f0ef24a7fc83ce57bad"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c90350a57c09afa4b1edf8990faf82c4" level="file"><did><unittitle>TML, 38-5 - Intraconazole for onychomycosis</unittitle><unitdate type="inclusive">1996 January 19</unitdate><container altrender="Record Storage Box (Paige)" id="68878b85d8dcb4a121f125b678fdc4ef" label="mixed materials [A0000000075851]" type="box">8</container><container id="df4c71b69d0c40a0488e68244f839339" parent="68878b85d8dcb4a121f125b678fdc4ef" type="folder">7-10</container></did><accessrestrict id="a3ae42f0dfac2f6884835c0dd4cbe74b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="838bd206e5b57f1350c9a04ae42f2583" level="file"><did><unittitle>TML, 38-100 - Latanoprost - A topical prostaglandin for glaucoma</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="b20fcd50a018f24c6448942622d9a1ab" label="mixed materials [A0000000075851]" type="box">8</container><container id="7311257e1e26d5989b7628551727f51f" parent="b20fcd50a018f24c6448942622d9a1ab" type="folder">11-14</container></did><accessrestrict id="2e48e9ac6a735700c373ee378f599caa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="45a205e5a189cb71c6708535b75c4937" level="file"><did><unittitle>TML, 38-97 - Lispro - A rapid onset insulin</unittitle><unitdate type="inclusive">1996 October 25</unitdate><container altrender="Record Storage Box (Paige)" id="a3bf1d63e7c052a54b3e01974e06e4c4" label="mixed materials [A0000000075851]" type="box">8</container><container id="f3a375b53dc1b48ba5e424cf1787e4a2" parent="a3bf1d63e7c052a54b3e01974e06e4c4" type="folder">15-16</container></did><accessrestrict id="0c7d5401af543b0c0983defbe212a6e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="2cbe2967f283fa20d7d713e0125238d8" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="185d1d59fd66317923e244ad52458830" label="mixed materials [A0000000075851]" type="box">8</container><container id="07bc6364c965a63e1e9470d872606b89" parent="185d1d59fd66317923e244ad52458830" type="folder">17-18</container></did><accessrestrict id="25976cdf1f32d7fc8a1e78cb2f48d34d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="f7093bc2141bbd10998f3dc5ff41875b" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="ea184d3496207131663b43b8515a4f2f" label="mixed materials [A0000000075852]" type="box">9</container><container id="44d4de64d9672c1918844b2125a6db92" parent="ea184d3496207131663b43b8515a4f2f" type="folder">1-3</container></did><accessrestrict id="5de98fca91cbe16591ff580840223c8c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e7f67d0b2048a576bdc2a8c6ef1f5674" level="file"><did><unittitle>TML, 38-13 - Nisoldipine - a new calcium-channel blocker for hypertension</unittitle><unitdate type="inclusive">1996 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="4ff7b68c25b00647639b53e63c90e5c7" label="mixed materials [A0000000075852]" type="box">9</container><container id="c5705a6f8622993cb569770607770bf7" parent="4ff7b68c25b00647639b53e63c90e5c7" type="folder">4-7</container></did><accessrestrict id="310f0f0a8b17bda4d5be0d11e8e3909a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="0ab086d0742f0a6f31a054d358cbefcf" level="file"><did><unittitle>TML, 35-62 - Nedocromil for asthma</unittitle><unitdate type="inclusive">1993 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="e6d997f8ca57825b5fb14c48f29f2bb5" label="mixed materials [A0000000075852]" type="box">9</container><container id="a9a0c473538d83bd0d9f4c06c887ac56" parent="e6d997f8ca57825b5fb14c48f29f2bb5" type="folder">8-12</container></did><accessrestrict id="d876b6e0e035d2d97ee9711f878a831c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9f3042b173404cf6a3ccd9df900d20c0" level="file"><did><unittitle>TML, 38-1 - New drugs for osteoporosis</unittitle><unitdate type="inclusive">1996 January 5</unitdate><container altrender="Record Storage Box (Paige)" id="9aab6dddd4cb658d4dff4893cc798725" label="mixed materials [A0000000075852]" type="box">9</container><container id="9887a36c498248b3ce715a337e111e61" parent="9aab6dddd4cb658d4dff4893cc798725" type="folder">13-18</container></did><accessrestrict id="059f4c0e348f3f79f9eac8942a1b7673"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e20404fc9c2c5857d90b819cb9c70cc0" level="file"><did><unittitle>TML, 38-53 - Prostatron</unittitle><unitdate type="inclusive">1996 June 7</unitdate><container altrender="Record Storage Box (Paige)" id="8ef6d24d4504482c99a7a88e7ea584c3" label="mixed materials [A0000000075852]" type="box">9</container><container id="e3f99a9287ca2a6bfcd8b2213f46908b" parent="8ef6d24d4504482c99a7a88e7ea584c3" type="folder">19-20</container></did><accessrestrict id="fa8555c81ed0ff184e52c7e939db327c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="cbfa8d04b93b4e3d89a843bbf9e3d7f8" level="file"><did><unittitle>TML, 38-107 - Pallidotomy for Parkinson's Disease</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="9629634a7cbff87e02150cc17c04fccc" label="mixed materials [A0000000075853]" type="box">10</container><container id="de52ba2664655f9f5e6e0d80a307cde0" parent="9629634a7cbff87e02150cc17c04fccc" type="folder">1-3</container></did><accessrestrict id="6ec525e7fd9b38dcd1bce23ad46d101c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c1416d4fc58c7899cbc27ca73d15c172" level="file"><did><unittitle>TML, 38-57 - Simethicone for gastrointestinal gas</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="abbc5612325fbe86446cbc1645e6514d" label="mixed materials [A0000000075853]" type="box">10</container><container id="d84f35f85b96fa118650d6f50acbd43a" parent="abbc5612325fbe86446cbc1645e6514d" type="folder">4-5</container></did><accessrestrict id="76d78aedee8d1ddf219a07affe27bb10"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="26af25957e59124a08f91eba499fc700" level="file"><did><unittitle>TML, 38-106 - Sodium Phenylbutyrate for urea cycle enzyme deficiencies</unittitle><unitdate type="inclusive">1996 November 22</unitdate><container altrender="Record Storage Box (Paige)" id="18fa19c3d846ac67540466eac14e5f71" label="mixed materials [A0000000075853]" type="box">10</container><container id="fdbc82b7a3af84bfa12ea2b11bd052d1" parent="18fa19c3d846ac67540466eac14e5f71" type="folder">6-7</container></did><accessrestrict id="8f55e867e223cf7fc8c205180e5bb1b9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="4273a72d699f99aeabfcab12d5bde513" level="file"><did><unittitle>TML, 38-72 - Terabinafine for onychomycosis</unittitle><unitdate type="inclusive">1996 August 16</unitdate><container altrender="Record Storage Box (Paige)" id="4f660bf84389de328c4cc7cb8d9dd351" label="mixed materials [A0000000075853]" type="box">10</container><container id="52a5183c364465fb8faad89567adf682" parent="4f660bf84389de328c4cc7cb8d9dd351" type="folder">8-11</container></did><accessrestrict id="f99d89a3af0b743be45c7d543c9a47b3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="afa8fcead3849c57e46148fac07fdf16" level="file"><did><unittitle>TML, 38-49 - Androderm (Testosterone patches)</unittitle><unitdate type="inclusive">1996 May 24</unitdate><container altrender="Record Storage Box (Paige)" id="065cad8f702c6b51cc765d872d692739" label="mixed materials [A0000000075853]" type="box">10</container><container id="8bf17d353f41df90752fc714808b3f03" parent="065cad8f702c6b51cc765d872d692739" type="folder">12-15</container></did><accessrestrict id="6c9daad633f6ca6f23f9cb9675ec5725"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e83fc33c009862fb85873ce44225451e" level="file"><did><unittitle>TML, 38-96 - Toptecan hydrochloride for metastic ovarian cancer</unittitle><unitdate type="inclusive">1996 October 25</unitdate><container altrender="Record Storage Box (Paige)" id="982cb0d1bec6489a8de32a84fdb0a20e" label="mixed materials [A0000000075853]" type="box">10</container><container id="25319d49e87dd6b9bbee32af884839ba" parent="982cb0d1bec6489a8de32a84fdb0a20e" type="folder">16-18</container></did><accessrestrict id="f4f4ca0b76dee28258679841660c3e53"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="1d1e2499f47a2c5a2498c508251c060e" level="file"><did><unittitle>TML, 38-3 - Valacyclovir</unittitle><unitdate type="inclusive">1996 January 5</unitdate><container altrender="Record Storage Box (Paige)" id="5f2ff3b880009a2227ccbe40a2706565" label="mixed materials [A0000000075853]" type="box">10</container><container id="0af4c3c5e6de8dc889aa049f2e3629c5" parent="5f2ff3b880009a2227ccbe40a2706565" type="folder">19</container></did><accessrestrict id="5e026f0f926c42121383574e48a743ca"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e3cd99c272218799e02c72a5e28f33c9" level="file"><did><unittitle>TML, 38-3 - Valacyclovir</unittitle><unitdate type="inclusive">1996 January 5</unitdate><container altrender="Record Storage Box (Paige)" id="95ff009ee050a6b364556529111a7a9e" label="mixed materials [A0000000075946]" type="box">11</container><container id="354f652497a6010e7bd64b414547ac17" parent="95ff009ee050a6b364556529111a7a9e" type="folder">1-2</container></did><accessrestrict id="ed67782a99870c0e712a42cf95c5cfc7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="2146f075bfb01adf0c99fddbe6268b26" level="file"><did><unittitle>TML, 38-104 - Trandolapril - An ACE inhibitor for treatment of hypertension</unittitle><unitdate type="inclusive">1996 November 22</unitdate><container altrender="Record Storage Box (Paige)" id="5a2a788cc8bc96b7e2cb479375440272" label="mixed materials [A0000000075946]" type="box">11</container><container id="dad1a31290a5ee91ebea402c4eb7e9ca" parent="5a2a788cc8bc96b7e2cb479375440272" type="folder">3-5</container></did><accessrestrict id="a1dd4aa7256167e609397b035b7478d7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="7a2f268994b16b4876604d64167ade0b" level="file"><did><unittitle>TML, 38-71 - Umbilical cord blood for bone marrow transplantation</unittitle><unitdate type="inclusive">1996 August 16</unitdate><container altrender="Record Storage Box (Paige)" id="ed790e8024973339cdbd248955f33d4d" label="mixed materials [A0000000075946]" type="box">11</container><container id="58058daaeb37659ba897c6e8495cfa86" parent="ed790e8024973339cdbd248955f33d4d" type="folder">6-8</container></did><accessrestrict id="c284795ebfbae6dd142f49e2c3d64449"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c7fa6ad1765f84becedf7fbe8dae1981" level="file"><did><unittitle>TML, 38-51 - Clarithromycine and omeprazole of helliobacter pylori</unittitle><unitdate type="inclusive">1996 June 7</unitdate><container altrender="Record Storage Box (Paige)" id="222d08d436257646b8992dc446a2eb8c" label="mixed materials [A0000000075946]" type="box">11</container><container id="6da984a0d45da26783e2c2711f6ecefa" parent="222d08d436257646b8992dc446a2eb8c" type="folder">9-11</container></did><accessrestrict id="d93e4e485f03621de43519409ecd0ebb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="d2847f832cf8b7dfa8bae10d4079561b" level="file"><did><unittitle>TML, 38-15 - New Uses of Thalidomide</unittitle><unitdate type="inclusive">1996 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="90d04b924c2cad3a8d8191c3084b4ac3" label="mixed materials [A0000000075946]" type="box">11</container><container id="2ada3d2f2a97fb590425a6520b960ef5" parent="90d04b924c2cad3a8d8191c3084b4ac3" type="folder">12-14</container></did><accessrestrict id="5a934c0b2b5e5cf25f836a73de95c999"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="07f911d357717fedb196ba2a95b08c6f" level="file"><did><unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="717a89ec5e9b363572db54991f742fee" label="mixed materials [A0000000075946]" type="box">11</container><container id="876eb01abf09ec4713823694593aca36" parent="717a89ec5e9b363572db54991f742fee" type="folder">15-19</container></did><accessrestrict id="7ad69902cf7b5b84adb8b1470b88ef97"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c0d2ae8c9a59eb2afc81bad688a8e0d9" level="file"><did><unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="5a7a259958424f3414b2432316034623" label="mixed materials [A0000000075854]" type="box">12</container><container id="ff9077931bd0b6d28e71c756a9158de3" parent="5a7a259958424f3414b2432316034623" type="folder">1-2</container></did><accessrestrict id="42570c5418d18c7d11e5ecb6d56fc38d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="0d91fc0adca0e054072c6a3fff1ac1f6" level="file"><did><unittitle>TML, 38-65 - Drugs past their expiration date</unittitle><unitdate type="inclusive">1996 July 19</unitdate><container altrender="Record Storage Box (Paige)" id="73a3209d12aad02e9a3e72f1a5dd80cf" label="mixed materials [A0000000075854]" type="box">12</container><container id="ec285ec4158c578e32a035e42e6cecec" parent="73a3209d12aad02e9a3e72f1a5dd80cf" type="folder">3-4</container></did><accessrestrict id="861175c1c60e1d08ff94909fca12e380"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="b6e8488842fc6d3ed56539b8c5e7c344" level="file"><did><unittitle>TML, 38-38 - Ibutilide</unittitle><unitdate type="inclusive">1996 April 12</unitdate><container altrender="Record Storage Box (Paige)" id="24404f3a8abdd14a0c99d012509dc868" label="mixed materials [A0000000075854]" type="box">12</container><container id="9408a29728d5f45b5df1a8931f998b1d" parent="24404f3a8abdd14a0c99d012509dc868" type="folder">5-6</container></did><accessrestrict id="d854aa1bc446941f011a8970567a2b37"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="93c5ceb8486269a6440d4a1164bd8a19" level="file"><did><unittitle>TML, 38-91 - DHEA</unittitle><unitdate type="inclusive">1996 October 11</unitdate><container altrender="Record Storage Box (Paige)" id="16d17ad5836d75a2b8e49c9b251dfd84" label="mixed materials [A0000000075854]" type="box">12</container><container id="4a791159888700cbd360ec3a3f70992e" parent="16d17ad5836d75a2b8e49c9b251dfd84" type="folder">7-9</container></did><accessrestrict id="0b753cb331038a0a1193ae254361f43e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="489aaa51c24f7c3822366d6381860b83" level="file"><did><unittitle>TML, 38-88 - Meropenem - A new parenteral broad-spectrum antibiotic</unittitle><unitdate type="inclusive">1996 September 27</unitdate><container altrender="Record Storage Box (Paige)" id="cfb9640a035e9c3e5330ed1283cf9474" label="mixed materials [A0000000075854]" type="box">12</container><container id="f7acc2e5fdb971565e4b559ff46cc46f" parent="cfb9640a035e9c3e5330ed1283cf9474" type="folder">10-14</container></did><accessrestrict id="06a4c2f05bc64d8b4ee6a3b07e593fe9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="3a54f51aec4a83bee985f1670be2aff6" level="file"><did><unittitle>TML, 38-39 - Methotrexate and Misoprostol for abortion</unittitle><unitdate type="inclusive">1996 April 26</unitdate><container altrender="Record Storage Box (Paige)" id="d5d1765822c21c0bba65c0674d214b84" label="mixed materials [A0000000075854]" type="box">12</container><container id="83ebf0a8ddba3b5e3085741870331d2d" parent="d5d1765822c21c0bba65c0674d214b84" type="folder">15</container></did><accessrestrict id="6b3edef9531f4a2fde2d3628c5d7cdd0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="43193a32312eb0204d12fd64fa6b6993" level="file"><did><unittitle>TML, 38-111 - Zafirlukast for asthma</unittitle><unitdate type="inclusive">1996 December 20</unitdate><container altrender="Record Storage Box (Paige)" id="501d5139ca71a401f5a522b9c54e5bed" label="mixed materials [A0000000075854]" type="box">12</container><container id="c1a369393c4795572a3db6c59911b675" parent="501d5139ca71a401f5a522b9c54e5bed" type="folder">16-18</container></did><accessrestrict id="13e892949bbc4a48ce8c4285b3b1007e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="49b7007dcadc3c636c88f299dc526e0d" level="file"><did><unittitle>TML, 31-83 - Samarium 153 lexidronam for painful bone metastases</unittitle><unitdate type="inclusive">1997 August 29</unitdate><container altrender="Record Storage Box (Paige)" id="87002b78c2d3d56c535c8a080a0b0614" label="mixed materials [A0000000075855]" type="box">13</container><container id="a5130d80192a43df59c534f11ebcbc80" parent="87002b78c2d3d56c535c8a080a0b0614" type="folder">1-3</container></did><accessrestrict id="592e1bece31e2f3f6b5ae1b6e1a8011e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="61b0c640e3f013a34c64133724020fa2" level="file"><did><unittitle>TML, 38-69 - Drugs for non-HIV viral infections</unittitle><unitdate type="inclusive">1997 August 1</unitdate><container altrender="Record Storage Box (Paige)" id="9c1996c5e0e488c83d1ef472fece5980" label="mixed materials [A0000000075855]" type="box">13</container><container id="3cfa18732ffb96ccaeb813f5f7615e39" parent="9c1996c5e0e488c83d1ef472fece5980" type="folder">4-12</container></did><accessrestrict id="84c4988675afd57f7b095139aa7bfdfe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="133977107f40fa3272c401b7abcc89de" level="file"><did><unittitle>TML, 39-18 - Zileuton for asthma</unittitle><unitdate type="inclusive">1997 February 28</unitdate><container altrender="Record Storage Box (Paige)" id="aa51868ecfd27f20b578cec6ae93a8eb" label="mixed materials [A0000000075855]" type="box">13</container><container id="042aa7b97d259122b2378e702ca3ae7e" parent="aa51868ecfd27f20b578cec6ae93a8eb" type="folder">13-14</container></did><accessrestrict id="4717fa288dd120e806e05499350ddf6f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="be46a606b805462c6cc03b6ec8b2c39e" level="file"><did><unittitle>TML, 39-9 - Zinc for the common cold</unittitle><unitdate type="inclusive">1997 January 31</unitdate><container altrender="Record Storage Box (Paige)" id="c35c07be0c29d3ce187cac9f744c7002" label="mixed materials [A0000000075855]" type="box">13</container><container id="4134be757d0c24bee8c341457d4b7919" parent="c35c07be0c29d3ce187cac9f744c7002" type="folder">15-17</container></did><accessrestrict id="ad1088be46d6652eb0405e32258a0bf9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="1a7499e6fbd604c0b75b6d778dc5c0f9" level="file"><did><unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="40989a0d23d857458569a802e4aa1708" label="mixed materials [A0000000075855]" type="box">13</container><container id="76d78a897fb8e62823a07d815897c263" parent="40989a0d23d857458569a802e4aa1708" type="folder">18-20</container></did><accessrestrict id="ebe0ac100a42ac94570bd02c0e0ccdbb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="c3fee2e8cf6e2d58695098807e086dab" level="file"><did><unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="a2fef3de21589b6dc04474b8d0f3207d" label="mixed materials [A0000000075856]" type="box">14</container><container id="6157e73b9aa2323906545f3d4b3ee005" parent="a2fef3de21589b6dc04474b8d0f3207d" type="folder">1</container></did><accessrestrict id="898d939f278bc6e6c335eb092f07c5a8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="393de6e6b75d4f4817695af30349dd68" level="file"><did><unittitle>TML, 39-80 - Ropivocaine - a new local anesthetic</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="7c823c5ca9c233181725ef17dab27105" label="mixed materials [A0000000075856]" type="box">14</container><container id="0259267093a8aaacb20a802039949c0d" parent="7c823c5ca9c233181725ef17dab27105" type="folder">2-4</container></did><accessrestrict id="7af0a96e2cfe06eaffa6999f5bfd2c77"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="4be741eb1bacb7f18527f5b2df647302" level="file"><did><unittitle>TML, 39-41 - Levofloxacin and sparfloxacin</unittitle><unitdate type="inclusive">1997 April 25</unitdate><container altrender="Record Storage Box (Paige)" id="dbca9ad9aadf0f78ac9dca0cbf3d61ec" label="mixed materials [A0000000075856]" type="box">14</container><container id="d205965cdd689e729b0494cfe7e67870" parent="dbca9ad9aadf0f78ac9dca0cbf3d61ec" type="folder">5-10</container></did><accessrestrict id="7550d2d00d3b056285daa384c568544b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b81fc7aadd5fecc407e846095655da0e" level="file"><did><unittitle>TML, 39-10 - Lasers in dermatologic surgery</unittitle><unitdate type="inclusive">1997 January 31</unitdate><container altrender="Record Storage Box (Paige)" id="5289108eb0b095de7e92b7dc6ada13e7" label="mixed materials [A0000000075856]" type="box">14</container><container id="97acff4acba41f2a87933a55f627db0f" parent="5289108eb0b095de7e92b7dc6ada13e7" type="folder">11-15</container></did><accessrestrict id="0f1f31dc544a7820b6b3740572840e2c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="d6a872b6263ad2beca76d2809d741c78" level="file"><did><unittitle>TML, 39-84 - Skin surgery with lasers - an additional note</unittitle><unitdate type="inclusive">1997 August 29</unitdate><container altrender="Record Storage Box (Paige)" id="cc81b5b69a5583b13b2c154f384653fa" label="mixed materials [A0000000075856]" type="box">14</container><container id="617004af2d23551801df4bee5037e4b5" parent="cc81b5b69a5583b13b2c154f384653fa" type="folder">16</container></did><accessrestrict id="37b13c54d0d04ba5299304f96256cfc0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="62572ae54e7b47c32783a5b7f9f92261" level="file"><did><unittitle>TML, 39-51 - Topiramate for epilepsy</unittitle><unitdate type="inclusive">1997 May 23</unitdate><container altrender="Record Storage Box (Paige)" id="f0db9fdec4f26e940378c446bf2e6a90" label="mixed materials [A0000000075856]" type="box">14</container><container id="0d5a0871e6a8b5c343398b8c93a7e24f" parent="f0db9fdec4f26e940378c446bf2e6a90" type="folder">17-19</container></did><accessrestrict id="1f453b72cb65c772c8bbcb8b965fc251"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="bbfc9de7adb6df0701f6173947f38bd2" level="file"><did><unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="a788d3f8873ca3d51d245e55d334aa27" label="mixed materials [A0000000075856]" type="box">14</container><container id="6cd899a61e89c1ab22ce3cd2831617c8" parent="a788d3f8873ca3d51d245e55d334aa27" type="folder">20</container></did><accessrestrict id="63c006cdd8a94fd253916b0a5c2fcbfc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6b378b12b2f16c81d85d36343d81a41b" level="file"><did><unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="c7ff952640763f9b62d7f098da31834c" label="mixed materials [A0000000075857]" type="box">15</container><container id="81d08feffd6981c95a3a7b21765dac8a" parent="c7ff952640763f9b62d7f098da31834c" type="folder">1-2</container></did><accessrestrict id="62290c3388efd25a1b03329c60a4c2c5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="bf256a51de793456a4c7d083f141288c" level="file"><did><unittitle>TML, 39-65 - Tiludronate for Paget's disease of bone</unittitle><unitdate type="inclusive">1997 July 18</unitdate><container altrender="Record Storage Box (Paige)" id="68520807b6541e13be0f51a9cea3957c" label="mixed materials [A0000000075857]" type="box">15</container><container id="f70f9c0ff6dd9e08bf267b9c3bff830d" parent="68520807b6541e13be0f51a9cea3957c" type="folder">3-5</container></did><accessrestrict id="a0af36cf2f0f39c3b6bf43a2f3d1a8f3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="e50c791d98c44790d8141d27cd4cfcab" level="file"><did><unittitle>TML, 39-62 - Tizanidine for spasticity</unittitle><unitdate type="inclusive">1997 July 4</unitdate><container altrender="Record Storage Box (Paige)" id="ae14185f0d753e3095fc96c63c2210a6" label="mixed materials [A0000000075857]" type="box">15</container><container id="27369f102c44a86cf9602be8567116f3" parent="ae14185f0d753e3095fc96c63c2210a6" type="folder">6-8</container></did><accessrestrict id="264d6479c0b4544b7007e8c452a7cee5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="12444cf584e83734f66bfc290040544a" level="file"><did><unittitle>TML, 39-49 - Troglitazone for non-insulin-dependent diabetes mellitus</unittitle><unitdate type="inclusive">1997 May 23</unitdate><container altrender="Record Storage Box (Paige)" id="b9b9128c6813073c6a7b44c34c85e7c5" label="mixed materials [A0000000075857]" type="box">15</container><container id="46a758986aec81607a7268bc836ee465" parent="b9b9128c6813073c6a7b44c34c85e7c5" type="folder">9-11</container></did><accessrestrict id="c2dbaf70c1400524b9601ade32d9aa09"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="64f0edfa5bd3b5159911a74e751d912b" level="file"><did><unittitle>TML, 39-43 - Valsartan for hypertension</unittitle><unitdate type="inclusive">1997 April 25</unitdate><container altrender="Record Storage Box (Paige)" id="75267cf2abd818e580cd361c4519e966" label="mixed materials [A0000000075857]" type="box">15</container><container id="2a752557eb160546b44639b1b8a13a68" parent="75267cf2abd818e580cd361c4519e966" type="folder">12-14</container></did><accessrestrict id="d5a76faf4ca30d9de5137cfcad807f6e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="eb014687998353d0fb60326357526127" level="file"><did><unittitle>TML, 39-1 - Drugs for treatment of peptic ulcers</unittitle><unitdate type="inclusive">1997 January 3</unitdate><container altrender="Record Storage Box (Paige)" id="1ca52e62b0292f1d63c3fd03a5cc090d" label="mixed materials [A0000000075857]" type="box">15</container><container id="6e0971d4731e801e48c4183030ef38c3" parent="1ca52e62b0292f1d63c3fd03a5cc090d" type="folder">15-20</container></did><accessrestrict id="1fcec8ea591c0f4b6123d11e89e69ddb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="3436a17eac9c6f31692eb5d354b51a44" level="file"><did><unittitle>TML, 39-109 - Pramipexole and Ropinirole for Parkinson's disease</unittitle><unitdate type="inclusive">1997 November 21</unitdate><container altrender="Record Storage Box (Paige)" id="394595be7f9a95e7d3285f34f4c0541d" label="mixed materials [A0000000075858]" type="box">16</container><container id="31c78488db30176ce877214c9c16791d" parent="394595be7f9a95e7d3285f34f4c0541d" type="folder">1-4</container></did><accessrestrict id="9f23fe9c137d23133c2b5049c5b64530"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="ea94f0229ffb76d4e8a48dbf172eec36" level="file"><did><unittitle>TML, 39-105 - New drugs for psoriasis</unittitle><unitdate type="inclusive">1997 November 7</unitdate><container altrender="Record Storage Box (Paige)" id="a00be80dee3930477eff6f0a3453591f" label="mixed materials [A0000000075858]" type="box">16</container><container id="188a1f3b20636fa84f30a226e3b0d59e" parent="a00be80dee3930477eff6f0a3453591f" type="folder">5-8</container></did><accessrestrict id="d1471d567708b0ca9a5c6d93f5f254f0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="12f50952f7ba8eb3afd7e492d332b4a1" level="file"><did><unittitle>TML, 39-33 - New drugs for psychiatric disorders</unittitle><unitdate type="inclusive">1997 April 11</unitdate><container altrender="Record Storage Box (Paige)" id="3b279b06384a59f2362af2b87bba0612" label="mixed materials [A0000000075858]" type="box">16</container><container id="7cc5f3d4e1e38d6b4e570801e1cf3270" parent="3b279b06384a59f2362af2b87bba0612" type="folder">9-15</container></did><accessrestrict id="dbaf4673299ed575f189876448054a58"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="123a71748e8ade20af228276bab2d8b6" level="file"><did><unittitle>TML, 39-117 - Quetiapine for schizophrenia</unittitle><unitdate type="inclusive">1997 December 19</unitdate><container altrender="Record Storage Box (Paige)" id="b8e23653776d5cb4d0943d3075d3b58b" label="mixed materials [A0000000075858]" type="box">16</container><container id="b46e05ba0e8d1821d7c4464004f66dad" parent="b8e23653776d5cb4d0943d3075d3b58b" type="folder">16-18</container></did><accessrestrict id="8bbc739b2ed931419befe4ab8eb4eb63"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="498df0f2d9dce92679b2aa347629be3f" level="file"><did><unittitle>TML, 39-17 - Reteplase (Retavase)</unittitle><unitdate type="inclusive">1997 February 28</unitdate><container altrender="Record Storage Box (Paige)" id="74883b9c66bf57e0a756002886078685" label="mixed materials [A0000000075859]" type="box">17</container><container id="cf4a153eab13d187c8c965f1592decdc" parent="74883b9c66bf57e0a756002886078685" type="folder">1-2</container></did><accessrestrict id="b2dca34162d6868414a816046edfdff2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6ba7d8b0dcb752d130b074f42b440dd7" level="file"><did><unittitle>TML, 39-53 - Donepezil (Aricept) for Alzheimer's disease</unittitle><unitdate type="inclusive">1997 June 6</unitdate><container altrender="Record Storage Box (Paige)" id="18c4c7a63f3fa6df0defa5b2fff90b5c" label="mixed materials [A0000000075859]" type="box">17</container><container id="ca2985ec8f591d38c538fe21701f8850" parent="18c4c7a63f3fa6df0defa5b2fff90b5c" type="folder">3-5</container></did><accessrestrict id="6532d645696e8a65297e0563e103f695"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="7c2e04e9e7b332289a442e6977a1f7d9" level="file"><did><unittitle>TML, 39-81 - Diagnostic tests for HIV</unittitle><unitdate type="inclusive">1997 August 29</unitdate><container altrender="Record Storage Box (Paige)" id="bf695fe1f674d66ec7cd92a8223fdb54" label="mixed materials [A0000000075859]" type="box">17</container><container id="fb0f85180448de4bfe73fb5c6118f4b9" parent="bf695fe1f674d66ec7cd92a8223fdb54" type="folder">6-10</container></did><accessrestrict id="9570ef3f38bf3a851322c3c3fb7d17cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fdd2b028e08760f46ba2467c4b638924" level="file"><did><unittitle>TML, 39-21 - Drugs of Choice - Cancer Chemotherapy</unittitle><unitdate type="inclusive">1997 March 14</unitdate><container altrender="Record Storage Box (Paige)" id="e4f704298a783f88c910bb7a9eeda753" label="mixed materials [A0000000075859]" type="box">17</container><container id="071afa4c9e25412e14ab076a229b25f8" parent="e4f704298a783f88c910bb7a9eeda753" type="folder">11-16</container></did><accessrestrict id="28f03f207bd6c378f505103883232f68"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="42935bf2b5b11b084838a1252d3b3db8" level="file"><did><unittitle>TML, 39-77 - Bupropion for smoking cessation</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="dbe65ac39043be7108996ee79bce7079" label="mixed materials [A0000000075859]" type="box">17</container><container id="6a7413c0c230d55a525339554cdcae88" parent="dbe65ac39043be7108996ee79bce7079" type="folder">17</container></did><accessrestrict id="6c0f62c3539d7b57d8122eb2501ba830"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="be3b6c8f67d8d9c4ef7e3226b17983fb" level="file"><did><unittitle>TML, 39-63 - Topical butenafine for tinea pedis</unittitle><unitdate type="inclusive">1997 July 4</unitdate><container altrender="Record Storage Box (Paige)" id="6cb19c1bceacc893daeb1394f0d8f187" label="mixed materials [A0000000075860]" type="box">18</container><container id="6a022e720623e71ca224f94f2c5061e3" parent="6cb19c1bceacc893daeb1394f0d8f187" type="folder">1-2</container></did><accessrestrict id="5cc6b055d5b6e621ab0c71131fdd66e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="856acb144bbba7a94b1cb63f73185f43" level="file"><did><unittitle>TML, 39-56 - Pentosan</unittitle><unitdate type="inclusive">1997 June 6</unitdate><container altrender="Record Storage Box (Paige)" id="b19060ea936e9eb78bb5efe3e5307c6c" label="mixed materials [A0000000075860]" type="box">18</container><container id="985cf7ab7b6cc6fa3b13f1ca79a488d1" parent="b19060ea936e9eb78bb5efe3e5307c6c" type="folder">3-4</container></did><accessrestrict id="9279dfdd8fa0fb9cdb6e31006d0ff6a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="afd34d20934d1be77bfc49f4d1241183" level="file"><did><unittitle>TML, 39-103 - Mibefradil - a new calcium-channel blocker</unittitle><unitdate type="inclusive">1997 November 7</unitdate><container altrender="Record Storage Box (Paige)" id="cdbb853e3c80c25ba6b3074b0bfbfb33" label="mixed materials [A0000000075860]" type="box">18</container><container id="6b97716ead5272ccae6bdb093971616f" parent="cdbb853e3c80c25ba6b3074b0bfbfb33" type="folder">5-8</container></did><accessrestrict id="bc77a13d4a14fc45f23bfb7a5bb57c5d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="de42e2f43ebae331da9c0b8180abb87c" level="file"><did><unittitle>TML, 39-59 - Midodrine for orthostatic hypotension</unittitle><unitdate type="inclusive">1997 June 20</unitdate><container altrender="Record Storage Box (Paige)" id="51de7f9a0ed7c566409120edd907ee17" label="mixed materials [A0000000075860]" type="box">18</container><container id="ac2368c7d8e8dffcf5d33fb0d76e8e15" parent="51de7f9a0ed7c566409120edd907ee17" type="folder">9-11</container></did><accessrestrict id="01d73c68e8dd39b1c0b73b6d7700c7a0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="96ceef3812b648bc28698beed66c5d75" level="file"><did><unittitle>TML, 39-47 - Treatment of Lyme disease</unittitle><unitdate type="inclusive">1997 May 9</unitdate><container altrender="Record Storage Box (Paige)" id="c597f4a69beb76bf5e6a1896ef5fcc51" label="mixed materials [A0000000075860]" type="box">18</container><container id="d15fa6680fd217fc3eebb8e281492cb4" parent="c597f4a69beb76bf5e6a1896ef5fcc51" type="folder">12-14</container></did><accessrestrict id="1456685e80bfcccf0ad9c93511c65c4d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="eaedccce6a322747a43e566f8dfc2b7d" level="file"><did><unittitle>TML - Drugs of Choice</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="95c3a0769e623da3b2994d6eba390030" label="mixed materials [A0000000075860]" type="box">18</container><container id="947c839d9864b09ad1c1324869f62fdb" parent="95c3a0769e623da3b2994d6eba390030" type="folder">15-17</container></did><accessrestrict id="640807ffbd5e5ea720da4f60f781a4b9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="95b6682482a9d062317fcf262cc7f718" level="file"><did><unittitle>TML, 39-85 - Influenza vaccine</unittitle><unitdate type="inclusive">1997 September 12</unitdate><container altrender="Record Storage Box (Paige)" id="3ae5ec92beea1917ae51c2e82760f2af" label="mixed materials [A0000000075860]" type="box">18</container><container id="ccc92a23af65ac87f29a70ccb28f3cca" parent="3ae5ec92beea1917ae51c2e82760f2af" type="folder">18</container></did><accessrestrict id="bae55e07ca01b84992a5b395e88b6ccc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="9c5534af6d0a227ae1ad47876c813383" level="file"><did><unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="2fee167f9974352862950537613a0a8b" label="mixed materials [A0000000075860]" type="box">18</container><container id="d4ff8963bc20b9add8e9ff794651c103" parent="2fee167f9974352862950537613a0a8b" type="folder">19</container></did><accessrestrict id="071f86249d57b3a639f1f0ac1e82c1db"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="8d02c5507ec798ca4d7bb6188acc62a5" level="file"><did><unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="f133d92cd1816fd89266ba320311e1e3" label="mixed materials [A0000000075861]" type="box">19</container><container id="12a34daab49035bbfe079c269405e826" parent="f133d92cd1816fd89266ba320311e1e3" type="folder">1</container></did><accessrestrict id="36454ffdeab70b1b39646403fa3b2960"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="0cdb2a091afd3228142c89eb37d2380a" level="file"><did><unittitle>TML, 39-118 - Imiquimod for genital warts</unittitle><unitdate type="inclusive">1997 December 19</unitdate><container altrender="Record Storage Box (Paige)" id="a1ed2120fa2b7fb5e5ee4ed7eb0a0500" label="mixed materials [A0000000075861]" type="box">19</container><container id="b7e31e94ebc2b15dc9db9a707e16f6e5" parent="a1ed2120fa2b7fb5e5ee4ed7eb0a0500" type="folder">2-3</container></did><accessrestrict id="d975c63ad23263fd275260f9460dcf1e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="f4d2ffb826a588ff6c493adbd06a92be" level="file"><did><unittitle>TML, 39-64 - Drugs for epilepsy</unittitle><unitdate type="inclusive">1997 February 6</unitdate><container altrender="Record Storage Box (Paige)" id="caf252ca0b61ea75e3992243c4f4cb67" label="mixed materials [A0000000075861]" type="box">19</container><container id="c35e0d132f625f579cda1fe149cd06c5" parent="caf252ca0b61ea75e3992243c4f4cb67" type="folder">4-6</container></did><accessrestrict id="c20b70cbd97aa855e62537fb259a09f6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="028b89ba84e332c879eab9899c191875" level="file"><did><unittitle>TML, 39-66 - Fosfomycin for urinary tract infections</unittitle><unitdate type="inclusive">1997 July 18</unitdate><container altrender="Record Storage Box (Paige)" id="7534fff78a004c84ed0282afa283e24c" label="mixed materials [A0000000075861]" type="box">19</container><container id="3fefaa322775b105ab4bad485e6b0976" parent="7534fff78a004c84ed0282afa283e24c" type="folder">7-9</container></did><accessrestrict id="e0aa9d9341298313dcd22b6a4157d3bc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="73ee7f93d0af26d64d0c1fc7ba0c7201" level="file"><did><unittitle>TML, 39-86 - Systemic antifungal drugs</unittitle><unitdate type="inclusive">1997 September 12</unitdate><container altrender="Record Storage Box (Paige)" id="f6effd52bb2e74c53cd1f9aceb940e7c" label="mixed materials [A0000000075861]" type="box">19</container><container id="7324c4bf64c44de844df8ea6fccca671" parent="f6effd52bb2e74c53cd1f9aceb940e7c" type="folder">10-13</container></did><accessrestrict id="226ecab6ab43654c9c5dd63a5e3e2b52"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6bf77dfe11efd36cf8146b826560cb4c" level="file"><did><unittitle>TML, 39-61 - Glatiramer acetate for relapsing mutiple sclerosis</unittitle><unitdate type="inclusive">1997 July 4</unitdate><container altrender="Record Storage Box (Paige)" id="237efa003172263137c3f0bccfb830d6" label="mixed materials [A0000000075861]" type="box">19</container><container id="8f5a41108fb1ca352df862166758d6c3" parent="237efa003172263137c3f0bccfb830d6" type="folder">14-16</container></did><accessrestrict id="58267fbb42c582dd03ac8830411c1803"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="f36ff800dacbd73013d42dab42cf5f5b" level="file"><did><unittitle>TML, 38-6 - Drugs for head lice</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="47c1f490313c54a395b8aa97f5c1f8af" label="mixed materials [A0000000075861]" type="box">19</container><container id="19d8a3775eefeb638ecb83a0ff70f960" parent="47c1f490313c54a395b8aa97f5c1f8af" type="folder">17-18</container></did><accessrestrict id="92296119b0cbe67e59973a003090f421"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="e13f3fa0ec576057f7033815a81111e1" level="file"><did><unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle><unitdate type="inclusive">1997 September 26</unitdate><container altrender="Record Storage Box (Paige)" id="02643685f02a3bd1def6996e2686291e" label="mixed materials [A0000000075861]" type="box">19</container><container id="6b7231609bd7a5f7b54847abb4dd977e" parent="02643685f02a3bd1def6996e2686291e" type="folder">19-20</container></did><accessrestrict id="e7cb03a6203eb58d2833529692c66d60"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="dfc2de9cdb5bf3a8437e564fa717ffbd" level="file"><did><unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle><unitdate type="inclusive">1997 September 26</unitdate><container altrender="Record Storage Box (Paige)" id="afb6732fc42bee07dc95447744cc9e06" label="mixed materials [A0000000075862]" type="box">20</container><container id="253a32e48af20e8c327e8e63c10872ce" parent="afb6732fc42bee07dc95447744cc9e06" type="folder">1-2</container></did><accessrestrict id="d913972842d3a79acf9b906df7f951e7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="95d8be151e4ef26242db019df375f791" level="file"><did><unittitle>TML, 39-94 - Drugs for hypertension</unittitle><unitdate type="inclusive">1997 November 1</unitdate><container altrender="Record Storage Box (Paige)" id="dfba9da6bf22d0560378e60b630f933a" label="mixed materials [A0000000075862]" type="box">20</container><container id="191be933b59f97590e377c8ef6edcae2" parent="dfba9da6bf22d0560378e60b630f933a" type="folder">3-5</container></did><accessrestrict id="2db96bdb2ad3f2367bdf1559b5ea1133"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="f8696aa81da52173ff18b97bd7eb4067" level="file"><did><unittitle>TML, 39-19 - Adapalene for acne</unittitle><unitdate type="inclusive">1997 February 28</unitdate><container altrender="Record Storage Box (Paige)" id="904305f2cfb234c9adcbc3097971880a" label="mixed materials [A0000000075862]" type="box">20</container><container id="f27c9cde8e813adfc7fb71585e8c53ed" parent="904305f2cfb234c9adcbc3097971880a" type="folder">6-7</container></did><accessrestrict id="cefd2ab82f2cd38f2cef5b4253fea1fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="d3c8f38c2b75ab98def9cb12e7933ba3" level="file"><did><unittitle>TML, 39-29 - Atorvastatin - a new lipid-lowering drug</unittitle><unitdate type="inclusive">1997 March 28</unitdate><container altrender="Record Storage Box (Paige)" id="63ade926f9a73f82d571a0823f2c3157" label="mixed materials [A0000000075862]" type="box">20</container><container id="c35121f0a3dff976e21578d90a0ab42d" parent="63ade926f9a73f82d571a0823f2c3157" type="folder">8-9</container></did><accessrestrict id="f50e6cdc96d78aa80586f8c46bb4b44f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b2a72d06fe2be2cec8bad5a6a0fda27b" level="file"><did><unittitle>TML, 39-45 - Azelastine nasal spray for allergic rhinitis</unittitle><unitdate type="inclusive">1997 May 9</unitdate><container altrender="Record Storage Box (Paige)" id="81ad18ea387ce23ec96437cdccb671a3" label="mixed materials [A0000000075862]" type="box">20</container><container id="8fc3e63d0775335757080675a4b6625f" parent="81ad18ea387ce23ec96437cdccb671a3" type="folder">10-13</container></did><accessrestrict id="2c8bdc164c637c083bf92b35d52554fc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="36e76c3b20aacff333ba5d98cfca27de" level="file"><did><unittitle>TML, 39-12 - Betaine for homocystinuria</unittitle><unitdate type="inclusive">1997 January 31</unitdate><container altrender="Record Storage Box (Paige)" id="11c5281bb5b8bd4d8df02251985e46ea" label="mixed materials [A0000000075862]" type="box">20</container><container id="f4b9ce61cfe8cd515d6e896d9a989f1a" parent="11c5281bb5b8bd4d8df02251985e46ea" type="folder">14-15</container></did><accessrestrict id="55bd4c86ccf4811f99aac2673693e945"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="e4ca902373c4579a78db0d3b8d513633" level="file"><did><unittitle>TML, 39-93 - Bromfenac for analgesia</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="e960e6e8199c27212418a9abf5165fd0" label="mixed materials [A0000000075862]" type="box">20</container><container id="570fa8b2f7802fc03b5f6286e63c79b7" parent="e960e6e8199c27212418a9abf5165fd0" type="folder">16-17</container></did><accessrestrict id="18bd5ce580d159e1acce03ad34266cc9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="1a9cef87a6b1f62bf27f90e19d47c4e1" level="file"><did><unittitle>TML, 39-54 - Brimonidine - an alpha2-agonist for glaucoma</unittitle><unitdate type="inclusive">1997 June 6</unitdate><container altrender="Record Storage Box (Paige)" id="e037f09ea40a6cb577e981228cecffff" label="mixed materials [A0000000075862]" type="box">20</container><container id="93f98caf23328938ce77ab5b6c26dbbc" parent="e037f09ea40a6cb577e981228cecffff" type="folder">18-19</container></did><accessrestrict id="c12a956b010223394c6ca9d2025942d6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="56fc5093674d1372e80ed218ae8bd368" level="file"><did><unittitle>TML, 39-13 - Safety of channel blockers</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="5c826f751aa25716401863456809a6e9" label="mixed materials [A0000000075862]" type="box">20</container><container id="17495bd213c5130e0bb315683229dd2d" parent="5c826f751aa25716401863456809a6e9" type="folder">20</container></did><accessrestrict id="12b089183fda270bbeecc135b190b589"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="1f85013ec13e639596b728f22f1aafc4" level="file"><did><unittitle>TML, 39-13 - Safety of channel blockers</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="fed353ba8286913825dbffb1f7cac886" label="mixed materials [A0000000075863]" type="box">21</container><container id="5fad696208e9862c1e501a30273e1821" parent="fed353ba8286913825dbffb1f7cac886" type="folder">1-2</container></did><accessrestrict id="8a33d90a046f00da2d8b9b030020c09e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b4a11be555144c67db801913b3a95361" level="file"><did><unittitle>TML, 39-58 - Cabergoline for hyperprolactinemia</unittitle><unitdate type="inclusive">1997 June 20</unitdate><container altrender="Record Storage Box (Paige)" id="163631cd3ac8f6adfc6afacddbb8d0dc" label="mixed materials [A0000000075863]" type="box">21</container><container id="c2467b45d288eb4d635353018d58ac1e" parent="163631cd3ac8f6adfc6afacddbb8d0dc" type="folder">3-6</container></did><accessrestrict id="300ca74e312c726f3bc6c5c2409ffa88"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="8fa954deb6dc2ce7385244a3d8abc5a9" level="file"><did><unittitle>TML - Dovonex</unittitle><unitdate type="inclusive">1993</unitdate><container altrender="Record Storage Box (Paige)" id="a62b33df7f0cee389e01e8c732c85d14" label="mixed materials [A0000000075863]" type="box">21</container><container id="1ae24666ea35a3835e425327415449bd" parent="a62b33df7f0cee389e01e8c732c85d14" type="folder">7</container></did><accessrestrict id="7ed0890a439df753466be5a70bc31770"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="c70f3345ad4c90f6af9d560ffb1f3777" level="file"><did><unittitle>TML, 39-108 - Olopatadine for allergic conjunctivitis</unittitle><unitdate type="inclusive">1997 November 21</unitdate><container altrender="Record Storage Box (Paige)" id="815d9e07e6f68f59c17c1afc1a86a29d" label="mixed materials [A0000000075863]" type="box">21</container><container id="fd96d9bbdf03db66dd88d3c0149aedee" parent="815d9e07e6f68f59c17c1afc1a86a29d" type="folder">8-9</container></did><accessrestrict id="7e05d25159387c3bcb0a7a1a1a57fbe9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="0f25168045c3874b852fc2566864c22b" level="file"><did><unittitle>TML, 37-1 - Drugs for asthma</unittitle><unitdate type="inclusive">1996 January 6</unitdate><container altrender="Record Storage Box (Paige)" id="4f39beb3afd7d9523739f45866546e82" label="mixed materials [A0000000075863]" type="box">21</container><container id="62f76d65979484c2f3406f7504264575" parent="4f39beb3afd7d9523739f45866546e82" type="folder">10-14</container></did><accessrestrict id="5124cbd46d2a439f4f59c00468b6016b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="dbe0049fdc51d967d42b54af228c58ae" level="file"><did><unittitle>TML, 39-32 - Intra-transurethral Alprostadil for impotence</unittitle><unitdate type="inclusive">1997 March 28</unitdate><container altrender="Record Storage Box (Paige)" id="7fc0553132767b95a249d2c21d83d923" label="mixed materials [A0000000075863]" type="box">21</container><container id="b64b7cb8bf68e48e33841be2ab9bdc34" parent="7fc0553132767b95a249d2c21d83d923" type="folder">15-16</container></did><accessrestrict id="108454fd852ec91b5893f1a78b4694b9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="3fff697896297fb5b3e546b99c7bb615" level="file"><did><unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="b2793686a953a42ce275bb7818c1944b" label="mixed materials [A0000000075863]" type="box">21</container><container id="8ea02ac55be2cb7236572562652835a2" parent="b2793686a953a42ce275bb7818c1944b" type="folder">17-21</container></did><accessrestrict id="6e01c10d6e482faec33ca1e6f744b4e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="ac009d8a6eba90db98f499f6852dd496" level="file"><did><unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="a2347ced7827c051f06fc373134f08d5" label="mixed materials [A0000000075864]" type="box">22</container><container id="82a56f72bfb18c909a3f52be60e85568" parent="a2347ced7827c051f06fc373134f08d5" type="folder">1-3</container></did><accessrestrict id="1cdb7a1ff11f6e216e339e64f20c58a7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="364c7d8d424593144cdef790c4e94d75" level="file"><did><unittitle>TML, 39-111 - AIDS - Drugs for HIV infection</unittitle><unitdate type="inclusive">1997 December 12</unitdate><container altrender="Record Storage Box (Paige)" id="410e89e33705923379cfc7a916e6b04f" label="mixed materials [A0000000075864]" type="box">22</container><container id="1f30eb193e991705929e4ebc38fa9d5a" parent="410e89e33705923379cfc7a916e6b04f" type="folder">4-9</container></did><accessrestrict id="a96e0ada70322de7df279993ca3ff3a5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fe5bfd483d4da9cb09abcd8d8e9114e4" level="file"><did><unittitle>TML, 39-97 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">1997 October 24</unitdate><container altrender="Record Storage Box (Paige)" id="0b908ba08c1716805efd12839c4dc9b9" label="mixed materials [A0000000075864]" type="box">22</container><container id="dd1ed4e0c8d45573b3d85015b0c6e998" parent="0b908ba08c1716805efd12839c4dc9b9" type="folder">10-15</container></did><accessrestrict id="ce3e85fc72e05bedc7f21da6973965b7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6568c1026445dec6f8e364671c21bd39" level="file"><did><unittitle>TML, 39-120 - Anagrelide for essential thrombocythemia</unittitle><unitdate type="inclusive">1997 December 19</unitdate><container altrender="Record Storage Box (Paige)" id="3b3c61434bcc7b4547c71d80d5712f1e" label="mixed materials [A0000000075864]" type="box">22</container><container id="1414d1fa737c65a361a1f5c6fe0799e4" parent="3b3c61434bcc7b4547c71d80d5712f1e" type="folder">16-18</container></did><accessrestrict id="8df589a9af326009da84ebecd5cf8932"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b0b4f71d2ecf84b337ced4a504f89306" level="file"><did><unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="d86ab09f05e8f500a01101794da5e0de" label="mixed materials [A0000000075864]" type="box">22</container><container id="8de616866a4ae00001091331c22a9c6c" parent="d86ab09f05e8f500a01101794da5e0de" type="folder">19</container></did><accessrestrict id="8df622f363be5b50961c92589e209dc4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b1ac2f651904161cd98b8d42f99e3aa1" level="file"><did><unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="136b1af3ce607d976eba7b000d38f95c" label="mixed materials [A0000000075865]" type="box">23</container><container id="543e8558934495a7e427315adae97d45" parent="136b1af3ce607d976eba7b000d38f95c" type="folder">1-4</container></did><accessrestrict id="181d3a4b218653d1790e4861871f62dd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="edca2ebba2d38b14ec07a5b9c16a0276" level="file"><did><unittitle>TML, 39-89 - Carvedilol for heart failure</unittitle><unitdate type="inclusive">1997 September 26</unitdate><container altrender="Record Storage Box (Paige)" id="590a5068f970ccc11e032f9676fccddd" label="mixed materials [A0000000075865]" type="box">23</container><container id="994fe07de5e0c90a55f6ae0e82eb20f6" parent="590a5068f970ccc11e032f9676fccddd" type="folder">5-9</container></did><accessrestrict id="f5705dc19e306f206ec780b8d160e15c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="3f1ba5c10401cadfc440c87da71224cb" level="file"><did><unittitle>TML, 39-57 - Topical penciclovir for herpes labialis</unittitle><unitdate type="inclusive">1997 June 20</unitdate><container altrender="Record Storage Box (Paige)" id="031a0035405c9176fbdff199edff165c" label="mixed materials [A0000000075865]" type="box">23</container><container id="c20219e03db898c2bf10a41faa92335c" parent="031a0035405c9176fbdff199edff165c" type="folder">10-11</container></did><accessrestrict id="053d8eeeb8327c9a50460b4a07f88f4f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6311bd1ab3c17838b525980881eb7804" level="file"><did><unittitle>TML, 38-17 - Drugs for migraine</unittitle><unitdate type="inclusive">1995 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="7b8cacceed756e4945c6a0694c5c6a28" label="mixed materials [A0000000075865]" type="box">23</container><container id="9eec0338cc4d3a8b0afed3cedf891498" parent="7b8cacceed756e4945c6a0694c5c6a28" type="folder">12-16</container></did><accessrestrict id="3d255045a576ae1c355c7f2fcc48b4a7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="d46efc5621917384073357b190321659" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="52e1402e6073445720d54c58221eb633" label="mixed materials [A0000000075865]" type="box">23</container><container id="9cef499e70c0b6af28761e496ee36a7b" parent="52e1402e6073445720d54c58221eb633" type="folder">17-21</container></did><accessrestrict id="663777121320adda427992b307d1db2f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fa4a7928ccfffaadb72cf4771e4d8edc" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="440d1291fbbbab6e34ce3c30010803f2" label="mixed materials [A0000000075866]" type="box">24</container><container id="1fabf8bc3a5670fb8d83eadaa4eb347c" parent="440d1291fbbbab6e34ce3c30010803f2" type="folder">1</container></did><accessrestrict id="702b01fd73a7deda0a72869d6f566a47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="318ae2efe1275c93a47e9ae522f706ea" level="file"><did><unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="73b8bf8b2a442addc4cb8fd3df0fc1e6" label="mixed materials [A0000000075866]" type="box">24</container><container id="3e9716d45d0601113598b7260dd5f5d2" parent="73b8bf8b2a442addc4cb8fd3df0fc1e6" type="folder">2-3</container></did><accessrestrict id="f2ea2b6f0f794d84b25ea1befb0a8255"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b4b3b22e307f4ce6c5d2eb8f6d664d9c" level="file"><did><unittitle>TML, 38-5 - Olanzapine for schizophrenia</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="05e78d6a39c6898056526bbc7e5f294a" label="mixed materials [A0000000075866]" type="box">24</container><container id="3e6cf05ac9d8886b24d861d56f9b6dc6" parent="05e78d6a39c6898056526bbc7e5f294a" type="folder">4-6</container></did><accessrestrict id="54d3d516459a5d0fc04e78b00339b8f9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b5cf0dfe90fdcc6067f140e30b6809d1" level="file"><did><unittitle>TML, 38-113 - Mirtazapine - a new anti-depressant</unittitle><unitdate type="inclusive">1996 December 20</unitdate><container altrender="Record Storage Box (Paige)" id="9e4f0fcf8d2c9f3152b3a5508f85c3c8" label="mixed materials [A0000000075866]" type="box">24</container><container id="39ce10608002065cc9fb6dadbe71a948" parent="9e4f0fcf8d2c9f3152b3a5508f85c3c8" type="folder">7-9</container></did><accessrestrict id="6a61863bdf42f359838de02eb3140260"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="c2e1fc197d7490d826da206b516a38a5" level="file"><did><unittitle>TML, 40-5 - Drugs of Choice - Rheumatoid Arthritis</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="3264302658d73e9e8b5401f8d9ec1e68" label="mixed materials [A0000000075866]" type="box">24</container><container id="96cecd6dad5383b873ea09a33b753438" parent="3264302658d73e9e8b5401f8d9ec1e68" type="folder">10-16</container></did><accessrestrict id="5d151812a70ad7aab1e31b15864a8198"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fc12244326436c163ce3062f2ee5441e" level="file"><did><unittitle>TML, 40-59 - Clopidogrel for reduction of artherosclerotic events</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="21898118d7712f4072e245f2406ccc0a" label="mixed materials [A0000000075867]" type="box">25</container><container id="e8a6d88b42faa4b6ad3954bbffc3a6ab" parent="21898118d7712f4072e245f2406ccc0a" type="folder">1-3</container></did><accessrestrict id="010c90cf26351f4881154a4f6ad41ad3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b00d90227ff22e5ebe7df4b968c6ec73" level="file"><did><unittitle>TML, 40-113 - Citalopram for depression</unittitle><unitdate type="inclusive">1998 December 4</unitdate><container altrender="Record Storage Box (Paige)" id="efb1552c42afdac877ec1908bed02e50" label="mixed materials [A0000000075867]" type="box">25</container><container id="d51539819288dde4f36e2d9f7ab21b40" parent="efb1552c42afdac877ec1908bed02e50" type="folder">4-8</container></did><accessrestrict id="e132e378e63282bf8014cd21bd84bf26"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="85788caeb20c27238d916bb497645405" level="file"><did><unittitle>TML, 40-52 - Anthrax vaccine</unittitle><unitdate type="inclusive">1998 May 8</unitdate><container altrender="Record Storage Box (Paige)" id="1114a7ca079d28d790fc3cbd467c9335" label="mixed materials [A0000000075867]" type="box">25</container><container id="84cf6da086b2478fc973969671da40b0" parent="1114a7ca079d28d790fc3cbd467c9335" type="folder">9-10</container></did><accessrestrict id="0a33ad6cdce119b325c656b5c6f11151"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="7481cf56a926bcaa665f596bebcba058" level="file"><did><unittitle>TML, 40-63 - Ginkgo Biloba for dementia</unittitle><unitdate type="inclusive">1998 June 19</unitdate><container altrender="Record Storage Box (Paige)" id="a238d3dda04d5cb9729b81c95553b2e0" label="mixed materials [A0000000075867]" type="box">25</container><container id="bfe22caebea8baae6158bb52ee4d5eaf" parent="a238d3dda04d5cb9729b81c95553b2e0" type="folder">11-13</container></did><accessrestrict id="16e326bcc4bc4a1b019667382b3e42a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="276f7a6dda26470f835e467b2e300373" level="file"><did><unittitle>TML, Sildenafil - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="a6f27d0f0e6d351e585eedb128f6d28d" label="mixed materials [A0000000075867]" type="box">25</container><container id="4a2a13d24d2994639f109a0a5ba70b6c" parent="a6f27d0f0e6d351e585eedb128f6d28d" type="folder">14-16</container></did><accessrestrict id="c072f69e2c5f4579df7b9a32a2d6638a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="8d9d5a14ea3c38a9bcf53eea15278788" level="file"><did><unittitle>TML, 40-69 - Hyaluronan injections for osteoarthritis of the knee</unittitle><unitdate type="inclusive">1998 July 3</unitdate><container altrender="Record Storage Box (Paige)" id="d162f148b64d8a3124b2ceb614cb2983" label="mixed materials [A0000000075867]" type="box">25</container><container id="1e75cb283d1bad2481f70fd9af6f878b" parent="d162f148b64d8a3124b2ceb614cb2983" type="folder">17-19</container></did><accessrestrict id="548bd13d1ee4dd091a7071fb17973086"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e605d151c50d15b7436fa8b95fabcc04" level="file"><did><unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle><unitdate type="inclusive">1998 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="e071fb53b40c351a5a8f6ff56fc2c4a1" label="mixed materials [A0000000075867]" type="box">25</container><container id="fa4f3dcafa4a8b3d4b2cc1da7f993dda" parent="e071fb53b40c351a5a8f6ff56fc2c4a1" type="folder">20-21</container></did><accessrestrict id="72272d08b8d2095400f484d84b5c8623"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a2c45fce823914fd5f240eb8ce64a6d3" level="file"><did><unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle><unitdate type="inclusive">1998 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="4dc89d1715a861586d93c2516331f0e5" label="mixed materials [A0000000075868]" type="box">26</container><container id="ee3af911b0c1d3a21b6a0d1e8e37b70a" parent="4dc89d1715a861586d93c2516331f0e5" type="folder">1</container></did><accessrestrict id="e61fbc122231a69d11de05471824b4f7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="58fc0933c16d75f16f20c226741f40fc" level="file"><did><unittitle>TML, 40-21 - Drugs that cause psychiatric symptoms</unittitle><unitdate type="inclusive">1998 February 13</unitdate><container altrender="Record Storage Box (Paige)" id="5864424cb92c7757c31fd3d69b935f5d" label="mixed materials [A0000000075868]" type="box">26</container><container id="2b66a620c401f0b4f51f5d91db7ebb41" parent="5864424cb92c7757c31fd3d69b935f5d" type="folder">2-5</container></did><accessrestrict id="cd18c294101a7fb036bca53986751b48"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f466040faafb3cd515b6f7e5924186a3" level="file"><did><unittitle>TML, 40-47 - Advice for Travelers</unittitle><unitdate type="inclusive">1998 April 24</unitdate><container altrender="Record Storage Box (Paige)" id="d5ab69dbe03f426fa3fc96de4dc2b068" label="mixed materials [A0000000075868]" type="box">26</container><container id="9958f7c75ec0b578fc177a65e861a2f9" parent="d5ab69dbe03f426fa3fc96de4dc2b068" type="folder">6-9</container></did><accessrestrict id="d3ea0598c816f490bd7b26c48572450a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="d9d7051c247d055cb3a4caa57119bc34" level="file"><did><unittitle>TML, 40-68 - Fenofibrate</unittitle><unitdate type="inclusive">1998 July 3</unitdate><container altrender="Record Storage Box (Paige)" id="fa69cb7889769c79e4bace4bb9f8426f" label="mixed materials [A0000000075868]" type="box">26</container><container id="8e2e6d9222e6db652ff115312b690e6a" parent="fa69cb7889769c79e4bace4bb9f8426f" type="folder">10-13</container></did><accessrestrict id="a905e6ecf288f2137eb025ea245ec0aa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="0902f98f4048374d057a60de2d1b7855" level="file"><did><unittitle>TML, 40-30 - Trovafloxacin</unittitle><unitdate type="inclusive">1998 March 13</unitdate><container altrender="Record Storage Box (Paige)" id="64e2c17b23f7f30df32e6f4782eb6ff3" label="mixed materials [A0000000075868]" type="box">26</container><container id="36afd8fdd0c9a8cefc90deb0f3a05975" parent="64e2c17b23f7f30df32e6f4782eb6ff3" type="folder">14-16</container></did><accessrestrict id="d64cfc2f0c18fe44c79492b16479dde8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="40a127b41aba4ab1210aebb60355f7eb" level="file"><did><unittitle>TML - Tuberculosis - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="45326e761ddb02dd1950ac20a270d08d" label="mixed materials [A0000000075868]" type="box">26</container><container id="c9d3dcd39c351393374d2c3fcdcddf3e" parent="45326e761ddb02dd1950ac20a270d08d" type="folder">17-18</container></did><accessrestrict id="aa2e94224c5f71c8078141e7e709d476"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="2821241f88ab33b4108c2fb8ef546a03" level="file"><did><unittitle>TML - Tuberculosis - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="7d74eb06a755782ca72dbf2b80261c46" label="mixed materials [A0000000075869]" type="box">27</container><container id="cab7a6e7c819bbf4f3390dab015971fe" parent="7d74eb06a755782ca72dbf2b80261c46" type="folder">1-2</container></did><accessrestrict id="0fedc35030a79ffd7934a9d9c5acbe14"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a5e3fba9d86330d4c75e3f31b4844108" level="file"><did><unittitle>TML, 40-51 - Sildenafil - An oral drug for impotence</unittitle><unitdate type="inclusive">1998 May 8</unitdate><container altrender="Record Storage Box (Paige)" id="3868fa54331a5ef31b3c9b53be82d281" label="mixed materials [A0000000075869]" type="box">27</container><container id="b34e346b7fd961eb6fe7fc8a837b259d" parent="3868fa54331a5ef31b3c9b53be82d281" type="folder">3-4</container></did><accessrestrict id="c2a74a29c84ba08cf5bbb6cb60889b41"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="41484f1614916c304d00c6a0e2776c25" level="file"><did><unittitle>TML, 40-67 - Sucralose - a new artificial sweetner</unittitle><unitdate type="inclusive">1998 July 3</unitdate><container altrender="Record Storage Box (Paige)" id="203a035ce351b0c07a9957fbe8020fc8" label="mixed materials [A0000000075869]" type="box">27</container><container id="4c5e9797ff91bdba7d1c8360f48af7fc" parent="203a035ce351b0c07a9957fbe8020fc8" type="folder">5-7</container></did><accessrestrict id="9e54423aecee12c7635588555d8c357f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="18a33071dfc9246e7c9a4f9970fc624f" level="file"><did><unittitle>TML, 40-17 - Grepafloxacin - a new fluoroquinolone</unittitle><unitdate type="inclusive">1998 January 30</unitdate><container altrender="Record Storage Box (Paige)" id="91c0d964be73dd48ceb8e6436d90dd4b" label="mixed materials [A0000000075869]" type="box">27</container><container id="32cd7b4b6775d2cde3edc8625cae9ce2" parent="91c0d964be73dd48ceb8e6436d90dd4b" type="folder">8-9</container></did><accessrestrict id="bc7dcf48bb1a978d5d8891678f65f0b7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="95bd003fd739d4b3a6ffdfb96fae1bc6" level="file"><did><unittitle>TML, 40-55 - Repaglinide for type 2 diabetes mellitus</unittitle><unitdate type="inclusive">1998 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="2b7ed5c51d51c14a438ef3b7b0c3952e" label="mixed materials [A0000000075869]" type="box">27</container><container id="86f80380ce6325677c477d1ec12a2a54" parent="2b7ed5c51d51c14a438ef3b7b0c3952e" type="folder">10-12</container></did><accessrestrict id="ea7f89c9aaeab7997ab0ab65a3fbabdf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="c689105113c5b23ebb896f340bf02ea0" level="file"><did><unittitle>TML, 40-62 - Crystal Ear hearing aid</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="ce59779541dcd1bedb9bc2ef0bec2ae1" label="mixed materials [A0000000075869]" type="box">27</container><container id="34909b6b95f35b47d7744128fef0982d" parent="ce59779541dcd1bedb9bc2ef0bec2ae1" type="folder">13</container></did><accessrestrict id="dc4b7b184944400de9cfe92635a05ead"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="705d7bf07e8ff402ef32c0df389a3828" level="file"><did><unittitle>TML, 40-89 - Antiplatelet</unittitle><unitdate type="inclusive">1998 September 11</unitdate><container altrender="Record Storage Box (Paige)" id="ec0bc6e6397bfc2ddab805fbe3019d38" label="mixed materials [A0000000075869]" type="box">27</container><container id="4090b62310d49e82e275e0c1fdef8056" parent="ec0bc6e6397bfc2ddab805fbe3019d38" type="folder">14-16</container></did><accessrestrict id="ae0c798c535816e3564f3b350306c0eb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="cc4045365330c91030e2afc2941ff362" level="file"><did><unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle><unitdate type="inclusive">1998 November 20</unitdate><container altrender="Record Storage Box (Paige)" id="1791467baab5ca99a453c62e408dedd4" label="mixed materials [A0000000075869]" type="box">27</container><container id="b87b3f384b36b96a9f5d0792f5fd5d47" parent="1791467baab5ca99a453c62e408dedd4" type="folder">17-19</container></did><accessrestrict id="d3830363a0deac040fb1a2187fcc43a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="74cd9f3df4304220a489f3cd523e97f4" level="file"><did><unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle><unitdate type="inclusive">1998 November 20</unitdate><container altrender="Record Storage Box (Paige)" id="c42fe9d8183294ef13625ab683670b54" label="mixed materials [A0000000075870]" type="box">28</container><container id="32bb2f7dd264e3d30476f79d7d8a3da4" parent="c42fe9d8183294ef13625ab683670b54" type="folder">1</container></did><accessrestrict id="78f65a64160f8c684e6ad4a73eb82afd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="8f7886d013678b0f444c0e7ce3af676b" level="file"><did><unittitle>TML, 40-65 - Rituximab for non-hodgkins lymphoma</unittitle><unitdate type="inclusive">1998 June 19</unitdate><container altrender="Record Storage Box (Paige)" id="c421d9d190860004b7dd37e5087d9dbc" label="mixed materials [A0000000075870]" type="box">28</container><container id="11597d7a6bc7e8689f2452713834c480" parent="c421d9d190860004b7dd37e5087d9dbc" type="folder">2</container></did><accessrestrict id="8e2b80b72a52938a5c321da498c8b722"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="236c02b396ea229adb1f079d93029f01" level="file"><did><unittitle>TML, 40-32 - Sibutramine for obesity</unittitle><unitdate type="inclusive">1998 March 13</unitdate><container altrender="Record Storage Box (Paige)" id="e2ebec81f133c03b61270bf78e79173d" label="mixed materials [A0000000075870]" type="box">28</container><container id="1f72b4e739cdb79ed9f5189029df48c1" parent="e2ebec81f133c03b61270bf78e79173d" type="folder">3-5</container></did><accessrestrict id="83216716b614ac8cc38fcaa01b43355e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="34d5d1374a9121f748a24968ebe6c128" level="file"><did><unittitle>TML, 40-27 - Zolmitriptan for migraine</unittitle><unitdate type="inclusive">1998 February 27</unitdate><container altrender="Record Storage Box (Paige)" id="5d85abcc02f9e891158bae77c26ad650" label="mixed materials [A0000000075870]" type="box">28</container><container id="0a361f53b25d3eefdc0365d6cd8e813e" parent="5d85abcc02f9e891158bae77c26ad650" type="folder">6-8</container></did><accessrestrict id="9f78fcde35549e85ae6f6ddddad23091"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f1f292c6e674c3d7e6f2610c2dbf9aec" level="file"><did><unittitle>TML, 40-73 - Becaplermin - Platelet-derived growth factor for diabetic ulcers</unittitle><unitdate type="inclusive">1998 July 17</unitdate><container altrender="Record Storage Box (Paige)" id="1419f02118ddad0bd3b5c9f184b1e055" label="mixed materials [A0000000075870]" type="box">28</container><container id="8d10bb0fb52194e84a93662f3d92c188" parent="1419f02118ddad0bd3b5c9f184b1e055" type="folder">9</container></did><accessrestrict id="a90cd7de6fbf79e2a9a41d8e6d5f1884"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="fae1826f224dc5554dd9d77d43d63320" level="file"><did><unittitle>TML, 40-19 - Arbutamine for stress testing</unittitle><unitdate type="inclusive">1998 January 2</unitdate><container altrender="Record Storage Box (Paige)" id="94a30d7eb6301193bb24fe37014c06e9" label="mixed materials [A0000000075870]" type="box">28</container><container id="f4de34f15adc827629057f15d41124b4" parent="94a30d7eb6301193bb24fe37014c06e9" type="folder">10-11</container></did><accessrestrict id="3cf800c016782dc93e3a36b622f7b36c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b4e4ab750a7b095f09a475bb6f5bb4c1" level="file"><did><unittitle>TML, 40-75 - Vitamin supplements</unittitle><unitdate type="inclusive">1998 July 31</unitdate><container altrender="Record Storage Box (Paige)" id="48d28ddbe8eff17d64dbf70d8e4c9cf4" label="mixed materials [A0000000075870]" type="box">28</container><container id="132ac9c66eed636b5f9b2b2d0a6689a9" parent="48d28ddbe8eff17d64dbf70d8e4c9cf4" type="folder">12-16</container></did><accessrestrict id="59259d5d91da3a2acb6cb86529f69bd9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="06914f95afdacb00ca224c63b35cc3e5" level="file"><did><unittitle>TML, 40-92 - Gliadel wafers for treatment of brain tumors</unittitle><unitdate type="inclusive">1998 September 11</unitdate><container altrender="Record Storage Box (Paige)" id="5486c4baa70efbb3911501c77f6d2091" label="mixed materials [A0000000075870]" type="box">28</container><container id="a0c9255849c9140308cc8475ed759ac7" parent="5486c4baa70efbb3911501c77f6d2091" type="folder">17-18</container></did><accessrestrict id="e29a7c4b92a2feed9fd0b7e0a0bb8f72"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f35a3fcbf2b099a50baf329b7d2a8f36" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="8e31ede5badcc8851a689916182da760" label="mixed materials [A0000000075870]" type="box">28</container><container id="1a3167c69006240629bd7cfece35c749" parent="8e31ede5badcc8851a689916182da760" type="folder">19</container></did><accessrestrict id="0093f9f9cae39c07366f1e9c0c119fa4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="bc19dc00f1b6834157cb02e6fcfef4a4" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="b359401e72cf6c1cd70c06c51a13d96e" label="mixed materials [A0000000075871]" type="box">29</container><container id="80949d7428111433a296b8fcbf5cb504" parent="b359401e72cf6c1cd70c06c51a13d96e" type="folder">1-5</container></did><accessrestrict id="530223b01deda9e053da32d105382b18"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="559cb584a41d6690a7e856498ab89795" level="file"><did><unittitle>TML, 40-106 - Trastuzumab for metastatic breast cancer</unittitle><unitdate type="inclusive">1998 November 6</unitdate><container altrender="Record Storage Box (Paige)" id="3af412bf7758f80ab8ed424cb43a8a03" label="mixed materials [A0000000075871]" type="box">29</container><container id="2e28472199dceaa2b061dad1c7dd1dbe" parent="3af412bf7758f80ab8ed424cb43a8a03" type="folder">6-7</container></did><accessrestrict id="cf7ce77fd85e6bc2a2e126d922cb2364"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="ece2250f2916521ae284b1830da4848e" level="file"><did><unittitle>TML, 40-114 - Three new drugs for HIV infection</unittitle><unitdate type="inclusive">1998 December 4</unitdate><container altrender="Record Storage Box (Paige)" id="e95285fad37969507337f9ccd36017cf" label="mixed materials [A0000000075871]" type="box">29</container><container id="e62a433c36a43aa21108ff7bb915b7c0" parent="e95285fad37969507337f9ccd36017cf" type="folder">8-11</container></did><accessrestrict id="4e7f5d2236f53f8ccc2b28a5bf8873c1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="7dd5458e0da29270a7d0b887632c23ac" level="file"><did><unittitle>TML, Sexually Trasmitted Diseases - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="8794d992327d0527093d7da6d8de161f" label="mixed materials [A0000000075871]" type="box">29</container><container id="f772599d43131f6441ccdf94523f93c8" parent="8794d992327d0527093d7da6d8de161f" type="folder">12-14</container></did><accessrestrict id="0b261ea329af56d20325ac31bcf03cbe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6e5b03bb37f1b1e46c63603fddb7f5a0" level="file"><did><unittitle>TML, 40-53 - Dolasetron</unittitle><unitdate type="inclusive">1998 May 8</unitdate><container altrender="Record Storage Box (Paige)" id="e726eb4f6133175800361e21b0dff8f6" label="mixed materials [A0000000075871]" type="box">29</container><container id="3c60f21963b861cf08493494f19567d8" parent="e726eb4f6133175800361e21b0dff8f6" type="folder">15-18</container></did><accessrestrict id="2f191b313a6f595b28c9d77fec25b021"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b33fb65d9a2e71bddfa4f269d47aeef6" level="file"><did><unittitle>TML, 40-18 - Irbesartan for hypertension</unittitle><unitdate type="inclusive">1998 January 30</unitdate><container altrender="Record Storage Box (Paige)" id="97277fd50890b8cd6cd44c0dc9a0fa10" label="mixed materials [A0000000075872]" type="box">30</container><container id="7bf9f3863fa08a4400a2a27405bbed94" parent="97277fd50890b8cd6cd44c0dc9a0fa10" type="folder">1-4</container></did><accessrestrict id="5fe32f0354336c745f49eaad8ec99c60"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6332598d843148b2b6fcca7483c23ff2" level="file"><did><unittitle>TML, 40-33 - The Choice of Antibacterial Drugs</unittitle><unitdate type="inclusive">1998 March 27</unitdate><container altrender="Record Storage Box (Paige)" id="af7191c41b288fa95a950bb37f4193a7" label="mixed materials [A0000000075872]" type="box">30</container><container id="34acd5951599cbb8397e99101b8c0dd5" parent="af7191c41b288fa95a950bb37f4193a7" type="folder">5-8</container></did><accessrestrict id="4de55d18dd59d1c77f9f4fdd38e7a4d2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6062e376e8011b03bf27092730e8219d" level="file"><did><unittitle>TML, 40-93 - New monoclonal antibodies to prevent transplant rejection</unittitle><unitdate type="inclusive">1998 September 25</unitdate><container altrender="Record Storage Box (Paige)" id="132ade0d0462d6a8814cfec17aa8c148" label="mixed materials [A0000000075872]" type="box">30</container><container id="e4849b34914fa75f19bc1ad648d28944" parent="132ade0d0462d6a8814cfec17aa8c148" type="folder">9-12</container></did><accessrestrict id="a10e4c82bc99d39cee6a7ddd1ca31b10"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="de828b3fc932777396bebd27f5fab7dd" level="file"><did><unittitle>TML, 40-117 - Choice of lipid-lowering drugs</unittitle><unitdate type="inclusive">1998 December 18</unitdate><container altrender="Record Storage Box (Paige)" id="b24bd3fbb3e4827fb2085f001cd069c5" label="mixed materials [A0000000075872]" type="box">30</container><container id="c5a0b661dba0e392cf2e381881ef6c81" parent="b24bd3fbb3e4827fb2085f001cd069c5" type="folder">13-16</container></did><accessrestrict id="ec87238d62e4af8195602bcb6756e8f3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="0bba41a40cc25a8da0e7a635fb7e3df8" level="file"><did><unittitle>TML - Drugs for Parasitic Infections</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="ef9aacafb6e0fc7a060ed40fd6874423" label="mixed materials [A0000000075872]" type="box">30</container><container id="30b80da58928e0b37cd93ff320867d9e" parent="ef9aacafb6e0fc7a060ed40fd6874423" type="folder">17-19</container></did><accessrestrict id="e69b8784cca126a51aa694fe76fa93ef"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="13029629c9a2c8c4645ba910bddc0ec5" level="file"><did><unittitle>TML - Drugs for Parasitic Infections</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="b71ceb70790ff3a8466bd65932265cc2" label="mixed materials [A0000000075873]" type="box">31</container><container id="4b7d2c5077e290474ce1cbaa37eb9818" parent="b71ceb70790ff3a8466bd65932265cc2" type="folder">1-3</container></did><accessrestrict id="efd535a28d84b26cb3f39bdbca07f951"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="c768307fb6b27100b14034cebd5227a9" level="file"><did><unittitle>TML, 40-43 - Toremifene and Letrozole for advance breast cancer</unittitle><unitdate type="inclusive">1998 April 10</unitdate><container altrender="Record Storage Box (Paige)" id="6e55c939f0fd6b9dce2d99dde984f38d" label="mixed materials [A0000000075873]" type="box">31</container><container id="5a7c1976005d97f7f46664b7ee0ca692" parent="6e55c939f0fd6b9dce2d99dde984f38d" type="folder">4-8</container></did><accessrestrict id="4fead382cbe8272480e24c54bdac4aa5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="edbc39d29ce93f5d2d89c1070b90a888" level="file"><did><unittitle>TML, 40-95 - Brinzolamide for glaucoma</unittitle><unitdate type="inclusive">1998 September 25</unitdate><container altrender="Record Storage Box (Paige)" id="60babc7c78f5716f75a9244bf18b0a6a" label="mixed materials [A0000000075873]" type="box">31</container><container id="98338c301237a2ddbe66e679cc92478d" parent="60babc7c78f5716f75a9244bf18b0a6a" type="folder">9-10</container></did><accessrestrict id="4761d1070aff6ae3d4f74655713baaa7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6d7c66707bdf53045a7ff953d6e108d3" level="file"><did><unittitle>TML, 40-45 - Tigabine for epilepsy</unittitle><unitdate type="inclusive">1998 April 10</unitdate><container altrender="Record Storage Box (Paige)" id="2e82f6c8cc43e14b6c71a29003d0012a" label="mixed materials [A0000000075873]" type="box">31</container><container id="df771d27611d7e8c84300b31b57c7a85" parent="2e82f6c8cc43e14b6c71a29003d0012a" type="folder">11-13</container></did><accessrestrict id="94fdedf900cf20f12d378b25deedc2ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a07a54028f90ac0076d2802b57942911" level="file"><did><unittitle>TML, 40-64 - A new rabies vaccine</unittitle><unitdate type="inclusive">1998 June 14</unitdate><container altrender="Record Storage Box (Paige)" id="80942e2e945f0b78a21feb03e6295067" label="mixed materials [A0000000075873]" type="box">31</container><container id="3912a2f912ed5849114077a3b15dc0d8" parent="80942e2e945f0b78a21feb03e6295067" type="folder">14-15</container></did><accessrestrict id="47ed997eea8759fcee2c1c993e8bbb47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3bd95f95656aa72b9a953a7b60fc1ff8" level="file"><did><unittitle>TML, 40-29 - Raloxifene for postmenopausal osteoporosis</unittitle><unitdate type="inclusive">1998 March 13</unitdate><container altrender="Record Storage Box (Paige)" id="64db38dbcc8bc08726be535992f72b9e" label="mixed materials [A0000000075873]" type="box">31</container><container id="ba1823c1b049cf67bc849403d8c116ed" parent="64db38dbcc8bc08726be535992f72b9e" type="folder">16-18</container></did><accessrestrict id="072da8fc19d0e0c642d2808e0b9452ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="fa4c88d1fa307e4c1c36721c687359e5" level="file"><did><unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="f138e47e917d3901fd23163f185b02b2" label="mixed materials [A0000000075873]" type="box">31</container><container id="2449baa079dbf94a4c3c097f88805bba" parent="f138e47e917d3901fd23163f185b02b2" type="folder">19</container></did><accessrestrict id="4326873ad2b2259141a757cbab189cb2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b31307f7682d799e34699487a403a926" level="file"><did><unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="e7a06443c16464c79226e9a12ab5b4ee" label="mixed materials [A0000000075874]" type="box">32</container><container id="cc673fa4a20f282edd4d65e3b379eb6d" parent="e7a06443c16464c79226e9a12ab5b4ee" type="folder">1-2</container></did><accessrestrict id="2802926a9875868eb77bbf4162293dea"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="c0f605353f7f9186d9e181b0e5a7b35c" level="file"><did><unittitle>TML, 40-15 - Budesonide turbuhaler for asthma</unittitle><unitdate type="inclusive">1998 January 16</unitdate><container altrender="Record Storage Box (Paige)" id="531df97afa4d0dd88f70a5b092f2cbff" label="mixed materials [A0000000075874]" type="box">32</container><container id="ff9862822ca169e6b1faccf1c70c136f" parent="531df97afa4d0dd88f70a5b092f2cbff" type="folder">3-8</container></did><accessrestrict id="63c818b79b8463447ba0a35c3ed08e0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="fc1c9413add7682bf34765d07e37871c" level="file"><did><unittitle>TML - Cholesterol-Lowering - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="1a887597dd4b680c5b0478e9a36b220e" label="mixed materials [A0000000075874]" type="box">32</container><container id="c164328565403b127aff0046d1fedabe" parent="1a887597dd4b680c5b0478e9a36b220e" type="folder">9-10</container></did><accessrestrict id="263b366a38ae16d96e1447c8e1c8953b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="9212aaed4209e15330e340d1c8675d23" level="file"><did><unittitle>TML - Parasitic Infections - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="3b51f991b04651fd28c26b978609424c" label="mixed materials [A0000000075874]" type="box">32</container><container id="1b5dd975da93698faa0a5ac3fa9a9dde" parent="3b51f991b04651fd28c26b978609424c" type="folder">11-14</container></did><accessrestrict id="5db4f9b0242f10ed336d20896e08899c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="367ee47d6747fc683d4571ad991fcb28" level="file"><did><unittitle>TML - Malaria - Drugs for parastic infections</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="47a19217735ad42fedaeee3ad8f911bf" label="mixed materials [A0000000075874]" type="box">32</container><container id="440ee165e5b1d7bdf771b606b31f581f" parent="47a19217735ad42fedaeee3ad8f911bf" type="folder">15-16</container></did><accessrestrict id="e3f66807c02c01517706efbf9eeaff5f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="d64c5c233f60d11993a1dd5cef9c5ec4" level="file"><did><unittitle>TML - Antimicrobial drugs - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="d2c1eae571de1a3b654129fdd79bdee2" label="mixed materials [A0000000075874]" type="box">32</container><container id="f5a525bc8ad7ffe50e86875b7684316d" parent="d2c1eae571de1a3b654129fdd79bdee2" type="folder">17</container></did><accessrestrict id="f6a6fff3786ff1d521cdf342567849ee"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3d41d005cf4c13e14913cd67a32a5047" level="file"><did><unittitle>TML - Antimicrobial drugs - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="ea43a590883ea3b93eec19b8055dd072" label="mixed materials [A0000000075875]" type="box">33</container><container id="7e77a48f074219bdca0f06e47545c20d" parent="ea43a590883ea3b93eec19b8055dd072" type="folder">1-2</container></did><accessrestrict id="8075ff059f0d4d931fa3535cefb097fc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a70dd9355ee98a30aebc26b8daacffc8" level="file"><did><unittitle>TML - Psychiatric Symptoms - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="11efbb4237006e1c525173b0e53ae0d9" label="mixed materials [A0000000075875]" type="box">33</container><container id="1485dd24d240adac9a12119f70e339e2" parent="11efbb4237006e1c525173b0e53ae0d9" type="folder">3</container></did><accessrestrict id="9dfab18fed33b99b2f9c6ca42c51a487"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="878b0cb8e4fc058b68a1ed9db09469eb" level="file"><did><unittitle>TML, 40-109 - Candesartan</unittitle><unitdate type="inclusive">1998 November 20</unitdate><container altrender="Record Storage Box (Paige)" id="f49057d4241f2a9137036ee2a45c8a84" label="mixed materials [A0000000075875]" type="box">33</container><container id="3d7dc022afd942ab0cfc270ed5c7ba96" parent="f49057d4241f2a9137036ee2a45c8a84" type="folder">4-6</container></did><accessrestrict id="ba7cc6a8281cf2cb771c412c8f89cd3f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e61911867cf616602aa72255f38dc9ba" level="file"><did><unittitle>TML, 40-77 - Interleukin-11</unittitle><unitdate type="inclusive">1998 July 31</unitdate><container altrender="Record Storage Box (Paige)" id="773aa23648beefad7ebba0ef08cc3cff" label="mixed materials [A0000000075875]" type="box">33</container><container id="b1663364b5c53c5cd56d52a84512ceef" parent="773aa23648beefad7ebba0ef08cc3cff" type="folder">7-9</container></did><accessrestrict id="4f66d0ee0cc0c75d98d5ce57dfee6a86"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="4f7233bf7c77fcfc22d806ea70169968" level="file"><did><unittitle>TML, 40-85 - Cefdinir</unittitle><unitdate type="inclusive">1998 August 28</unitdate><container altrender="Record Storage Box (Paige)" id="e22ac035c61bbf999b08a128a9cbee3b" label="mixed materials [A0000000075875]" type="box">33</container><container id="85eee7a78e78c5feaa80dcf1f02d581c" parent="e22ac035c61bbf999b08a128a9cbee3b" type="folder">10-12</container></did><accessrestrict id="028c35e32d1addf3672d48cb03ad70d7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="910ff3d576f61dcba1783abe6210dff1" level="file"><did><unittitle>TML, 40-79 - Drugs for pain</unittitle><unitdate type="inclusive">1998 August 14</unitdate><container altrender="Record Storage Box (Paige)" id="b65469b2ced5381e63cb78c93b50cfcf" label="mixed materials [A0000000075875]" type="box">33</container><container id="880333713727f57b93743399cc0722a8" parent="b65469b2ced5381e63cb78c93b50cfcf" type="folder">13-17</container></did><accessrestrict id="72993e3876c2683037ab6df23f908193"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="960c1722fd9da508635b32ac38c60f80" level="file"><did><unittitle>TML, 40-87 - Risedronate</unittitle><unitdate type="inclusive">1998 August 28</unitdate><container altrender="Record Storage Box (Paige)" id="5511ff93a4d6130e0ce93d6b4b199d60" label="mixed materials [A0000000075875]" type="box">33</container><container id="e0b6bde704bc8b9806562c7fbd90d69a" parent="5511ff93a4d6130e0ce93d6b4b199d60" type="folder">18-19</container></did><accessrestrict id="c3d8c6875a01ba6968c3fea93fe65185"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="8e8879c55ee8242081f7f64851b4db08" level="file"><did><unittitle>TML, 40-87 - Risedronate</unittitle><unitdate type="inclusive">1998 August 28</unitdate><container altrender="Record Storage Box (Paige)" id="6ddc695500de600da8ae7ffd4b81787c" label="mixed materials [A0000000075876]" type="box">34</container><container id="c2dabd56b32fa6ca30f1afaa54fc483e" parent="6ddc695500de600da8ae7ffd4b81787c" type="folder">1-2</container></did><accessrestrict id="54d5c0c828c3316a8382b3f15461804c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="5d664f33dcd2cabbe962a4227379c390" level="file"><did><unittitle>TML, 40-94 - Lepirudin for heparin-induced thrombocytopenia</unittitle><unitdate type="inclusive">1998 September 25</unitdate><container altrender="Record Storage Box (Paige)" id="744acb284a04253b9e6e92fa8d92c397" label="mixed materials [A0000000075876]" type="box">34</container><container id="9da074bbea56096b42621bbe0df07df3" parent="744acb284a04253b9e6e92fa8d92c397" type="folder">3-4</container></did><accessrestrict id="df311ee9e0d78fb33b148774389da7c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3d76a36572332e4c480702f762cc9918" level="file"><did><unittitle>TML, 40-25 - Propecia and Rogaine Extra Stength for Alopecia</unittitle><unitdate type="inclusive">1998 February 27</unitdate><container altrender="Record Storage Box (Paige)" id="a5c80cd1b45e42da7ca26c0eba3288df" label="mixed materials [A0000000075876]" type="box">34</container><container id="8959e147ff26076f2fec8524ce3c02cc" parent="a5c80cd1b45e42da7ca26c0eba3288df" type="folder">5-8</container></did><accessrestrict id="c3ab3185c9cf9153482322e821491aa5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="affe7599f3c787d823e95823bfc0cbfc" level="file"><did><unittitle>TML, 40-106 - Capecitabine for metastatic breast cancer</unittitle><unitdate type="inclusive">1998 November</unitdate><container altrender="Record Storage Box (Paige)" id="428d04c7e773e79a3b094d8118ceba8b" label="mixed materials [A0000000075876]" type="box">34</container><container id="3872706d54c076309e1c52fe7dd00516" parent="428d04c7e773e79a3b094d8118ceba8b" type="folder">9-10</container></did><accessrestrict id="544789c77c743995f3e1041b8e18aab6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="2e2e66929019d8531954a7ad095700fb" level="file"><did><unittitle>TML, 40-13 - Cerivastatin for hypercholesterolemia</unittitle><unitdate type="inclusive">1998 January 16</unitdate><container altrender="Record Storage Box (Paige)" id="0ce89f2dae2e523fc9fa33afca5c812f" label="mixed materials [A0000000075876]" type="box">34</container><container id="511edeac5b4aacef70ec98db2c7e55e2" parent="0ce89f2dae2e523fc9fa33afca5c812f" type="folder">11-13</container></did><accessrestrict id="c00a8622a08054369fa43b3f435559cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="4043d39a1cb0cf7a9edea397c7574337" level="file"><did><unittitle>TML, 40-101 - Tolterodine for overactive bladder</unittitle><unitdate type="inclusive">1998 October 23</unitdate><container altrender="Record Storage Box (Paige)" id="26ae90fda0fdda9cc5f656a64dea0bdd" label="mixed materials [A0000000075876]" type="box">34</container><container id="6a44f040b737e757d5b8cc1344f1cfa2" parent="26ae90fda0fdda9cc5f656a64dea0bdd" type="folder">14-16</container></did><accessrestrict id="5ed653620eb193653bb7be17c3823301"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e5341af61e6a0539c242e29242b615c6" level="file"><did><unittitle>TML, 40-102 - An Emergency Contraceptive Kit</unittitle><unitdate type="inclusive">1998 October 23</unitdate><container altrender="Record Storage Box (Paige)" id="6cb3af58d75ebfa30bea41716c5de955" label="mixed materials [A0000000075876]" type="box">34</container><container id="1ce0ad3e2ccd8b2b9a5524920596f7c8" parent="6cb3af58d75ebfa30bea41716c5de955" type="folder">17-18</container></did><accessrestrict id="5f3dbedbdfcd288cd297f8d578fd4ced"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3f39fb343e118836671bfce7c8c9e0be" level="file"><did><unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle><unitdate type="inclusive">1998 July 17</unitdate><container altrender="Record Storage Box (Paige)" id="0ed052ec573649bd34a3ccce25a90200" label="mixed materials [A0000000075876]" type="box">34</container><container id="dd7e871f4582ce6ccd8e29f9b9a0fb2f" parent="0ed052ec573649bd34a3ccce25a90200" type="folder">19</container></did><accessrestrict id="a3bdebd3c863cd5e8915acd5b9e97a95"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e43a7710b28863a0de4803cfd4c0b542" level="file"><did><unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle><unitdate type="inclusive">1998 July 17</unitdate><container altrender="Record Storage Box (Paige)" id="df76bd5112845abb9bde09790da35b78" label="mixed materials [A0000000075877]" type="box">35</container><container id="2fd0c6bd24afed079c076920e8109422" parent="df76bd5112845abb9bde09790da35b78" type="folder">1-2</container></did><accessrestrict id="4b8fa308ff1db3b9b6869466f7f0fe98"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f487b7ea1e7909af55b4d7eeee8db68c" level="file"><did><unittitle>TML, 40-103 - Thalidomide</unittitle><unitdate type="inclusive">1998 October 23</unitdate><container altrender="Record Storage Box (Paige)" id="d293e6c297c075f653bedab124c5b994" label="mixed materials [A0000000075877]" type="box">35</container><container id="975726d06e425978c5959c1a7ceaac7c" parent="d293e6c297c075f653bedab124c5b994" type="folder">3-6</container></did><accessrestrict id="afd021cfb4388a63de5e218998fd47c7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="31cfa0b79a02b7866aa0dc7e48743280" level="file"><did><unittitle>TML, 40-97 - New Triptans and other drugs for migraine</unittitle><unitdate type="inclusive">1998 October 9</unitdate><container altrender="Record Storage Box (Paige)" id="d723f50540a248532fe7fcd118f8ba20" label="mixed materials [A0000000075877]" type="box">35</container><container id="98663a37069b8a9132c2d4c89e1c871b" parent="d723f50540a248532fe7fcd118f8ba20" type="folder">7-12</container></did><accessrestrict id="43083e8c7ccdb0aa74b842657cd508ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f35138cee47bea646beb32b2995d4598" level="file"><did><unittitle>TML, 40-91 - Influenza vaccine, 1998-1999</unittitle><unitdate type="inclusive">1998 September 11</unitdate><container altrender="Record Storage Box (Paige)" id="7dca001589016f8e5c9caf082fcedcb2" label="mixed materials [A0000000075877]" type="box">35</container><container id="2b486233337860995cbe3e7c58c70e31" parent="7dca001589016f8e5c9caf082fcedcb2" type="folder">13</container></did><accessrestrict id="a29dd57181aa1c5e6c3a1e5d3b488af7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="7c2b7e050833f74d66d0b600d186eae5" level="file"><did><unittitle>TML, 40-105 - Creatine and Androstenedione - two "dietary supplements"</unittitle><unitdate type="inclusive">1998 November 6</unitdate><container altrender="Record Storage Box (Paige)" id="c2446ad8acb419329453a4ee96550351" label="mixed materials [A0000000075877]" type="box">35</container><container id="5d7cd8a8819a343fcb1a7234fd547abf" parent="c2446ad8acb419329453a4ee96550351" type="folder">14-16</container></did><accessrestrict id="bcbeeba99d41f442379b4633e1dc7778"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a4342729d9ef2567742167972402009f" level="file"><did><unittitle>TML, 39-107 - St. John's Wort</unittitle><unitdate type="inclusive">1997 November 21</unitdate><container altrender="Record Storage Box (Paige)" id="02a916b7f17722f4ab7ec6183e5b4fc7" label="mixed materials [A0000000075877]" type="box">35</container><container id="461b2c50ff7b17b4f477aa5985f86439" parent="02a916b7f17722f4ab7ec6183e5b4fc7" type="folder">17-18</container></did><accessrestrict id="f27838dbfd9cecfa9e71bf77f07fe682"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="ddfb397d4b944785854d8ea719c202bd" level="file"><did><unittitle>TML, 41-73 - Malathion for treatment of head lice</unittitle><unitdate type="inclusive">1999 August 13</unitdate><container altrender="Record Storage Box (Paige)" id="3fba94baa77d610edba9869f7841e3d4" label="mixed materials [A0000000075878]" type="box">36</container><container id="9b1589ed00a85909d8503c3bb67e9116" parent="3fba94baa77d610edba9869f7841e3d4" type="folder">1-2</container></did><accessrestrict id="854b0f58396665c4e2d4a0465f949fd7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="35b97709b422b46ecdc94c987c5952ec" level="file"><did><unittitle>TML, 41-39 - Advice for travelers</unittitle><unitdate type="inclusive">1999 April 23</unitdate><container altrender="Record Storage Box (Paige)" id="80ef45af2ba99e4f115f27b66cc2498f" label="mixed materials [A0000000075878]" type="box">36</container><container id="ec9a454ee719ec19419db4a7195e0569" parent="80ef45af2ba99e4f115f27b66cc2498f" type="folder">3-4</container></did><accessrestrict id="04ad6f830bf72709637049c7b301499d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="f916a9e5c338ff7fc1707311815267f1" level="file"><did><unittitle>TML, 41-30 - Modafinil for narcolepsy</unittitle><unitdate type="inclusive">1999 March 26</unitdate><container altrender="Record Storage Box (Paige)" id="a67c1441fb95e704c681436aaea9411d" label="mixed materials [A0000000075878]" type="box">36</container><container id="b833a4d305360026a09d66fb46b04f06" parent="a67c1441fb95e704c681436aaea9411d" type="folder">5-7</container></did><accessrestrict id="113f676d893d247079b5e4ff614aec1e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="2fc16ae414cf9dd501de68ee706014d5" level="file"><did><unittitle>TML, 41-51 - Levalbuterol for asthma</unittitle><unitdate type="inclusive">1999 June 4</unitdate><container altrender="Record Storage Box (Paige)" id="efe420b32db139a194f602ead8084bdd" label="mixed materials [A0000000075878]" type="box">36</container><container id="2681eb86ced1eeca81c8b01c508f8733" parent="efe420b32db139a194f602ead8084bdd" type="folder">8-10</container></did><accessrestrict id="17d7935132e18e8bac890aeefcb5960f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="3922b9c381c0b19cb3d63cbe803305a6" level="file"><did><unittitle>TML, 41-16 - Mometasone furoate nasal spray for allergic rhinitis</unittitle><unitdate type="inclusive">1999 February 12</unitdate><container altrender="Record Storage Box (Paige)" id="9b52db31259de5f71c76b55f1f12f5f0" label="mixed materials [A0000000075878]" type="box">36</container><container id="79e5a106fbbee288fa1597dcba13da87" parent="9b52db31259de5f71c76b55f1f12f5f0" type="folder">11-12</container></did><accessrestrict id="481e161096febedcc11b1ed837e0109b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="4d4ebb415f82a62d6c6b5091a9afeb7a" level="file"><did><unittitle>TML, 41-50 - Vaccine for rotavirus</unittitle><unitdate type="inclusive">1999 May 21</unitdate><container altrender="Record Storage Box (Paige)" id="45a386b06ba3aafa8cea0bfef2d3e316" label="mixed materials [A0000000075878]" type="box">36</container><container id="2b07284e04cd4a5689814582b7e68ee3" parent="45a386b06ba3aafa8cea0bfef2d3e316" type="folder">13-14</container></did><accessrestrict id="b72eb586cf031b15f2ce8b6037f013b2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="65d972dc57e884b250ec76744f2d84f9" level="file"><did><unittitle>TML, 41-91 - Two neuraminidase inhibitors for treatment of influenza</unittitle><unitdate type="inclusive">1999 October 8</unitdate><container altrender="Record Storage Box (Paige)" id="1045159692314af600746174d2ee5e66" label="mixed materials [A0000000075878]" type="box">36</container><container id="fa93afaea220c46b61d17d481885a4ff" parent="1045159692314af600746174d2ee5e66" type="folder">15-17</container></did><accessrestrict id="6e3fe48fdf68db20082fc8bad62e904f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="26fd68ebafc0d8085fe92d2eb77fcbf6" level="file"><did><unittitle>TML, 41-93 - Zaleplon for insomnia</unittitle><unitdate type="inclusive">1999 October 8</unitdate><container altrender="Record Storage Box (Paige)" id="39350539cdb14603b862ed516ce8ff6a" label="mixed materials [A0000000075879]" type="box">37</container><container id="8145b89e42b01d96f56c70e78636fdb8" parent="39350539cdb14603b862ed516ce8ff6a" type="folder">1-4</container></did><accessrestrict id="b25acf713bbbe8621cf294856e16ba28"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="ec877eb8397cacf7d82d77f65b127412" level="file"><did><unittitle>TML, 41-1 - Tamoxife for the prevention of breast cancer</unittitle><unitdate type="inclusive">1999 January 1</unitdate><container altrender="Record Storage Box (Paige)" id="7f1a598d5874ee0887428e6dc3d89222" label="mixed materials [A0000000075879]" type="box">37</container><container id="8d06bfc0a6fc4be6efa912fdc518a739" parent="7f1a598d5874ee0887428e6dc3d89222" type="folder">5-6</container></did><accessrestrict id="5090105f2f60079c4d3f971adf860516"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="94ff8cec3e58b5c4d7bd8582a705f051" level="file"><did><unittitle>TML, 41-123 - Temozolomide</unittitle><unitdate type="inclusive">1999 December 17</unitdate><container altrender="Record Storage Box (Paige)" id="1c0806979d79f2c6d5803474aa820987" label="mixed materials [A0000000075879]" type="box">37</container><container id="d54dbec572d7b863e50e316a253e4805" parent="1c0806979d79f2c6d5803474aa820987" type="folder">7-8</container></did><accessrestrict id="7a64776358d5df180bb0a5ddbff0bef7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a4b43b9f4b92e02c161ee56d03e178c9" level="file"><did><unittitle>TML, 41-53 - Interferon plus ribavirin for chronic hepatitis C</unittitle><unitdate type="inclusive">1999 June 4</unitdate><container altrender="Record Storage Box (Paige)" id="b25ec792bc41a8f7ff9c922f91e6fb99" label="mixed materials [A0000000075879]" type="box">37</container><container id="076eaf6330631c30698ac3801ae18bee" parent="b25ec792bc41a8f7ff9c922f91e6fb99" type="folder">9-11</container></did><accessrestrict id="af177345fcae67c9d255185c0a10e870"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="024012e8b7f7de531d716961ead029ce" level="file"><did><unittitle>TML, 41-49 - Miglitol for Type 2 diabetes mellitus</unittitle><unitdate type="inclusive">1999 May 21</unitdate><container altrender="Record Storage Box (Paige)" id="94eb968656b82af851b00c38176174bd" label="mixed materials [A0000000075879]" type="box">37</container><container id="bbbd3f0ba89306c983a6d449372d5a86" parent="94eb968656b82af851b00c38176174bd" type="folder">12-13</container></did><accessrestrict id="d6f81a58c2dc3eaf1f79b5dc23f9a66b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a9621527ed50246d7a862b61f10afb79" level="file"><did><unittitle>TML, 41-110 - Rabeprazole</unittitle><unitdate type="inclusive">1999 November 9</unitdate><container altrender="Record Storage Box (Paige)" id="1a98a7b3f1087831d2387d9e0d2af90c" label="mixed materials [A0000000075879]" type="box">37</container><container id="6ec2699246c1a2606300cdfae3111665" parent="1a98a7b3f1087831d2387d9e0d2af90c" type="folder">14-15</container></did><accessrestrict id="fa2239be1fca64f3de4ed0688d43b5a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="fcec222c26512f8ebe8b672bf459fbe9" level="file"><did><unittitle>TML, 41-21 - Rifapentine for tuberculosis</unittitle><unitdate type="inclusive">1999 February 26</unitdate><container altrender="Record Storage Box (Paige)" id="48ba1058abbf8b57be9740da87020390" label="mixed materials [A0000000075879]" type="box">37</container><container id="8e8f39a263e3f90456137bfb73fc1bd6" parent="48ba1058abbf8b57be9740da87020390" type="folder">16-17</container></did><accessrestrict id="5eabb94693fe31a0f053df4c9645327d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="c2530250616ca691ba7d71e8d92ca5e1" level="file"><did><unittitle>TML, 41-109 - Quinupristin (Dalfopristin)</unittitle><unitdate type="inclusive">1999 November 19</unitdate><container altrender="Record Storage Box (Paige)" id="da3021e90b3918bfcec44355453dd556" label="mixed materials [A0000000075879]" type="box">37</container><container id="8300be996d586258f1f59769d1df6d7f" parent="da3021e90b3918bfcec44355453dd556" type="folder">18-19</container></did><accessrestrict id="96db099c24d150d666b7ebe07b50d611"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e80acff708763c79ba27fdf7b90311e5" level="file"><did><unittitle>TML, 41-71 - Rosiglitazone for Type 2 diabetes mellitus</unittitle><unitdate type="inclusive">1999 August 13</unitdate><container altrender="Record Storage Box (Paige)" id="636d361dab5d4d48d0c5a86602489c14" label="mixed materials [A0000000075880]" type="box">38</container><container id="4b6cf74a8805fa62c0bfd4a0514d9792" parent="636d361dab5d4d48d0c5a86602489c14" type="folder">1-3</container></did><accessrestrict id="165ec4ab5ea0c075fdbea5fe2e192f3d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="703b499487840917db1eeb7a3bbf97c3" level="file"><did><unittitle>TML - Drugs of Choice - Rheumatoid Arthritis</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="abe54d562b1a619fca93b542417ac1ca" label="mixed materials [A0000000075880]" type="box">38</container><container id="b48bf25e83e0eb8270fec3100c0d4ae4" parent="abe54d562b1a619fca93b542417ac1ca" type="folder">4-7</container></did><accessrestrict id="15f525d3017c59fe2b80a8ae96ac839d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="d1121bbf04acf6873bc6f6be66e80e1c" level="file"><did><unittitle>TML, 41-59 - Rofecoxib for osteoarthritis and pain</unittitle><unitdate type="inclusive">1999 July 2</unitdate><container altrender="Record Storage Box (Paige)" id="a87bd0151107d14443f33e69081b18db" label="mixed materials [A0000000075880]" type="box">38</container><container id="238d55bfe4cf5e79ccbde06438de170e" parent="a87bd0151107d14443f33e69081b18db" type="folder">8-10</container></did><accessrestrict id="11221f9e1bc9230aebbe4b8afe4c8c85"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="755deaec93a3a8f46413cdb9d38a9847" level="file"><did><unittitle>TML, 41-84 - Pneumococcal vaccine</unittitle><unitdate type="inclusive">1999 September 10</unitdate><container altrender="Record Storage Box (Paige)" id="35a7a2352165aa821b065a81e5ef42de" label="mixed materials [A0000000075880]" type="box">38</container><container id="fc03f3501b9b156bdf708aaac216f904" parent="35a7a2352165aa821b065a81e5ef42de" type="folder">11-13</container></did><accessrestrict id="ad40d9598ad03e97e0de7ff5b12324c2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="0ee2e8ec8ef4a025a102da4125d330c6" level="file"><did><unittitle>TML, 41-20 - Homeopathic products</unittitle><unitdate type="inclusive">1999 February 26</unitdate><container altrender="Record Storage Box (Paige)" id="5fafed4759c4774fa1ddf48a44801eda" label="mixed materials [A0000000075880]" type="box">38</container><container id="d2482919aff62a22ff4905be3c68520b" parent="5fafed4759c4774fa1ddf48a44801eda" type="folder">14-16</container></did><accessrestrict id="1d27c989e3d0f4c9ca2d59fcac0ed578"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="0f8ace5b9ab967ce17459254fb17ca75" level="file"><did><unittitle>TML, 41-55 - Orlistat for obesity</unittitle><unitdate type="inclusive">1999 June 18</unitdate><container altrender="Record Storage Box (Paige)" id="1060d1fa0143d4d7ea21deac11f869cd" label="mixed materials [A0000000075880]" type="box">38</container><container id="be7ec99dbb34726821741df7f4538b3a" parent="1060d1fa0143d4d7ea21deac11f869cd" type="folder">17</container></did><accessrestrict id="3afad4f5d733d9716d22ba16c44983fc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="b2928e0b146edbf6a03684604b2f6230" level="file"><did><unittitle>TML, 41-69 - Prosorba column for rheumatoid arthritis</unittitle><unitdate type="inclusive">1999 July 30</unitdate><container altrender="Record Storage Box (Paige)" id="b810bf683a1945ac57907d2a7009f47a" label="mixed materials [A0000000075880]" type="box">38</container><container id="b6ffd6f5019e7b274e76db9d31e89f02" parent="b810bf683a1945ac57907d2a7009f47a" type="folder">18</container></did><accessrestrict id="f89d8a299f3aa1cb78fdeda3584f26e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e394fdb910a180949b33fcfe30e8b17c" level="file"><did><unittitle>TML, 41-23 - Drugs for hypertension</unittitle><unitdate type="inclusive">1999 March 12</unitdate><container altrender="Record Storage Box (Paige)" id="a3fdf70f6344120d30d4cb3748c903f1" label="mixed materials [A0000000075881]" type="box">39</container><container id="68ac28967e305e72704ef47006d2e210" parent="a3fdf70f6344120d30d4cb3748c903f1" type="folder">1-6</container></did><accessrestrict id="a85ce10fe729a0b9b0f29f163788bcd8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="1a3e95e6f5eb2cbf5b0cdb530d4df8b2" level="file"><did><unittitle>TML, 41-113 - Drugs for non-HIV viral infection</unittitle><unitdate type="inclusive">1999 December 3</unitdate><container altrender="Record Storage Box (Paige)" id="22ab193c0e622d52d503b2502ff07995" label="mixed materials [A0000000075881]" type="box">39</container><container id="fa03d4412f9f30e9e6d52e755a38635d" parent="22ab193c0e622d52d503b2502ff07995" type="folder">7-10</container></did><accessrestrict id="ddc058cf574899e5d0347e37efa9598e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e42d2f63edb58feb20931053061b1339" level="file"><did><unittitle>TML, 41-112 - Pioglitazone (Actos)</unittitle><unitdate type="inclusive">1999 November 19</unitdate><container altrender="Record Storage Box (Paige)" id="b441a585ca9fe3dfacfd8a0154c7f13d" label="mixed materials [A0000000075881]" type="box">39</container><container id="2a7374831b20f35083bc3d5c775929f2" parent="b441a585ca9fe3dfacfd8a0154c7f13d" type="folder">11</container></did><accessrestrict id="2bf75590065032d73df0e0fa13732a7d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="28427104a307e9895b1500110c4ba78c" level="file"><did><unittitle>TML, 41-43 - Suncreens - Are they safe and effective</unittitle><unitdate type="inclusive">1999 May 7</unitdate><container altrender="Record Storage Box (Paige)" id="fe49efc4b9c627b5959ad28f4f192100" label="mixed materials [A0000000075881]" type="box">39</container><container id="6bd2b0348c3e6553771ce1b1e1601dd6" parent="fe49efc4b9c627b5959ad28f4f192100" type="folder">12-16</container></did><accessrestrict id="d50144a362c7ab5f8c046503c10ecf2a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a4c7b991a97b85bed8305af27776e491" level="file"><did><unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle><unitdate type="inclusive">1999 June 18</unitdate><container altrender="Record Storage Box (Paige)" id="d8e1e027b59dadebed2cb09e6a4ba9f2" label="mixed materials [A0000000075881]" type="box">39</container><container id="b7a300796510427d46a89a0ba099e80a" parent="d8e1e027b59dadebed2cb09e6a4ba9f2" type="folder">17-18</container></did><accessrestrict id="9b77ea87c2f2795c19e71f426864b471"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="efd202ef6564adfebc4106108c9561f2" level="file"><did><unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle><unitdate type="inclusive">1999 June 18</unitdate><container altrender="Record Storage Box (Paige)" id="fa0b19b8187dc712c9231a5d1b251aee" label="mixed materials [A0000000075882]" type="box">40</container><container id="3375803d370c3f1334529bbb8568cd85" parent="fa0b19b8187dc712c9231a5d1b251aee" type="folder">1-2</container></did><accessrestrict id="6304e26af10a0e94e7ef043fee53ad70"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="5422bbde47d91ace2df22b5b7527a0e6" level="file"><did><unittitle>TML, 41-105 - A new ACE inhibitorand two new angiotensin receptor blockers for hypertension</unittitle><unitdate type="inclusive">1999 November 5</unitdate><container altrender="Record Storage Box (Paige)" id="70b520f0d7839c8d65f5fc6c2491e5de" label="mixed materials [A0000000075882]" type="box">40</container><container id="956c24e5afce05273adcefd2fe39e831" parent="70b520f0d7839c8d65f5fc6c2491e5de" type="folder">3-6</container></did><accessrestrict id="e16a540da639162df21cb6fa8cf623e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="087aeda452bdc8c1f70b599b752d152a" level="file"><did><unittitle>TML, 41-67 - A new conjugated estrogen</unittitle><unitdate type="inclusive">1999 July 30</unitdate><container altrender="Record Storage Box (Paige)" id="37a378d4ff161053784091dff85d4c20" label="mixed materials [A0000000075882]" type="box">40</container><container id="8bb394cae8b84d14c9d395f7cd0c434c" parent="37a378d4ff161053784091dff85d4c20" type="folder">7-8</container></did><accessrestrict id="3dd21eec3f06c65a80aa71eae6b88575"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e1ba3784eccce1db97752b63119a9737" level="file"><did><unittitle>TML, 41-15 - Drugs and vaccines against biological warfare</unittitle><unitdate type="inclusive">1999 February 12</unitdate><container altrender="Record Storage Box (Paige)" id="9b9f5d16586b52fad7843c7535322dd8" label="mixed materials [A0000000075882]" type="box">40</container><container id="1c38789e968c51a44a271c5d352d5955" parent="9b9f5d16586b52fad7843c7535322dd8" type="folder">9</container></did><accessrestrict id="a078c6c919634b8920e26478d73bef6a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="ee9f72d21997962aa5e1d76e60f28954" level="file"><did><unittitle>TML, 41-68 - Laser hair removal</unittitle><unitdate type="inclusive">1999 July 30</unitdate><container altrender="Record Storage Box (Paige)" id="34151fbf459bed76b4086c021f46f5e8" label="mixed materials [A0000000075882]" type="box">40</container><container id="596cc2a7e649c9af0a85c3499a203a54" parent="34151fbf459bed76b4086c021f46f5e8" type="folder">10-11</container></did><accessrestrict id="0797b526bde059f59517ea165bdcb518"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="0f4d6a53975d9232738144f364667da0" level="file"><did><unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="523dae667ae8b92ac4e179789002aa76" label="mixed materials [A0000000075882]" type="box">40</container><container id="ed7ebe8b59c3c7bdfa89aab75202d7df" parent="523dae667ae8b92ac4e179789002aa76" type="folder">12-16</container></did><accessrestrict id="ca7184a59b6ddfe5ef00a19434c19c48"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="5db523527161519d86f176dd07137b4b" level="file"><did><unittitle>TML, 41-5 - Drugs for Asthma</unittitle><unitdate type="inclusive">1999 January 15</unitdate><container altrender="Record Storage Box (Paige)" id="920e5c8799ac42dee872a6a3c7924758" label="mixed materials [A0000000075883]" type="box">41</container><container id="907d4e7fe6ed26b1848b67f7cdd19776" parent="920e5c8799ac42dee872a6a3c7924758" type="folder">1-5</container></did><accessrestrict id="24b467056399b27bd316ca395f5c8a5e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="3c1f55d592280bce047dbd773f816697" level="file"><did><unittitle>TML, 41-12 - Drugs for chronic heart failure</unittitle><unitdate type="inclusive">1999 January 29</unitdate><container altrender="Record Storage Box (Paige)" id="87d8e7a91015d304c7684524cd8e4db4" label="mixed materials [A0000000075883]" type="box">41</container><container id="15f529bd8e63438adef857d13f8b191d" parent="87d8e7a91015d304c7684524cd8e4db4" type="folder">6-8</container></did><accessrestrict id="a82b9541fad7707df8ff8e0ecec045a1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a5ef95fdd53a4ad00be13d575b720a90" level="file"><did><unittitle>TML, 41-32 - Valrubicin for bladder cancer</unittitle><unitdate type="inclusive">1999 March 26</unitdate><container altrender="Record Storage Box (Paige)" id="2489738b1c4ebcaaddbf563699986d30" label="mixed materials [A0000000075883]" type="box">41</container><container id="6693f46f2f7b09414dbba80eeb40e674" parent="2489738b1c4ebcaaddbf563699986d30" type="folder">9</container></did><accessrestrict id="1246d47b99a5b28275ca7ac909e04e17"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="c9b5394af1307b91512bebaa47987a03" level="file"><did><unittitle>TML, 41-19 - Infliximab (Remicade) for Crohn's disease</unittitle><unitdate type="inclusive">1999 February 26</unitdate><container altrender="Record Storage Box (Paige)" id="aab6bb12bed2bd34d735b64e97ee0902" label="mixed materials [A0000000075883]" type="box">41</container><container id="590c62e5071b44f3ee1b6e74b9c5232e" parent="aab6bb12bed2bd34d735b64e97ee0902" type="folder">10-11</container></did><accessrestrict id="bceed6a85bb227d8a5c9b54693104fa7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="9431f5004a39b8a0d9a05be98633933b" level="file"><did><unittitle>TML, 41-82 - Influenza vaccine, 1999-2000</unittitle><unitdate type="inclusive">1999 September 10</unitdate><container altrender="Record Storage Box (Paige)" id="4d63028979691bd046c3f74c6926abc7" label="mixed materials [A0000000075883]" type="box">41</container><container id="347bae1accc61878d5e454e206eb27e6" parent="4d63028979691bd046c3f74c6926abc7" type="folder">12-13</container></did><accessrestrict id="cab250b6e8f335e1e9356ce49870aa0f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="aa75d744d2b7b8eae4e0c83305434171" level="file"><did><unittitle>TML, 41-81 - Spironolactone for heart failure</unittitle><unitdate type="inclusive">1999 September 10</unitdate><container altrender="Record Storage Box (Paige)" id="0fdd30e0ee75a5aabd8b38fb56e4bf00" label="mixed materials [A0000000075883]" type="box">41</container><container id="6139d90316dbf71e69ab7bd9e7694dd4" parent="0fdd30e0ee75a5aabd8b38fb56e4bf00" type="folder">14-15</container></did><accessrestrict id="4baffc7980c89aadb8cef585c345f731"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="12a411c26719cadf670414ea9db35b3a" level="file"><did><unittitle>TML, 41-2 - Growth-hormone-releasing factor for growth hormone deficiency</unittitle><unitdate type="inclusive">1999 January 1</unitdate><container altrender="Record Storage Box (Paige)" id="0fe9ddef96d06c09c97f1b672d69998d" label="mixed materials [A0000000075883]" type="box">41</container><container id="13cef60f418d8c4645ed0fdd7ed73943" parent="0fe9ddef96d06c09c97f1b672d69998d" type="folder">16-18</container></did><accessrestrict id="f46608e112550ebc9f422dd17a55e3b3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="50fdbec047db8cdec50f09ae8f09ce33" level="file"><did><unittitle>TML, 41-18 - Saw Palmetto for benign prostatic hyperplasia</unittitle><unitdate type="inclusive">1999 February 12</unitdate><container altrender="Record Storage Box (Paige)" id="2599e5e2774731b9a0cf43551ff42e7a" label="mixed materials [A0000000075884]" type="box">42</container><container id="ca0344722c7e92d04b3227ab4836a8b6" parent="2599e5e2774731b9a0cf43551ff42e7a" type="folder">1-3</container></did><accessrestrict id="ebda9b553416d292abf3337874edf243"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="12974761e15d5b5a631f8a1708a1d0e6" level="file"><did><unittitle>TML, 41-107 - SAMe for depression</unittitle><unitdate type="inclusive">1999 November 5</unitdate><container altrender="Record Storage Box (Paige)" id="18dacb6e25b0875b6ea0f29b0096cc8d" label="mixed materials [A0000000075884]" type="box">42</container><container id="50cd3e524ec04e06b5f40da38004d89f" parent="18dacb6e25b0875b6ea0f29b0096cc8d" type="folder">4-7</container></did><accessrestrict id="9f6ccc892b5225ac4e542904aba616bf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="2891c6463578c91c35a01dfbc0867c34" level="file"><did><unittitle>TML, 41-3 - Palivizumab (Synagis) for prevention of RSV infection</unittitle><unitdate type="inclusive">1999 January 1</unitdate><container altrender="Record Storage Box (Paige)" id="562a216e39b3cde477a1cb1e30eeb68a" label="mixed materials [A0000000075884]" type="box">42</container><container id="03a118eaa8fc63bb0f294ae149998f76" parent="562a216e39b3cde477a1cb1e30eeb68a" type="folder">8-9</container></did><accessrestrict id="b084224a8b4665a510e8da9d5962cae8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="aa2d0e7ffb5da88f1ad0bda04c4f91da" level="file"><did><unittitle>TML, 41:47 - Generic Drugs</unittitle><unitdate type="inclusive">1999 May 21</unitdate><container altrender="Record Storage Box (Paige)" id="65fd0b6e4fa902733329a9f34181e694" label="mixed materials [A0000000075884]" type="box">42</container><container id="b1120e1ca843980517f7ef94c5310414" parent="65fd0b6e4fa902733329a9f34181e694" type="folder">10-15</container></did><accessrestrict id="d25ac57dbed224f7c437f5c406d80bfb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="d463206ca7312a03520c55b4035d6d7c" level="file"><did><unittitle>TML, 41-64 - Amprenavir - a new HIV protease inhibitor</unittitle><unitdate type="inclusive">1999 July 16</unitdate><container altrender="Record Storage Box (Paige)" id="0b3524d55630a8be69b2ef0e24765e70" label="mixed materials [A0000000075884]" type="box">42</container><container id="6e6245c74d073f4c392e1877d59afdda" parent="0b3524d55630a8be69b2ef0e24765e70" type="folder">16-17</container></did><accessrestrict id="bebb6703e7e1148e21f6bff4883b5f0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="dacba7e70abbc68ca64fcd4963a6f95a" level="file"><did><unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">1999 August 27</unitdate><container altrender="Record Storage Box (Paige)" id="936335f712a3cf79cd53a96a5fd724e4" label="mixed materials [A0000000075884]" type="box">42</container><container id="cf439d8d22b7a9ec8041d5df1ca620d0" parent="936335f712a3cf79cd53a96a5fd724e4" type="folder">18</container></did><accessrestrict id="a555f10f258ebdc237376c5bf299600d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="813dc879c0e4261b5ae728f45f81e536" level="file"><did><unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">1999 August 27</unitdate><container altrender="Record Storage Box (Paige)" id="d506abb003f86f6f3ee3e0c9f7ed3724" label="mixed materials [A0000000075885]" type="box">43</container><container id="84a1fa574ad0830c60f2ca670d545ff1" parent="d506abb003f86f6f3ee3e0c9f7ed3724" type="folder">1-3</container></did><accessrestrict id="64327b946a10f94bc40f30737c8f1cd2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="bdc50b4955f16ee4564f9a2f1ecc15ee" level="file"><did><unittitle>TML, 41-95 - The Choice of antibacterial drugs</unittitle><unitdate type="inclusive">1999 October 22</unitdate><container altrender="Record Storage Box (Paige)" id="e0fe1bbad05c0e97d38e34d556cb92ea" label="mixed materials [A0000000075885]" type="box">43</container><container id="7890fedbb74aae20185da8fcb365721b" parent="e0fe1bbad05c0e97d38e34d556cb92ea" type="folder">4-8</container></did><accessrestrict id="6b1bb72d82bf5bc8c23cfe7d730b6597"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="9edd35ab1f22644cf6c65fedb0f5fd9d" level="file"><did><unittitle>TML, 41-63 - Cosmetic use of botulinum toxin</unittitle><unitdate type="inclusive">1999 July 16</unitdate><container altrender="Record Storage Box (Paige)" id="cfff71e131da5cb8aef4003bc52d48a8" label="mixed materials [A0000000075885]" type="box">43</container><container id="8ad9da68300780f84f0f87a5e7f5b639" parent="cfff71e131da5cb8aef4003bc52d48a8" type="folder">9-12</container></did><accessrestrict id="dfa20e59cc18902aef49d7b5c22d5eb5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="cadd4aba2aafedf04d2457bcd20ecb68" level="file"><did><unittitle>TML, 41-29 - Lyme disease vaccine</unittitle><unitdate type="inclusive">1999 March 26</unitdate><container altrender="Record Storage Box (Paige)" id="61d76a11aba767379937791fb2ab965a" label="mixed materials [A0000000075885]" type="box">43</container><container id="4b2bc6bd33782207f6e0dc9189e7a0ec" parent="61d76a11aba767379937791fb2ab965a" type="folder">13-16</container></did><accessrestrict id="ebb5315c0e462b0e2629b5dcb90203c8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="bb27af27ca7507bfd777f78da0d17147" level="file"><did><unittitle>TML, 41-121 - Rapid diagnostic tests for influenza</unittitle><unitdate type="inclusive">1999 December 17</unitdate><container altrender="Record Storage Box (Paige)" id="f81552ad5997252110fadebf26ba75f6" label="mixed materials [A0000000075885]" type="box">43</container><container id="141518d499e24f30d678bd94a85c5645" parent="f81552ad5997252110fadebf26ba75f6" type="folder">17-18</container></did><accessrestrict id="86662934e660af89d7aeaa4e4d013446"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="cf44b51a4bbfd2f5063743b63c4a93e3" level="file"><did><unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">1999 September 24</unitdate><container altrender="Record Storage Box (Paige)" id="0f31c208e43045ccc10c1c3a1593a03a" label="mixed materials [A0000000075885]" type="box">43</container><container id="30a8367662db4d77f6a1b3425ac43fe8" parent="0f31c208e43045ccc10c1c3a1593a03a" type="folder">19</container></did><accessrestrict id="53ace92e24d776a3c07d0e679ac418eb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="98fd7e915d5c04bccf9bfee05be98149" level="file"><did><unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">1999 September 24</unitdate><container altrender="Record Storage Box (Paige)" id="9e8adb2c4c83e95fd8c543f8a792491b" label="mixed materials [A0000000075886]" type="box">44</container><container id="e166b1c474cec4b84f8969daa350be86" parent="9e8adb2c4c83e95fd8c543f8a792491b" type="folder">1-3</container></did><accessrestrict id="4fa538c8b0c22de3e0eea7db981ae287"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="47b865bf089a172b75b4d43ce7a1e447" level="file"><did><unittitle>TML, 41-33 - Depression and anxiety</unittitle><unitdate type="inclusive">1999 April 9</unitdate><container altrender="Record Storage Box (Paige)" id="09a1a0878f56fcabfec2da548c41e9f6" label="mixed materials [A0000000075886]" type="box">44</container><container id="5792b41656a1105ecf5c45c009a5fa6f" parent="09a1a0878f56fcabfec2da548c41e9f6" type="folder">4-13</container></did><accessrestrict id="b0f422d658f31862e120da53fa05b6f9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="71225c0666898a85e784b2cb281888c6" level="file"><did><unittitle>TML, 41-122 - Corneal surgery for correction of refractive errors</unittitle><unitdate type="inclusive">1999 December 17</unitdate><container altrender="Record Storage Box (Paige)" id="bde4859a115ed886d95143e7b7e95f5c" label="mixed materials [A0000000075886]" type="box">44</container><container id="557d30b4c810086f06a49e4c9ba0c649" parent="bde4859a115ed886d95143e7b7e95f5c" type="folder">14-16</container></did><accessrestrict id="383c5c203f77ebf4dd9e3dfe67c24cf7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="45f2b2be0a5f877794d8dab41d1e2c89" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="8adfd48cb7bbafe78b352b7ec60b3a04" label="mixed materials [A0000000075886]" type="box">44</container><container id="50881d32a8aef02934eded0ed8f1e6ae" parent="8adfd48cb7bbafe78b352b7ec60b3a04" type="folder">17-18</container></did><accessrestrict id="149a9e74e2c2eb4d35105c1043e77fd1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="59f39d33e558df2c7a53b2df2d17a4ae" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="4b6abd8e72a5b70737d62c212d04ab93" label="mixed materials [A0000000075887]" type="box">45</container><container id="b596f93fee9570671a1a98e12f7316f8" parent="4b6abd8e72a5b70737d62c212d04ab93" type="folder">1-3</container></did><accessrestrict id="6cab2eae0fd66d97ea7c349b2f4718db"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="8d82b612550e56f5febd997b649248f6" level="file"><did><unittitle>TML - Drugs for Cardiac Arrhythmias</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="baf5cc456d0278e9f7b9f5f575e7df8e" label="mixed materials [A0000000075887]" type="box">45</container><container id="19e439349942296dcc4f7866d0794413" parent="baf5cc456d0278e9f7b9f5f575e7df8e" type="folder">4-9</container></did><accessrestrict id="9ea5dcafb096eb9d1dba6ab8571932c7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="729c9bb0e1660ceb032fe6da8350333c" level="file"><did><unittitle>TML - Drugs of Choice for cancer chemotherapy</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="874977ac90bbc2eb9dc0c12c0c077e3c" label="mixed materials [A0000000075887]" type="box">45</container><container id="c658f692f8037230a49567df9b5dc08f" parent="874977ac90bbc2eb9dc0c12c0c077e3c" type="folder">10-16</container></did><accessrestrict id="5ad67e35d3361f03756bfe78c6e60019"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="737148b055ba101acbd8ee7df7c07e4c" level="file"><did><unittitle>TML, 41-44 - Cilostazol for intermittent claudication</unittitle><unitdate type="inclusive">1999 May 7</unitdate><container altrender="Record Storage Box (Paige)" id="7b3b6f9e03aa2798f155fbfe3e7bddf9" label="mixed materials [A0000000075887]" type="box">45</container><container id="107ba11cd2f2d52e50ed87bee7c242b2" parent="7b3b6f9e03aa2798f155fbfe3e7bddf9" type="folder">17-20</container></did><accessrestrict id="91985532c77a98b2be6619b3829a2c87"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="6e0f28a2b5a8cac84be32ec338816dac" level="file"><did><unittitle>TML, 41-11 - Celecoxib for arthritis</unittitle><unitdate type="inclusive">1999 January 29</unitdate><container altrender="Letter Document Box" id="e3b0dbf2b4a817928f394ce2ebf262d7" label="mixed materials [A0000000075888]" type="box">46</container><container id="c0d1049dd38c6f35dc17741fd5ef3513" parent="e3b0dbf2b4a817928f394ce2ebf262d7" type="folder">1-4</container></did><accessrestrict id="5220646ffa341e43aaef650d57ef5cbb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="47ee2aa0e1414311aab659a0b7791d48" level="file"><did><unittitle>TML, 41-61 - Drug interactions</unittitle><unitdate type="inclusive">1999 July 2</unitdate><container altrender="Letter Document Box" id="c7a18963088f33edcab40d129954f8ba" label="mixed materials [A0000000075945]" type="box">103</container><container id="75e1f06eeeb283c7736c3782abb813a3" parent="c7a18963088f33edcab40d129954f8ba" type="folder">1-4</container></did><accessrestrict id="2310dca3aaada449df04e476753e097f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="ca7a582ccc3762635c6b2b1ab49c2e38" level="file"><did><unittitle>TML, 42-51 - Ciclopirox (Penlac) nail lacquer for onychomysis</unittitle><unitdate type="inclusive">2000 June 12</unitdate><container altrender="Record Storage Box (Paige)" id="f0eababdc265965fbebdf92d2df1b7f5" label="mixed materials [A0000000075889]" type="box">47</container><container id="50adc12a3683742cc4bba1b653631ad1" parent="f0eababdc265965fbebdf92d2df1b7f5" type="folder">1-2</container></did><accessrestrict id="9580c594e1986354a883d0b4d0b71bc3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="4b13f0ecb976a0758dff29129231c5ab" level="file"><did><unittitle>TML, 42-70 - Cevimeline (Evoxac) for dry mouth</unittitle><unitdate type="inclusive">2000 August 7</unitdate><container altrender="Record Storage Box (Paige)" id="bc51da58868b8729e3365b9f28b18c02" label="mixed materials [A0000000075889]" type="box">47</container><container id="60adf4bbfc78f574eb02649bbbbfef65" parent="bc51da58868b8729e3365b9f28b18c02" type="folder">3</container></did><accessrestrict id="ab5ca835a64facd8b0328a6bddeaa9db"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="65fedbec948e0fc83c65d93e86ad6afd" level="file"><did><unittitle>TML, 42-13 - Sirolimus (Rapamune) for transplant rejection</unittitle><unitdate type="inclusive">2000 February 7</unitdate><container altrender="Record Storage Box (Paige)" id="c7cf2959cff59c9b86a77f7a71412789" label="mixed materials [A0000000075889]" type="box">47</container><container id="9f559e27ae40e81a71807b27fe5dd46a" parent="c7cf2959cff59c9b86a77f7a71412789" type="folder">4-6</container></did><accessrestrict id="7082abcbc2a52e308ef67322853d8731"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="43b3f1afcb8ce7fdcc73ea538a9dcaef" level="file"><did><unittitle>TML, 42-56 - Drug interactions with St. John's Wort</unittitle><unitdate type="inclusive">2000 June 26</unitdate><container altrender="Record Storage Box (Paige)" id="e934d6ada34e44fc5e9d6af39be33cfd" label="mixed materials [A0000000075889]" type="box">47</container><container id="cab01e375f88ccd8f427988cc3ae681d" parent="e934d6ada34e44fc5e9d6af39be33cfd" type="folder">7-9</container></did><accessrestrict id="fc05579a4affa53f15f6bf7701c8c36c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="13d9761c756a2fe7adb0ccd2bd89e5c3" level="file"><did><unittitle>TML, 42-27 - Curosurf</unittitle><unitdate type="inclusive">2000 March 20</unitdate><container altrender="Record Storage Box (Paige)" id="20198aa5cf5518a4986cb988e865c41e" label="mixed materials [A0000000075889]" type="box">47</container><container id="7c9bf24bae6c57061ef0a2f6dc2bce10" parent="20198aa5cf5518a4986cb988e865c41e" type="folder">10-12</container></did><accessrestrict id="a42091b45287859d025abbb92f4814dc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c1fd925b81d971c06ec273ef08f3cb74" level="file"><did><unittitle>TML, 42-81 - Photodynamic therapy with veterfporfin (Visudyne) for macular degeneration</unittitle><unitdate type="inclusive">2000 September 4</unitdate><container altrender="Record Storage Box (Paige)" id="148dba69b703dd33cf7196fc03d609a3" label="mixed materials [A0000000075889]" type="box">47</container><container id="610f7e27a9bec9acbc4c6d79f21e6026" parent="148dba69b703dd33cf7196fc03d609a3" type="folder">13-15</container></did><accessrestrict id="25831287c40dd007e7ad4f179aa90da2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="259c3ccf591bab51ffdaba3a9994e765" level="file"><did><unittitle>TML, 42-57 - Drugs for rheumatoid arthritis</unittitle><unitdate type="inclusive">2000 July 10</unitdate><container altrender="Record Storage Box (Paige)" id="0cb24b4e9bf58af30491eb46f7c8cadd" label="mixed materials [A0000000075889]" type="box">47</container><container id="6decdd8b95ca99e8dc3610a8d93d5c03" parent="0cb24b4e9bf58af30491eb46f7c8cadd" type="folder">16-20</container></did><accessrestrict id="162cb0e7647f4a98954f5445c257c882"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="62b6871b865b6d75c47266161b21cb21" level="file"><did><unittitle>TML, 42-113 - Phenylpropanolamine</unittitle><unitdate type="inclusive">2000 December 11</unitdate><container altrender="Record Storage Box (Paige)" id="a9e4aa9541ba750da17fae2f5cb82596" label="mixed materials [A0000000075890]" type="box">48</container><container id="501ec0ac680f208e61fd8539f1c7b9d1" parent="a9e4aa9541ba750da17fae2f5cb82596" type="folder">1</container></did><accessrestrict id="3a8380c96fc7714fa7d33e8fc9eda5f1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="7e8cf0d2095db89bdcf602dcfa388b37" level="file"><did><unittitle>TML, 42-94 - Zonisamide (Zonegran) for epilepsy</unittitle><unitdate type="inclusive">2000 August 1</unitdate><container altrender="Record Storage Box (Paige)" id="005050978a63981ebe9095fa6d4dbf03" label="mixed materials [A0000000075890]" type="box">48</container><container id="36d390d4d93d9ec4755adebc4f7fd08d" parent="005050978a63981ebe9095fa6d4dbf03" type="folder">2-4</container></did><accessrestrict id="af9a344f43755a6c943435e3e709888a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="505b60f40ff960c724ff856e304ce951" level="file"><did><unittitle>TML, 42-10 - Emergency Contraception - Plan B</unittitle><unitdate type="inclusive">2000 January 24</unitdate><container altrender="Record Storage Box (Paige)" id="dbf135525fb1472adbd2810e5a627f14" label="mixed materials [A0000000075890]" type="box">48</container><container id="8fa6b48da8247f519386018b70f40e0d" parent="dbf135525fb1472adbd2810e5a627f14" type="folder">5</container></did><accessrestrict id="3cd71612bf2f98b55022fa5ad125e9e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="86b41328d3a3f3bd0b39258221d169af" level="file"><did><unittitle>TML, 42-42 - Oral contraceptives</unittitle><unitdate type="inclusive">2000 May 15</unitdate><container altrender="Record Storage Box (Paige)" id="06d881a07ba2bf83e1b86d97f0d2f242" label="mixed materials [A0000000075890]" type="box">48</container><container id="1b9efef5548bba3691a0e6e792d02e71" parent="06d881a07ba2bf83e1b86d97f0d2f242" type="folder">6-11</container></did><accessrestrict id="362a441b3fc8d8a82b31585a57ea0665"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="5af9d8711bf691d44ab3b1e5bb256681" level="file"><did><unittitle>TML, 42-17 - Phytoestrogens</unittitle><unitdate type="inclusive">2000 February 21</unitdate><container altrender="Record Storage Box (Paige)" id="7946dbac78c67281ea0521bfde8812c5" label="mixed materials [A0000000075890]" type="box">48</container><container id="0a60337e4759fe83c8dc457311e3e676" parent="7946dbac78c67281ea0521bfde8812c5" type="folder">12-14</container></did><accessrestrict id="b6923da0f1e80e36ed724d7930240ab0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="408be2b8c6034a613b1211f2ecf9b661" level="file"><did><unittitle>TML, 42-29 - Calcium citrate vs Calcium carbonate calcium supplements</unittitle><unitdate type="inclusive">2000 April 3</unitdate><container altrender="Record Storage Box (Paige)" id="c56f629c534e2af3dd9c38a2c158d635" label="mixed materials [A0000000075890]" type="box">48</container><container id="3e62630a245bda3ef6e0e93f726659bb" parent="c56f629c534e2af3dd9c38a2c158d635" type="folder">15-16</container></did><accessrestrict id="f012aa712ae69a791944518eafe15ae9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="3335c85c5f584c0623918d305860bba9" level="file"><did><unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle><unitdate type="inclusive">2000 May 29</unitdate><container altrender="Record Storage Box (Paige)" id="d0aa81cec4677000b6b1a799b5dee7c3" label="mixed materials [A0000000075890]" type="box">48</container><container id="5d10df69c704ea5716418c7ff1e8e081" parent="d0aa81cec4677000b6b1a799b5dee7c3" type="folder">17-18</container></did><accessrestrict id="55427e8bb48ad2b8315333c1ff339476"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c6d41dc2321b4992a2ce79264290f903" level="file"><did><unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle><unitdate type="inclusive">2000 May 29</unitdate><container altrender="Record Storage Box (Paige)" id="7c73d9b8c683abdca7c884c09f9aab84" label="mixed materials [A0000000075891]" type="box">49</container><container id="e5a8a69b71d5261a7a1e9e8024cec4bb" parent="7c73d9b8c683abdca7c884c09f9aab84" type="folder">1</container></did><accessrestrict id="a4945089c03fcb0a219bdaccf387431a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="1ff03efd208b21a2efb1beeeca59fbe2" level="file"><did><unittitle>TML, 42-41 - Dofetilide for atrial fibrillation</unittitle><unitdate type="inclusive">2000 May 15</unitdate><container altrender="Record Storage Box (Paige)" id="017c0410fa09d75567aaabc9d1c4f5d7" label="mixed materials [A0000000075891]" type="box">49</container><container id="43126483a297f9bc99de3c8ae3aba22f" parent="017c0410fa09d75567aaabc9d1c4f5d7" type="folder">2-4</container></did><accessrestrict id="f05aa84b2f28b6ffb33fe96ec43cd992"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="97e9932d34799dd8520be9e13f8a01ce" level="file"><did><unittitle>TML, 40-102 - Colesevelam (Welchol) for hypercholesterolemia</unittitle><unitdate type="inclusive">2000 October 30</unitdate><container altrender="Record Storage Box (Paige)" id="57d3b12b12c29d14799c527cc950df6f" label="mixed materials [A0000000075891]" type="box">49</container><container id="925c3907ffd547924a848fe608e04271" parent="57d3b12b12c29d14799c527cc950df6f" type="folder">5</container></did><accessrestrict id="349dee1a0f2981a7afaffa486ad92400"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b1e989f44b7978ab2b1aaaf201f34aeb" level="file"><did><unittitle>TML, 42-108 - Docosanal cream (Abreva) for recurrent herpes labialis</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="70f9c6a6ef1088490b48cd8fb47a9f50" label="mixed materials [A0000000075891]" type="box">49</container><container id="9995e20ad10faa76e8048a56f5b355fb" parent="70f9c6a6ef1088490b48cd8fb47a9f50" type="folder">6</container></did><accessrestrict id="086b94bfdd5ebcae1564c66a07d71bf4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="e0e61fb5a1e14299b5769bb3645966af" level="file"><did><unittitle>TML, 42-106 - Temecteplase (TNKASE) for thrombolysis</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="e18bea8c019c9806845b3a8d3f88dd81" label="mixed materials [A0000000075891]" type="box">49</container><container id="f33d7fe7f2e8ed9488cf6ec5f843967b" parent="e18bea8c019c9806845b3a8d3f88dd81" type="folder">7-10</container></did><accessrestrict id="6881f1eb6305a22e4485bcca7bf92f20"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="3d342507f2c128f34587c4f458c47ae3" level="file"><did><unittitle>TML, 42-113 - Valproate and other anticonvulsants for psychiatric disorders</unittitle><unitdate type="inclusive">2000 December 11</unitdate><container altrender="Record Storage Box (Paige)" id="294affcc4cef6b6cdf54472a04f45f26" label="mixed materials [A0000000075891]" type="box">49</container><container id="18551397040f60723318ed1599c58bfa" parent="294affcc4cef6b6cdf54472a04f45f26" type="folder">11-14</container></did><accessrestrict id="175706ce1b1be1373cdbf4234daea11e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="89f1be4de95ddec6822bda7f0e83b385" level="file"><did><unittitle>TML, 42-8 - Prevention of malaria</unittitle><unitdate type="inclusive">2000 January 24</unitdate><container altrender="Record Storage Box (Paige)" id="1191c221409d55a7faedbd53f2bb7d01" label="mixed materials [A0000000075891]" type="box">49</container><container id="4411cfd8e0e495d96fc7273a1591a789" parent="1191c221409d55a7faedbd53f2bb7d01" type="folder">15</container></did><accessrestrict id="9af6ac60aa40dc6005ce4edb57dc6970"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="da557a8aeefe93b11b7b65ef3275ee26" level="file"><did><unittitle>TML, 42-37 - Lyme disease</unittitle><unitdate type="inclusive">2000 May 1</unitdate><container altrender="Record Storage Box (Paige)" id="3b47c9ee798bc40c03815af2a19a21e3" label="mixed materials [A0000000075891]" type="box">49</container><container id="e21e667577c242d97d32a797b37900a9" parent="3b47c9ee798bc40c03815af2a19a21e3" type="folder">16-18</container></did><accessrestrict id="50f594b6d9dec7b83b3b83386b475dcd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b9d25758af7747ace6aaf80757aac85f" level="file"><did><unittitle>TML, 42-18 - Aspirin for primary prevention of cardiovascular disease</unittitle><unitdate type="inclusive">2000 February 21</unitdate><container altrender="Record Storage Box (Paige)" id="d8dbfb27cea0d285e80d2a90bcb8f0c8" label="mixed materials [A0000000075891]" type="box">49</container><container id="8a1f8f8dce9d84adfe51b031297418f5" parent="d8dbfb27cea0d285e80d2a90bcb8f0c8" type="folder">19-20</container></did><accessrestrict id="bd7e6d6a5d2765181060a6c4e5bc8024"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="8827ef8acb277df2d477589d43015ed3" level="file"><did><unittitle>TML, 42-73 - Drugs for pain</unittitle><unitdate type="inclusive">2000 August 21</unitdate><container altrender="Record Storage Box (Paige)" id="3cdcac4c1041efce4ddd3e8e8b985a9f" label="mixed materials [A0000000075892]" type="box">50</container><container id="15168dcf702fb7c406390a1ccaf61dd9" parent="3cdcac4c1041efce4ddd3e8e8b985a9f" type="folder">1-6</container></did><accessrestrict id="45351d67ab671d76012768894632e65f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="7ca68fc3cc569b193dc410a094f9a61f" level="file"><did><unittitle>TML, 42-19 - Drugs for Asthma</unittitle><unitdate type="inclusive">2000 March 6</unitdate><container altrender="Record Storage Box (Paige)" id="261b5ada83062465c2d42c0b5e5a3ce1" label="mixed materials [A0000000075892]" type="box">50</container><container id="be594e9383727da1020879f7112cdce9" parent="261b5ada83062465c2d42c0b5e5a3ce1" type="folder">7-10</container></did><accessrestrict id="843840cc3a1f4f944dcd68fb679ac778"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="11f2fac87764b93bfe43bd87321c6e78" level="file"><did><unittitle>TML, 42-49 - Androgel</unittitle><unitdate type="inclusive">2000 June 1</unitdate><container altrender="Record Storage Box (Paige)" id="0e1b53b2345e56dbc91459a87002a8d4" label="mixed materials [A0000000075892]" type="box">50</container><container id="50a4aef701b40946d2fe73949d83e094" parent="0e1b53b2345e56dbc91459a87002a8d4" type="folder">11-13</container></did><accessrestrict id="373b10f2aaf453294914d4fe78b9487f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f519c54c8f624fc16003fa1c04fa88f0" level="file"><did><unittitle>TML, 42-97 - Drugs for prevention and treatment of postmenopausal osteoporosis</unittitle><unitdate type="inclusive">2000 October 16</unitdate><container altrender="Record Storage Box (Paige)" id="e4afbd99534d1112cfb91fb2cc47c1b8" label="mixed materials [A0000000075892]" type="box">50</container><container id="3e5773d32ee917ef393635f042f1a58b" parent="e4afbd99534d1112cfb91fb2cc47c1b8" type="folder">14-18</container></did><accessrestrict id="f6c66097c55fc7906c4f0813a2f589d8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="da9eaff7a676c3ce93fb52a83c4df992" level="file"><did><unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle><unitdate type="inclusive">2000 October 2</unitdate><container altrender="Record Storage Box (Paige)" id="edd403fc1cb8d5612a2f8e5efe77d4ed" label="mixed materials [A0000000075892]" type="box">50</container><container id="6714848d04330c57a15f5735e9660ad8" parent="edd403fc1cb8d5612a2f8e5efe77d4ed" type="folder">19-20</container></did><accessrestrict id="0b717ab0083f68384631636b834fec64"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f307fe5a6bafa6083a914965f47c224f" level="file"><did><unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle><unitdate type="inclusive">2000 October 2</unitdate><container altrender="Record Storage Box (Paige)" id="3610b66b9d5718b3384d2ff58bba81a5" label="mixed materials [A0000000075893]" type="box">51</container><container id="0b5a82748272e83c7747a2d4388d9fb9" parent="3610b66b9d5718b3384d2ff58bba81a5" type="folder">1</container></did><accessrestrict id="dc26934d88198182e177b592f4868a43"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0d88056c01b79b6a4d890ffb52ef26d7" level="file"><did><unittitle>TML, 42-31 - Bexrotene</unittitle><unitdate type="inclusive">2000 April 3</unitdate><container altrender="Record Storage Box (Paige)" id="2635296ef116a7044d01955fd79340eb" label="mixed materials [A0000000075893]" type="box">51</container><container id="572bc068d16a1fb1f16bf0ed6b94ef7b" parent="2635296ef116a7044d01955fd79340eb" type="folder">2-4</container></did><accessrestrict id="9a8c86a85c6d5ea077e55d9b7597d55f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="78aad480d71976b1ac63856f8414b2de" level="file"><did><unittitle>TML, 42-116 - Portable Defibrillators</unittitle><unitdate type="inclusive">2000 December 11</unitdate><container altrender="Record Storage Box (Paige)" id="1102fd29d0f43c4a0b13d87024bfaf2c" label="mixed materials [A0000000075893]" type="box">51</container><container id="dadd90304702840291e9b5002368024d" parent="1102fd29d0f43c4a0b13d87024bfaf2c" type="folder">5-6</container></did><accessrestrict id="da50ccc68a37dbb555145dfbcf8f1e7c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="8856ac6d297ba039f5f59b8393406463" level="file"><did><unittitle>TML, 42-111 - Drugs that may cause cognitive disorders in the elderly</unittitle><unitdate type="inclusive">2000 November 27</unitdate><container altrender="Record Storage Box (Paige)" id="1a6e0b51a8cee9e67f895fa841470228" label="mixed materials [A0000000075893]" type="box">51</container><container id="6ede92db770d15db5974485566213609" parent="1a6e0b51a8cee9e67f895fa841470228" type="folder">7-10</container></did><accessrestrict id="2247b3013b5d4bd66554d265282ec46f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="d791d0f324ea7d0ebc4dcab430fc3a36" level="file"><did><unittitle>TML, 42-36 - Substituting for troglitazone (Rezulin)</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="407835807bb0f48c844b7e5ef04f1eb9" label="mixed materials [A0000000075893]" type="box">51</container><container id="b3c948cc819c2cbeef9c2581e6a4b433" parent="407835807bb0f48c844b7e5ef04f1eb9" type="folder">11</container></did><accessrestrict id="35757c84324de4837de836a4d664e4bd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="390553fd7a4eea2f5cbee5002f2322bc" level="file"><did><unittitle>TML, 42-109 - Atovaquone - Proguanil (Malarone) for malaria</unittitle><unitdate type="inclusive">2000 November 27</unitdate><container altrender="Record Storage Box (Paige)" id="8e8ce1bdea359f0162b4c935f7a66088" label="mixed materials [A0000000075893]" type="box">51</container><container id="ac3a2be15b679b7b18f6f541aaf46a62" parent="8e8ce1bdea359f0162b4c935f7a66088" type="folder">12-15</container></did><accessrestrict id="717bd1e1f90c70ff656382467cc26f89"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="102174d0143d0b7b46d5dbdfb6ee2e6c" level="file"><did><unittitle>TML, 42-39 - Ketotifen and Pemirlostat - New drugs for allergic conjunctivitis</unittitle><unitdate type="inclusive">2000 May 1</unitdate><container altrender="Record Storage Box (Paige)" id="d30bb65eabd932b2334e0731b9e52972" label="mixed materials [A0000000075893]" type="box">51</container><container id="63032cbc887552c03355d670ce1a688e" parent="d30bb65eabd932b2334e0731b9e52972" type="folder">16-17</container></did><accessrestrict id="c0dedfa65ff00b42eaec283e7dbe5ee3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="968dfa06d929ab040463fb621fb94e15" level="file"><did><unittitle>TML - HAT - Systemic antifungal</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="3eb0ab5c60e874b713025ff1a3c0882a" label="mixed materials [A0000000075893]" type="box">51</container><container id="fd744505ead86bb65f366ce8cb4649d6" parent="3eb0ab5c60e874b713025ff1a3c0882a" type="folder">18-19</container></did><accessrestrict id="a7608b2e6d21017e82cac99f4c300d04"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ffb773729eccb5c024461cb32728a1f5" level="file"><did><unittitle>TML - HAT - Systemic antifungal</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="e2af108a1e647258a373d68a276ac282" label="mixed materials [A0000000075894]" type="box">52</container><container id="438bdef3e7c5d6dca3141e316a8a4d89" parent="e2af108a1e647258a373d68a276ac282" type="folder">1-2</container></did><accessrestrict id="fc274c9d6d48168ac3a11ea6067869e0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b5adf750afaa8fb0be9aa2061a43e3b8" level="file"><did><unittitle>TML, 42-96 - Eflornithine cream for facial hair reduction</unittitle><unitdate type="inclusive">2000 October 2</unitdate><container altrender="Record Storage Box (Paige)" id="a7dec2bef6ec03ea104a9a7fb42e7f4e" label="mixed materials [A0000000075894]" type="box">52</container><container id="68a0563059b1b2a68577eddbbaa53b42" parent="a7dec2bef6ec03ea104a9a7fb42e7f4e" type="folder">3</container></did><accessrestrict id="97998d665049bfafbdf7f044ef962ac2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c88b481d9cf92fe516e086aa696f2759" level="file"><did><unittitle>TML, 42-67 - Gemtuzumab for relapsed acute myeloid leukemia</unittitle><unitdate type="inclusive">2000 July 24</unitdate><container altrender="Record Storage Box (Paige)" id="797c75d8e9fe3f6e6143a5790aaea6c9" label="mixed materials [A0000000075894]" type="box">52</container><container id="70fe0503c5b1c706947136b668e35090" parent="797c75d8e9fe3f6e6143a5790aaea6c9" type="folder">4-5</container></did><accessrestrict id="8158423ad1861ed096a1f762bea5ed19"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="d316d036d1c1c8b5e65cc5a3309c50cf" level="file"><did><unittitle>TML, 42-52 - Atkin's diet</unittitle><unitdate type="inclusive">2000 June 12</unitdate><container altrender="Record Storage Box (Paige)" id="8892227f5e1414cc1e311dde02cc46f8" label="mixed materials [A0000000075894]" type="box">52</container><container id="c3edb360a2cf37b02092175ff57034e0" parent="8892227f5e1414cc1e311dde02cc46f8" type="folder">6-8</container></did><accessrestrict id="0024c5f9b90643b42da0ff940f490484"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f039186b802088d6736b63d8692ff877" level="file"><did><unittitle>TML, 42-71 - Hypnotic drugs</unittitle><unitdate type="inclusive">2000 August 7</unitdate><container altrender="Record Storage Box (Paige)" id="77c2608a39c8d051dd8785924b1b565f" label="mixed materials [A0000000075894]" type="box">52</container><container id="75dcd2edb814468ba7b327f5e94764e3" parent="77c2608a39c8d051dd8785924b1b565f" type="folder">9-12</container></did><accessrestrict id="66081d4df14137512de48118dd485bfc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ddaac639270ba0e3369ea6c5bef18c02" level="file"><did><unittitle>TML, 42-79 - Influenza update 2000-2001</unittitle><unitdate type="inclusive">2000 September 4</unitdate><container altrender="Record Storage Box (Paige)" id="4f155eb9f74abe243439797a81012cc5" label="mixed materials [A0000000075894]" type="box">52</container><container id="6a28409f10d4e93a00412ce52f413c35" parent="4f155eb9f74abe243439797a81012cc5" type="folder">13-14</container></did><accessrestrict id="2370a9ec5de5c8b19f6823b89c720366"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="3b89f483901c2a204aeb8a707d5f619e" level="file"><did><unittitle>TML, 42-35 - Exemestane for advanced breast cancer</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="754aa0b983e5cf555214e59da59fdec5" label="mixed materials [A0000000075894]" type="box">52</container><container id="cd3011df807b56ae903de56f091ee97a" parent="754aa0b983e5cf555214e59da59fdec5" type="folder">15-17</container></did><accessrestrict id="908ae2bf04aa596e7e5c1b4a0b435a1a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="5b4d37f27c36f2cf78b12c02f16d9dd0" level="file"><did><unittitle>TML, 42-12 - Epirubicin for adjuvant therapy in node-positive breast cancer</unittitle><unitdate type="inclusive">2000 February 7</unitdate><container altrender="Record Storage Box (Paige)" id="30f8d3cd32dd7835a548319e74a827f7" label="mixed materials [A0000000075894]" type="box">52</container><container id="b3674ee8798503476965d87d379bea70" parent="30f8d3cd32dd7835a548319e74a827f7" type="folder">18-20</container></did><accessrestrict id="231c8f3761cd29bf8b9da59c1db76773"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ea21c93279b7213ac4ebcf26ac90ac01" level="file"><did><unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="f3b87f8a12d5c67f6895a848adb2a62f" label="mixed materials [A0000000075894]" type="box">52</container><container id="6ad6b494e7b34a04f3be1cac116baebd" parent="f3b87f8a12d5c67f6895a848adb2a62f" type="folder">21</container></did><accessrestrict id="ecde6f626cda50967973b161a20fcc74"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0670855c3da978011ef91e63b94b8614" level="file"><did><unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="9c75becc98bd20e9b5f7e6264e0611f7" label="mixed materials [A0000000075895]" type="box">53</container><container id="834ef7930e189b1e8cf93fb04b15785d" parent="9c75becc98bd20e9b5f7e6264e0611f7" type="folder">1-2</container></did><accessrestrict id="b1545fba52ccf81c38c8688169dab34a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b9f3b0c3756751d471fc83952e9cdb9e" level="file"><did><unittitle>TML - HAT - Adverse Effects</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="fa43b4aeb16fb18b84396878685017f2" label="mixed materials [A0000000075895]" type="box">53</container><container id="20d455dde388aafbb2565407c7a96d50" parent="fa43b4aeb16fb18b84396878685017f2" type="folder">3-4</container></did><accessrestrict id="f035a5812a9a5ba9f187b537f909316a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0f64e1cb70a81058fe2a570f1ccb8c4a" level="file"><did><unittitle>TML - Perinopril - A new ACE inhibitor for hypertension</unittitle><unitdate type="inclusive">2000 May 26</unitdate><container altrender="Record Storage Box (Paige)" id="d38f553d0529a8d82314c09dc797bf4a" label="mixed materials [A0000000075895]" type="box">53</container><container id="b5cf1f919752615aa854cf781da9f722" parent="d38f553d0529a8d82314c09dc797bf4a" type="folder">5-8</container></did><accessrestrict id="8e19dab12d3196a7486bcf0f13a7475f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="9370ffe6e8855002d778fc797c644238" level="file"><did><unittitle>TML, 42-65 - Pantoprazole (Protonix)</unittitle><unitdate type="inclusive">2000 July 24</unitdate><container altrender="Record Storage Box (Paige)" id="af502e6a5d6c52ed2194904b318265f6" label="mixed materials [A0000000075895]" type="box">53</container><container id="91e88067a0d5a0c0f11ef11e98602898" parent="af502e6a5d6c52ed2194904b318265f6" type="folder">9-12</container></did><accessrestrict id="a1015b3acc8c847466def1105f15644b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="354614b4cdeb7c25dce7323acfe3837f" level="file"><did><unittitle>TML, 42-15 - Gatifloxacin and Moxifloxacin - Two new fluoroquinolones</unittitle><unitdate type="inclusive">2000 February 21</unitdate><container altrender="Record Storage Box (Paige)" id="03a0ab593d33c8c4329ec516b81e0be9" label="mixed materials [A0000000075895]" type="box">53</container><container id="cefd12726457bd0d4c571d43031e0502" parent="03a0ab593d33c8c4329ec516b81e0be9" type="folder">13-18</container></did><accessrestrict id="5bf74d558644f64e23255ce061463c78"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ee26dc57604d2e8beb15f5282094c199" level="file"><did><unittitle>TML, HAT - Antimicrobial Dosage</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="57156f165a795852687bccc6deb66744" label="mixed materials [A0000000075895]" type="box">53</container><container id="b2fcd8f77a6c0502b5cb5e8cb066f022" parent="57156f165a795852687bccc6deb66744" type="folder">19</container></did><accessrestrict id="11c3455a2f2e87c2b16773aa9e6aea7c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="a088080df443869d26625b88cfb8357c" level="file"><did><unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="9e81f7236be78631b2d732cd003d646b" label="mixed materials [A0000000075895]" type="box">53</container><container id="85bf91b3894009849ddd15039dbe8aaa" parent="9e81f7236be78631b2d732cd003d646b" type="folder">20</container></did><accessrestrict id="204852f90f3648c6b6e5e6274cb652ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="4786db2a3aa9c724f7f60dcf4fcf9164" level="file"><did><unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="74ceb4f8d3b2f0c33c01d2e167e39ec3" label="mixed materials [A0000000075896]" type="box">54</container><container id="3fe7e6246c8c4b934df7be0fa82f6ced" parent="74ceb4f8d3b2f0c33c01d2e167e39ec3" type="folder">1-2</container></did><accessrestrict id="19470d2540faf3143d53c5e0f0f04553"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ff8898d4bdb05f23855cdb33eaefc878" level="file"><did><unittitle>TML, 42-53 - Alosetron (Lotronex) for irritable bowel syndrome</unittitle><unitdate type="inclusive">2000 June 26</unitdate><container altrender="Record Storage Box (Paige)" id="67f983b1dfb15831beb09a5767b91952" label="mixed materials [A0000000075896]" type="box">54</container><container id="ae366abe4f7e9b57912dd90fbd65cdeb" parent="67f983b1dfb15831beb09a5767b91952" type="folder">3-4</container></did><accessrestrict id="a92fba8d7b374bd5ed2b6377d7f5dfcf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c83dbfe7a53fd4d335c81b6902eff92d" level="file"><did><unittitle>TML, 42-25 - Conjugated pneumococcal vaccine for infants and children</unittitle><unitdate type="inclusive">2000 March 20</unitdate><container altrender="Record Storage Box (Paige)" id="f2b749b2296a2a75c7e19b1154289f00" label="mixed materials [A0000000075896]" type="box">54</container><container id="9bbe16951d0a3a7cf41d17efbdcd284a" parent="f2b749b2296a2a75c7e19b1154289f00" type="folder">5-7</container></did><accessrestrict id="aee461894cb0482b20c2792522b46e12"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0c6944c64d3e895d17a92cb7a840b2cc" level="file"><did><unittitle>TML, 42-69 - Meningococcal vaccine - College students</unittitle><unitdate type="inclusive">2000 August 7</unitdate><container altrender="Record Storage Box (Paige)" id="0d69507f029365c56e24b43b461490fe" label="mixed materials [A0000000075896]" type="box">54</container><container id="365d66005c110b1fff726aaf3ba79c7b" parent="0d69507f029365c56e24b43b461490fe" type="folder">8-9</container></did><accessrestrict id="df37cebc2f1268161ba89264e0aa24c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f8521e46162fc0e16135537e8fe60e0e" level="file"><did><unittitle>TML, 42-80 - A new long-acting methylphenidate</unittitle><unitdate type="inclusive">2000 September 4</unitdate><container altrender="Record Storage Box (Paige)" id="4bbb4954ec5d039ed60615d75a870ea1" label="mixed materials [A0000000075896]" type="box">54</container><container id="9e12b9183893e0d895eca127d8dc88fa" parent="4bbb4954ec5d039ed60615d75a870ea1" type="folder">10-11</container></did><accessrestrict id="a4aa4fa7be7331aba5f8a5db5ecf9418"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="77d873ab9fa6653d75e07ecd29388474" level="file"><did><unittitle>TML, 42-17 - Entacapone for Parkinson's disease</unittitle><unitdate type="inclusive">2000 January 24</unitdate><container altrender="Record Storage Box (Paige)" id="eab038b52aab5fc23b6d8941396ca66c" label="mixed materials [A0000000075896]" type="box">54</container><container id="792539940f94a40211b97130b60d8659" parent="eab038b52aab5fc23b6d8941396ca66c" type="folder">12-14</container></did><accessrestrict id="c4cc72e54e77645b47ebceda334dae90"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="2c3c36361f7d26d6245b10967d53cba6" level="file"><did><unittitle>TML, 42-45 - Linezolid (Zyvox)</unittitle><unitdate type="inclusive">2000 May 29</unitdate><container altrender="Record Storage Box (Paige)" id="da830f15ec9d7a5098a8d2f2a90e862f" label="mixed materials [A0000000075896]" type="box">54</container><container id="3b67b033ef6cc30e37bbef9d3837debd" parent="da830f15ec9d7a5098a8d2f2a90e862f" type="folder">15-18</container></did><accessrestrict id="134bd94a116d4a00868b6be7c821b669"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f3db800fbd8c30fd18c0ce7421c0675c" level="file"><did><unittitle>TML, 42-1 - Drugs for HIV</unittitle><unitdate type="inclusive">2000 January 10</unitdate><container altrender="Record Storage Box (Paige)" id="879d867e7c01a547b18e741bdcaf52fa" label="mixed materials [A0000000075896]" type="box">54</container><container id="c6798bc6a783ce2857586b1d02a96e6f" parent="879d867e7c01a547b18e741bdcaf52fa" type="folder">19-21</container></did><accessrestrict id="6357a8604ec2f14301f33a46a3a3ee64"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c29c016865d236b6f578b647c46a6676" level="file"><did><unittitle>TML, 42-1 - Drugs for HIV</unittitle><unitdate type="inclusive">2000 January 10</unitdate><container altrender="Record Storage Box (Paige)" id="b8df4624774e8a2b54d0913ab25655f9" label="mixed materials [A0000000075897]" type="box">55</container><container id="e039175f2f45169ffdafa6b20ac91b6a" parent="b8df4624774e8a2b54d0913ab25655f9" type="folder">1-2</container></did><accessrestrict id="8e3afc9c0897bcf7957059afb787d613"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0ef84e9be7c32e14ccb4cf39bfd45359" level="file"><did><unittitle>TML - Rheumatoid Arthritis - Reprints</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="6f9135eeb4a642fa72e1c83f03ec0877" label="mixed materials [A0000000075897]" type="box">55</container><container id="fdc26d15fa47d949eb069ca26e201cb6" parent="6f9135eeb4a642fa72e1c83f03ec0877" type="folder">3-6</container></did><accessrestrict id="9bb37702887fbb2a3b6b04978a2797eb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="cc6bb16d28e33a08e3172f055c9bc2b1" level="file"><did><unittitle>TML, 42-11 - Aggrenox - A combination of antiplatelet drugs for stroke prevention</unittitle><unitdate type="inclusive">2000 February 7</unitdate><container altrender="Record Storage Box (Paige)" id="fbad0d045c50271c88a1d8d96ab74f05" label="mixed materials [A0000000075897]" type="box">55</container><container id="d9f410d6e5c2d17b855bd528de7db98d" parent="fbad0d045c50271c88a1d8d96ab74f05" type="folder">7-8</container></did><accessrestrict id="b6c3f76765c91d59d07d1942830fb182"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="7fc91d920ef13c04bcd488ff67fb27eb" level="file"><did><unittitle>TML - 42-54 - Beta Blockers for heart failure</unittitle><unitdate type="inclusive">2000 June 26</unitdate><container altrender="Record Storage Box (Paige)" id="6508823fa1e5eadf1bf2329a5d17d1a9" label="mixed materials [A0000000075897]" type="box">55</container><container id="1c793f3e34d510c92f1d334693e1e176" parent="6508823fa1e5eadf1bf2329a5d17d1a9" type="folder">9-13</container></did><accessrestrict id="ddd4e956f4e4703f485c6e09538b3de5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="2659d96c29ea4c72cecf071a3ffe82cf" level="file"><did><unittitle>TML, 42-83 - Drugs of Choice - Cancer chemotherapy</unittitle><unitdate type="inclusive">2000 September 18</unitdate><container altrender="Record Storage Box (Paige)" id="b06f9795749fc96b5a3ac3de42cbbee1" label="mixed materials [A0000000075897]" type="box">55</container><container id="88b4f42c383f8882d86ed36f7afbb6ce" parent="b06f9795749fc96b5a3ac3de42cbbee1" type="folder">14-18</container></did><accessrestrict id="fdc72de4846ddb965722a850fb816e7f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="85452dc178e1dadec0332fe42563215d" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Tuberculosis</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="397c02d5aac929c53d280ca3c8a1e329" label="mixed materials [A0000000075898]" type="box">56</container><container id="766abb554f166296171b8cbb862c4435" parent="397c02d5aac929c53d280ca3c8a1e329" type="folder">1-4</container></did><accessrestrict id="f9bcd6fc9775a8cd44d753ed67359607"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="9c48a5236a35ed8f3ce7136401b6da9e" level="file"><did><unittitle>TML, 42-101 - Mifepristone (RU 486)</unittitle><unitdate type="inclusive">2000 October 30</unitdate><container altrender="Record Storage Box (Paige)" id="db9c5470dfd41896bda2f89819316ec5" label="mixed materials [A0000000075898]" type="box">56</container><container id="e4cd5b7ed0d605fecfa1c308bd64ead3" parent="db9c5470dfd41896bda2f89819316ec5" type="folder">5-8</container></did><accessrestrict id="512097af868e6310c2ef7aa3a3ab7af5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="41cb55e32ff2281af228fcf98e48db43" level="file"><did><unittitle>TML - Osteoporosis - Reprints</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="3c1d809e4452e330b3cb01091b8d1c94" label="mixed materials [A0000000075898]" type="box">56</container><container id="09565feb35122459e1b242158a9b3493" parent="3c1d809e4452e330b3cb01091b8d1c94" type="folder">9-12</container></did><accessrestrict id="a1eb04973eb4447d22f3324b1056f9bf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="669d4a856fe8af2c5b04130d94fa8d3e" level="file"><did><unittitle>TML - Asthma - Reprints</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="0417b56209a9cccba72159493073153d" label="mixed materials [A0000000075898]" type="box">56</container><container id="71cb371c7bf2e9d9d6a857f9add7633f" parent="0417b56209a9cccba72159493073153d" type="folder">13-16</container></did><accessrestrict id="38e2af006895a52bd2de3eb894293ec3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0ec6c4e753e63df5926b6bb8dc0ec41d" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="3ee80cedc5b17b8ab386f3356ebe95cf" label="mixed materials [A0000000075898]" type="box">56</container><container id="4124c8c4c506f15c400acbfcd4e25de0" parent="3ee80cedc5b17b8ab386f3356ebe95cf" type="folder">17-20</container></did><accessrestrict id="d8d94d63528159d44953c7215892b5f2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="1716a9979d5479baf368216eb3017f50" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Letter Document Box" id="de4a6dbfc65b4d19ec39c12ae785692b" label="mixed materials [A0000000075899]" type="box">57</container><container id="efa23d479b4b0ccfc785d15181123a34" parent="de4a6dbfc65b4d19ec39c12ae785692b" type="folder">1-4</container></did><accessrestrict id="7be18115960dc69ccd463738ce3438d7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="296856f8c0a6139989dec83e2967a3f6" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Letter Document Box" id="bb91c7277d73194af005794a1e4d0748" label="mixed materials [A0000000075899]" type="box">57</container><container id="1930e9e610e66f94d04eddc684316f96" parent="bb91c7277d73194af005794a1e4d0748" type="folder">5</container></did><accessrestrict id="44a20fdcc0c5ee5bc8f27d1eb7439095"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="41a4f1b5ec21dcacfcb1590a26be0255" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Letter Document Box" id="68f068b18b2bc027c62871c0c9936a8f" label="mixed materials [A0000000075900]" type="box">58</container><container id="5695fdaae24dabc3db49d4399ad21ff8" parent="68f068b18b2bc027c62871c0c9936a8f" type="folder">1-3</container></did><accessrestrict id="aae3719b7a851cb67c17470197b044d1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="8d745390980b9c7fe7639600ac855496" level="file"><did><unittitle>TML, 43-92 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">2001 October 29</unitdate><container altrender="Record Storage Box (Paige)" id="b141927117c582a898598b508d6f2e4b" label="mixed materials [A0000000075901]" type="box">59</container><container id="70f25bfd51e307947320eeeb4370eae6" parent="b141927117c582a898598b508d6f2e4b" type="folder">1-3</container></did><accessrestrict id="08c08b71a5f549bb03c9e539391bf0c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c8e27cfe3b70673df671446dc0f171dd" level="file"><did><unittitle>TML, 43-43 - Choice of Lipid-lowering drugs</unittitle><unitdate type="inclusive">2001 May 28</unitdate><container altrender="Record Storage Box (Paige)" id="dfc6e108c29452dbcacb02d44cc30b37" label="mixed materials [A0000000075901]" type="box">59</container><container id="fe32fa4750e90f1431bf433952a774a1" parent="dfc6e108c29452dbcacb02d44cc30b37" type="folder">4-10</container></did><accessrestrict id="12c485e70ce77057b564f5f005de3180"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="b12b140d39cce8b86f62018ce31197dd" level="file"><did><unittitle>TML, 43-1 - Lopinavir - Ritonavir - A protease-inhibitor combination</unittitle><unitdate type="inclusive">2001 January 8</unitdate><container altrender="Record Storage Box (Paige)" id="755f67cd6cf24842e3b79eb986d6479d" label="mixed materials [A0000000075901]" type="box">59</container><container id="ec8ff325b4e03e32a89e7d7d49dee48a" parent="755f67cd6cf24842e3b79eb986d6479d" type="folder">11-13</container></did><accessrestrict id="cb4f314cadf4551b7cb834b70eadf1cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="f3e4fd1faa4faa99ba52ed68b8dde6c9" level="file"><did><unittitle>TML, 43-87 - Drugs and vaccines against biological warfare</unittitle><unitdate type="inclusive">2001 October 19</unitdate><container altrender="Record Storage Box (Paige)" id="7ccdcdf20064c0dece3667ee52ecdfce" label="mixed materials [A0000000075901]" type="box">59</container><container id="b5fca4d19fa9b7c22e1ac80d4c3a14ed" parent="7ccdcdf20064c0dece3667ee52ecdfce" type="folder">14-17</container></did><accessrestrict id="19d192e97e549e2b446276124a3eb6b6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="f8fecc1cfd922fa2df867ba43e2d95e6" level="file"><did><unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="92ea3e90cabbb8fda18912e56f2e0e7b" label="mixed materials [A0000000075901]" type="box">59</container><container id="a1bcbb60de43e3519728d2b763ad9ca8" parent="92ea3e90cabbb8fda18912e56f2e0e7b" type="folder">18</container></did><accessrestrict id="bf0a0b9053f30a04f40935cc85ba1264"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3283e79cbed2dd24ba8423865f0e23c0" level="file"><did><unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="ce9c21ecde3997e7c876dcfcfbbb4c61" label="mixed materials [A0000000075902]" type="box">60</container><container id="3ac59d5fa2793c2bf43e7a79273d4e40" parent="ce9c21ecde3997e7c876dcfcfbbb4c61" type="folder">1</container></did><accessrestrict id="f2c531fe46fbd0a55fbf3a371d0cfb12"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="b08aa5d6ed86fd5fceee0126fd84fd06" level="file"><did><unittitle>TML, 43-9 - Beta-Blockers</unittitle><unitdate type="inclusive">2001 February 5</unitdate><container altrender="Record Storage Box (Paige)" id="902db4009dd74c9dcb7301de21e0ac7c" label="mixed materials [A0000000075902]" type="box">60</container><container id="4c095967b4ffd99f6ddd1c2f06e224dd" parent="902db4009dd74c9dcb7301de21e0ac7c" type="folder">2-6</container></did><accessrestrict id="6048933eb3a55f5f2d6a90721d4dd65f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="efb930d3872ae9d77c1298a07d7d5921" level="file"><did><unittitle>TML, 43-62 - Balsalazide (Colazal) for ulcerative colitis</unittitle><unitdate type="inclusive">2001 July</unitdate><container altrender="Record Storage Box (Paige)" id="00d78ca603bc3d095d22ac8450874e05" label="mixed materials [A0000000075902]" type="box">60</container><container id="4a65910a1dbb84f10b79db88ff7d7ef0" parent="00d78ca603bc3d095d22ac8450874e05" type="folder">7-9</container></did><accessrestrict id="a454b4aa29b54507db7a4b31bd4c8d5f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="b522bd1a5159bd2d2194d2263cc22904" level="file"><did><unittitle>TML, 43-11 - Argatroban for treatment of heparin-induced thrombocytopenia</unittitle><unitdate type="inclusive">2001 February 5</unitdate><container altrender="Record Storage Box (Paige)" id="556a81480144be42c84137b90da93d48" label="mixed materials [A0000000075902]" type="box">60</container><container id="769b9d20bb2d1878209847e735d7a210" parent="556a81480144be42c84137b90da93d48" type="folder">10-12</container></did><accessrestrict id="a20e6edf2b912e65b1924e6cbfaf7256"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="46514d81205269c17a4b19d49a573235" level="file"><did><unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="efeb86c16f995c15f46630519076a762" label="mixed materials [A0000000075902]" type="box">60</container><container id="fff479744f332c9182d02771a149d825" parent="efeb86c16f995c15f46630519076a762" type="folder">13-15</container></did><accessrestrict id="0ac715d063832982eec2283c964a4110"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="6dc4850ed3f15e6085336df184251532" level="file"><did><unittitle>TML - Drugs of Choice - Osteoporosis</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="158b6edd220d5c090731fbc467bb6924" label="mixed materials [A0000000075902]" type="box">60</container><container id="d0db11ed3fb7d7447e90ce687f9a2f5f" parent="158b6edd220d5c090731fbc467bb6924" type="folder">16</container></did><accessrestrict id="a5d61d385919f6ecefd5058c2bf3e8d5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="02fc378d7f3b4b93e45c3eef89379858" level="file"><did><unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle><unitdate type="inclusive">2001 August 20</unitdate><container altrender="Record Storage Box (Paige)" id="47aace565ebf4fc2fdb8d71b3c598fb3" label="mixed materials [A0000000075902]" type="box">60</container><container id="7a9fc0a5e7c315f6274470b4164053fb" parent="47aace565ebf4fc2fdb8d71b3c598fb3" type="folder">17-18</container></did><accessrestrict id="a1e5c73ef6115e61a317948cb85a9927"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2c6bff42d1f14c6a829324e9782c498a" level="file"><did><unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle><unitdate type="inclusive">2001 August 20</unitdate><container altrender="Record Storage Box (Paige)" id="6f4455f6f940d65d3c7049eefdb36400" label="mixed materials [A0000000075903]" type="box">61</container><container id="48275d2455fd818dbdd620548587795a" parent="6f4455f6f940d65d3c7049eefdb36400" type="folder">1-3</container></did><accessrestrict id="5b52a18cd7491854824957b6528aa161"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="6bf6928a0695a21bf35c621f43a5b338" level="file"><did><unittitle>TML - Antimicrobial prophylaxis and Endocarditis - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="98d47f6fa0345ceb15c4e732f8a97099" label="mixed materials [A0000000075903]" type="box">61</container><container id="b0e5a436ac26fcac91c24b99147c1d2d" parent="98d47f6fa0345ceb15c4e732f8a97099" type="folder">4-6</container></did><accessrestrict id="7c855f662c00758a77e6169900e656ac"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="e83ae1dbb9d2dcd79b2efc11e8415787" level="file"><did><unittitle>TML - AIDS - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="82e940c897657ff96446cd993f5e0f2b" label="mixed materials [A0000000075903]" type="box">61</container><container id="630fa2a4975c0a95b785762045a8954f" parent="82e940c897657ff96446cd993f5e0f2b" type="folder">7-11</container></did><accessrestrict id="6f3b8da68a968edcf7612c6c7ab0d96d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c6e64d3eb72280cbc65604fd0d1ef63b" level="file"><did><unittitle>TML, 43-91 - Post Exposure Anthrax prophylaxis</unittitle><unitdate type="inclusive">2001 October 29</unitdate><container altrender="Record Storage Box (Paige)" id="1dd8d468360cbfeaa284e4e39c9bdfd9" label="mixed materials [A0000000075903]" type="box">61</container><container id="90f6d59cda92fefaf8c528d9204e5635" parent="1dd8d468360cbfeaa284e4e39c9bdfd9" type="folder">12-13</container></did><accessrestrict id="c107fed35cdd31085f732308990ad842"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="41aa0763a7e36f6ce380706ce01181e3" level="file"><did><unittitle>TML, 43-54 - PEG-Intron for chronic Hepatitis C</unittitle><unitdate type="inclusive">2001 June 25</unitdate><container altrender="Record Storage Box (Paige)" id="c434a12c10b12bd4216f01e98904b5a1" label="mixed materials [A0000000075903]" type="box">61</container><container id="40fda22f7636df061eb2e7ce274f18f0" parent="c434a12c10b12bd4216f01e98904b5a1" type="folder">14-16</container></did><accessrestrict id="10b78f31b326647359759629918503ac"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="21f79f7c6b4acd8a596b33dacb48841b" level="file"><did><unittitle>TML, 43-110 - Insulin Glargine - a new long-acting insulin</unittitle><unitdate type="inclusive">2001 August 6</unitdate><container altrender="Record Storage Box (Paige)" id="f763f46747f999f74dac5ae3a8d1e291" label="mixed materials [A0000000075903]" type="box">61</container><container id="d272508dd587c7c8851261ac997ac0ac" parent="f763f46747f999f74dac5ae3a8d1e291" type="folder">17-19</container></did><accessrestrict id="ce544613fec94a632b764ccaa6155e27"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2eed515acb400c24339036029a7a8f49" level="file"><did><unittitle>TML, 43-29 - Nateglinide for Type 2 diabetes</unittitle><unitdate type="inclusive">2001 April 2</unitdate><container altrender="Record Storage Box (Paige)" id="2cb34faeeacb4bc49f89e650e280cd92" label="mixed materials [A0000000075904]" type="box">62</container><container id="03f86509e001e58dd9a19b77acd103ca" parent="2cb34faeeacb4bc49f89e650e280cd92" type="folder">1-3</container></did><accessrestrict id="7bf007b3c2f616cf82e76b675923a0ae"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ccba2cedcccf56cdefa0e205fc19e877" level="file"><did><unittitle>TML - Drugs of Choice - Cancer</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="d45a0bdbdcf92dde86cf82671d2227cb" label="mixed materials [A0000000075904]" type="box">62</container><container id="63752b2dfb685431e9d2a344d7a22ca7" parent="d45a0bdbdcf92dde86cf82671d2227cb" type="folder">4-5</container></did><accessrestrict id="d687a473729a78247a1c380123065159"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8b4de852b3dcabc7ad6e003cb57745bf" level="file"><did><unittitle>TML, 43-100 - Nesiritide for decompensated congestive heart failure</unittitle><unitdate type="inclusive">2001 November 12</unitdate><container altrender="Record Storage Box (Paige)" id="d82623468f20f8d7b93b21ba1a3c75e9" label="mixed materials [A0000000075904]" type="box">62</container><container id="faa2ac3dc571a5a839c052529264b6b1" parent="d82623468f20f8d7b93b21ba1a3c75e9" type="folder">6-9</container></did><accessrestrict id="60722a1253dc5c989a1fb84363bf8347"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ae81e26ee03016b7e8a19efe2323b2b6" level="file"><did><unittitle>TML, 43-35 - Non-Sedating Antihistamines</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="1624dbe206379c2d8510e5a51d3c33fa" label="mixed materials [A0000000075904]" type="box">62</container><container id="f226e9675e04b5f7131786967acf6b5d" parent="1624dbe206379c2d8510e5a51d3c33fa" type="folder">10-13</container></did><accessrestrict id="e3c9df3f442f047a5b6b393b36042f5b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ebbf6e65860c02f436f6ca0982c14e3e" level="file"><did><unittitle>TML, 43-17 - Drugs for hypertension</unittitle><unitdate type="inclusive">2001 March 5</unitdate><container altrender="Record Storage Box (Paige)" id="4ee44f46a0bff0da24d0181f718a199b" label="mixed materials [A0000000075904]" type="box">62</container><container id="e011126abd48a12874e2396e14d982bd" parent="4ee44f46a0bff0da24d0181f718a199b" type="folder">14-18</container></did><accessrestrict id="3e2fa8d34c5d3f85b91b8b755235d673"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="dc20397e0f8fc97006ecdf0d5f679b73" level="file"><did><unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle><unitdate type="inclusive">2001 July 23</unitdate><container altrender="Record Storage Box (Paige)" id="3a0bb83301c995bf7b0326c26a68b9ea" label="mixed materials [A0000000075904]" type="box">62</container><container id="ee2bcd0a625b7e65e1e4a0632c7cc91a" parent="3a0bb83301c995bf7b0326c26a68b9ea" type="folder">19</container></did><accessrestrict id="bedf8436e8ecc88cef43b4466703321f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2a3e11c7291578855058677f583ba4cc" level="file"><did><unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle><unitdate type="inclusive">2001 July 23</unitdate><container altrender="Record Storage Box (Paige)" id="27bb6159b6dafdd19508a205087d85b7" label="mixed materials [A0000000075905]" type="box">63</container><container id="b3475e728b163610d1ef1eae8ed525fb" parent="27bb6159b6dafdd19508a205087d85b7" type="folder">1-2</container></did><accessrestrict id="1faf2fbe4c747499b17f777c7da8d367"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="7aeba34ec44547fe9581d43a0fc4043e" level="file"><did><unittitle>TML, 43-6 - Nebulized Budesonide for Asthma in children</unittitle><unitdate type="inclusive">2001 January 27</unitdate><container altrender="Record Storage Box (Paige)" id="ed7ade1e41739a41b236c312e0a55a27" label="mixed materials [A0000000075905]" type="box">63</container><container id="fa2ac7ca0f281a68fbe8897396867001" parent="ed7ade1e41739a41b236c312e0a55a27" type="folder">3-7</container></did><accessrestrict id="d1f83bcd9d1dba630ab83fe624589365"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9011b2319d9d385461bdca83ff03a269" level="file"><did><unittitle>TML, 42-2 - Cool Click - a needle-free device for growth hormone delivery</unittitle><unitdate type="inclusive">2001 January 8</unitdate><container altrender="Record Storage Box (Paige)" id="8ee1e65508e10129aa96dc31004b4892" label="mixed materials [A0000000075905]" type="box">63</container><container id="d06af0e5aca38ae220c450e69ad71a56" parent="8ee1e65508e10129aa96dc31004b4892" type="folder">8-10</container></did><accessrestrict id="d1142cfc576dc71445c5513786f60e47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="43f128e719abd7716a8b552dab41b4ca" level="file"><did><unittitle>TML, 43-84 - Cord Blood Banks</unittitle><unitdate type="inclusive">2001 October 1</unitdate><container altrender="Record Storage Box (Paige)" id="5b96a6073339cc6b009f655f84833c1e" label="mixed materials [A0000000075905]" type="box">63</container><container id="7713398581e0f3647edbbaeba4fa88df" parent="5b96a6073339cc6b009f655f84833c1e" type="folder">11-14</container></did><accessrestrict id="d355e32a24f6cffb35162f5a565f8aad"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2ca4ec46f32a50a21f55760304d5080b" level="file"><did><unittitle>TML, 43-59 - Initital treatment of Parkinson's disease</unittitle><unitdate type="inclusive">2001 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="382c9404b08bd6359391c09c137e7967" label="mixed materials [A0000000075905]" type="box">63</container><container id="d1d173e0ec2e3f4a376ad4d9bea07ae1" parent="382c9404b08bd6359391c09c137e7967" type="folder">15-16</container></did><accessrestrict id="12449f363aa33b967622999d1c656f25"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="f4881e412a79293a02fce06ab7ada62d" level="file"><did><unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="d9c5b09963115f5b8077c86cba4aa9ff" label="mixed materials [A0000000075905]" type="box">63</container><container id="f162ae7377856a6174f21d80e8796750" parent="d9c5b09963115f5b8077c86cba4aa9ff" type="folder">17-20</container></did><accessrestrict id="762520a711ae5cf2f881c37d75c585e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="076a7f8b55c4644de3dc62c6db843a72" level="file"><did><unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="bb05ca4e913d3f8b70e6d20dccc368c2" label="mixed materials [A0000000075906]" type="box">64</container><container id="625b69cde7dcd250c7308d9e423182a2" parent="bb05ca4e913d3f8b70e6d20dccc368c2" type="folder">1-2</container></did><accessrestrict id="0e6e931602cabb1fe060a758f1e09d3e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="98d5e522f0e12ef676f68b6296b375c4" level="file"><did><unittitle>TML, 43-61 - Lung Cancer screening</unittitle><unitdate type="inclusive">2001 July 23</unitdate><container altrender="Record Storage Box (Paige)" id="724af44813cdb11c5e39fe9f462f8d79" label="mixed materials [A0000000075906]" type="box">64</container><container id="2b1468ace72e2e5db1fbd54d55b0b6c3" parent="724af44813cdb11c5e39fe9f462f8d79" type="folder">3-5</container></did><accessrestrict id="1fa9376a18b8cabf3a1ced8db4bc6995"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="bbfbf04fd92af083cfe5f2803138df54" level="file"><did><unittitle>TML, 43-7 - Mirena</unittitle><unitdate type="inclusive">2001 January 22</unitdate><container altrender="Record Storage Box (Paige)" id="6791db0cb01c65aba3bcbdba275064d9" label="mixed materials [A0000000075906]" type="box">64</container><container id="4aac37ff07a97a8b9803287c2d5092d5" parent="6791db0cb01c65aba3bcbdba275064d9" type="folder">6-8</container></did><accessrestrict id="6eb2c131de0d820a3d57bfd6b90300e6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3b86dfd5896dc8ed385111ad16cbd218" level="file"><did><unittitle>TML, 43-109 - Darbopoetin (Aranesp) - a long acting erythropoietin</unittitle><unitdate type="inclusive">2001 December 10</unitdate><container altrender="Record Storage Box (Paige)" id="16e94319062a485ea245afed92b886c0" label="mixed materials [A0000000075906]" type="box">64</container><container id="35b05f1136b4facf271afe3cf4146fe5" parent="16e94319062a485ea245afed92b886c0" type="folder">9-10</container></did><accessrestrict id="f505d3982f99b3e642ccbf40fbd75883"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="0f9927bdf850374dd901cc030c68dc7c" level="file"><did><unittitle>TML - Drugs for chronic heart failure</unittitle><unitdate type="inclusive">2001 April 6</unitdate><container altrender="Record Storage Box (Paige)" id="a1cee3ca3beb80954a6279963dc2aa13" label="mixed materials [A0000000075906]" type="box">64</container><container id="42ebb40fc78eb5f45f59ba1526743c39" parent="a1cee3ca3beb80954a6279963dc2aa13" type="folder">11-14</container></did><accessrestrict id="6be4b2a90096d23f4c7270994aa74f17"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="97fc093a6a8e4909bb2c604168b0b754" level="file"><did><unittitle>TML, 43-58 - Caspofungin (Candidas) for aspergillosis</unittitle><unitdate type="inclusive">2001 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="f2838a1dc1c7e1f53b16e313f0f57795" label="mixed materials [A0000000075906]" type="box">64</container><container id="144f2ce4b7d1b95153318f090aa5fc58" parent="f2838a1dc1c7e1f53b16e313f0f57795" type="folder">15-18</container></did><accessrestrict id="f836855e02f4d6fe9f63b628886a4c85"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="6da20ff4a72dc0604ae511c5634291e7" level="file"><did><unittitle>TML, 43-55 - A new snake antivenin</unittitle><unitdate type="inclusive">2001 June 25</unitdate><container altrender="Record Storage Box (Paige)" id="dbcaaad8828288c85234e95c7cba5ca3" label="mixed materials [A0000000075906]" type="box">64</container><container id="bdf89623f354ea0231699373fd6cc427" parent="dbcaaad8828288c85234e95c7cba5ca3" type="folder">19-20</container></did><accessrestrict id="f08173f37c2607c4d273372be7fedab1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ede8d569017eb650ffb86947aa817ebe" level="file"><did><unittitle>TML, 43-110 - Zometa (Zoledronic Acid) for injection</unittitle><unitdate type="inclusive">2001 December 10</unitdate><container altrender="Record Storage Box (Paige)" id="8833803d189a9e4437b3428fb20e6e3f" label="mixed materials [A0000000075907]" type="box">65</container><container id="7460de79e5641c4e455b5bc2d6663ffd" parent="8833803d189a9e4437b3428fb20e6e3f" type="folder">1-3</container></did><accessrestrict id="3a54c329c0d6d0bc229bdd0616332d9d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a2f1959db87c3ed2aeb2a70eafd0d767" level="file"><did><unittitle>TML, 43-51 - Ziprasidone (Geodon) for schizophrenia</unittitle><unitdate type="inclusive">2001 June 11</unitdate><container altrender="Record Storage Box (Paige)" id="3dd947a0679e840c3c58070c8edcd2ea" label="mixed materials [A0000000075907]" type="box">65</container><container id="86445760bb4437a31a3f06dc9fa55165" parent="3dd947a0679e840c3c58070c8edcd2ea" type="folder">4-7</container></did><accessrestrict id="810ad5d825ba01f69c55af09b52e33af"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8068f52546b65b321ac2f5fa6a731f4c" level="file"><did><unittitle>TML, - Drugs for depression and anxiety</unittitle><unitdate type="inclusive">2001 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="acbc455067db156d805f69c7b6508caa" label="mixed materials [A0000000075907]" type="box">65</container><container id="3512578d0aa61721162186bf3ee44b55" parent="acbc455067db156d805f69c7b6508caa" type="folder">8-10</container></did><accessrestrict id="67940cb71724cb07bb1c047808a223cf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="55a8ca16b598343eb87537a2d296ecd1" level="file"><did><unittitle>TML, 43-15 - PC-Spes</unittitle><unitdate type="inclusive">2001 February 19</unitdate><container altrender="Record Storage Box (Paige)" id="cbae462ce58a2197e735910792b37add" label="mixed materials [A0000000075907]" type="box">65</container><container id="fd61f75b6d7770e80459be1786447868" parent="cbae462ce58a2197e735910792b37add" type="folder">11-12</container></did><accessrestrict id="75c2794ebd1f11660bcef03019daccd2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ebe0e5315e3cdfa6495aed9cdada44d6" level="file"><did><unittitle>TML, 43-83 - Metadate (Extended-Release Methylphenidate)</unittitle><unitdate type="inclusive">2001 October 1</unitdate><container altrender="Record Storage Box (Paige)" id="f97fa4992c5c643f2b96c76577d15b6b" label="mixed materials [A0000000075907]" type="box">65</container><container id="efbf3801c01d458a2fe040d66ad8d7b5" parent="f97fa4992c5c643f2b96c76577d15b6b" type="folder">13-16</container></did><accessrestrict id="07f8b933648e23ed47138c1bef096df8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="833ebff3fb7c7c45c0c064414304d04f" level="file"><did><unittitle>TML, 43-49 - Gleevec (STI-571) for chronic myeloid leukemia</unittitle><unitdate type="inclusive">2001 June 11</unitdate><container altrender="Record Storage Box (Paige)" id="b1657f452230c8950de8a059cb5a13a2" label="mixed materials [A0000000075907]" type="box">65</container><container id="256fd2bb9ac721b4c4cbeca8a30ddc59" parent="b1657f452230c8950de8a059cb5a13a2" type="folder">17-18</container></did><accessrestrict id="8a48c9bb323707808cd2699c098b90df"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="e579c81ba72fe1f002ea554c42ec0eb7" level="file"><did><unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="6dc11db54b4708983080345ada2ed041" label="mixed materials [A0000000075907]" type="box">65</container><container id="ad81144a569d5d65939fb55969622ba9" parent="6dc11db54b4708983080345ada2ed041" type="folder">19</container></did><accessrestrict id="5b72b0c715fd854e87ba957e71353a88"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2c8e55774a1bb77e5eb47e4cd5592dca" level="file"><did><unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="6f1e61f61b51dab0420747224aa5eacb" label="mixed materials [A0000000075908]" type="box">66</container><container id="f9b740c03166811b6b34c94378f2e749" parent="6f1e61f61b51dab0420747224aa5eacb" type="folder">1</container></did><accessrestrict id="45e2eef135b65b2a4bc8bfac6895eae6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a3e98844edbadfd1126f96dcee9fa072" level="file"><did><unittitle>TML, 43-89 - Insulin Aspart - a new rapid-acting insulin</unittitle><unitdate type="inclusive">2001 October 15</unitdate><container altrender="Record Storage Box (Paige)" id="30cd8e27c15ce2c92e99d5fad79b9bb1" label="mixed materials [A0000000075908]" type="box">66</container><container id="7ef6be6be8a2d2937abfb70c805d8d39" parent="30cd8e27c15ce2c92e99d5fad79b9bb1" type="folder">2-3</container></did><accessrestrict id="95db9e419544c222951aae12dd139e45"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2330e815d4bdfd9c12c459306864dcca" level="file"><did><unittitle>TML, 43-103 - Drugs for HIV infection</unittitle><unitdate type="inclusive">2001 November 26</unitdate><container altrender="Record Storage Box (Paige)" id="1f1c85d01d4de1cac6aa6beeeba20d0a" label="mixed materials [A0000000075908]" type="box">66</container><container id="e8a4737b356393929edfa45c658e0574" parent="1f1c85d01d4de1cac6aa6beeeba20d0a" type="folder">4-7</container></did><accessrestrict id="ba5d1519c239af0bb83357cd9431cc00"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c9e718e37292bcb43f7c0f24dd8175bb" level="file"><did><unittitle>TML, 43-26 - Once-a-Week Alendronate (Fosamaz)</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="bfb24fd2b23819d01d2793ec07805aa3" label="mixed materials [A0000000075908]" type="box">66</container><container id="f13e1045b0cefde44eba08be18eab3ae" parent="bfb24fd2b23819d01d2793ec07805aa3" type="folder">8</container></did><accessrestrict id="3aaad115d37c1f7c6a8b419cea0284e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ce9f44342b0f523de0bfcb639e0134e8" level="file"><did><unittitle>TML - Drugs of Choice - Migraine - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="468c05f72cea31c158f43bc7e8bd67da" label="mixed materials [A0000000075908]" type="box">66</container><container id="b82b6ffc8f80cd700b2aaf4fe51b88d1" parent="468c05f72cea31c158f43bc7e8bd67da" type="folder">9-10</container></did><accessrestrict id="9d4ad8765f4f79883181f256eb7f9879"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8c50daa78ebe0875cf14c75e503ea1c1" level="file"><did><unittitle>TML, Drugs of Choice - Pain</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="896fba8193924c81e176a11a88445ebb" label="mixed materials [A0000000075908]" type="box">66</container><container id="86525d1993b61160bc9a4585e0857b61" parent="896fba8193924c81e176a11a88445ebb" type="folder">11</container></did><accessrestrict id="3b2728fff814b6aa47a93b6386e34381"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="468e734f765a9be3853dd86c21c17c5d" level="file"><did><unittitle>TML, 43-25 - Direct-to-Consumer advertisements for Glucophage XR</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="79b061493dbc8b7818adb140ab2a1039" label="mixed materials [A0000000075908]" type="box">66</container><container id="0cb32fabea93bc5ce4445d1be4ef6980" parent="79b061493dbc8b7818adb140ab2a1039" type="folder">12</container></did><accessrestrict id="82bce5eadd0f640bbbd014ce96f624b7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d63b61dd440fbe48748ed3adaaa153a3" level="file"><did><unittitle>TML, 43-13 - Palivizumab update</unittitle><unitdate type="inclusive">2001 February 19</unitdate><container altrender="Record Storage Box (Paige)" id="5c67ac65d06ea5bd08203ad102c5b798" label="mixed materials [A0000000075908]" type="box">66</container><container id="7088aabaa7c15d76a75f9cba5837608d" parent="5c67ac65d06ea5bd08203ad102c5b798" type="folder">13-14</container></did><accessrestrict id="a7dd4884d34880dfc26867a2d2428bf1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="07c5a88addbecee925056539789a95ce" level="file"><did><unittitle>TML, 43-14 - Tinzaparin for treatment of deep vein thrombosis</unittitle><unitdate type="inclusive">2001 February 19</unitdate><container altrender="Record Storage Box (Paige)" id="22d26ef63639138f1d7216e32ea5475a" label="mixed materials [A0000000075908]" type="box">66</container><container id="0cfee6d90a1400337e1c197fce333daf" parent="22d26ef63639138f1d7216e32ea5475a" type="folder">15-17</container></did><accessrestrict id="e9948bb5cd6966ff6405e6dc4196d47e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3c99102c3cbe6573776800745f8ae469" level="file"><did><unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="cca725e717e7bd4084dbe4fa04954084" label="mixed materials [A0000000075908]" type="box">66</container><container id="0383cef898034637859fbb39d468a7e6" parent="cca725e717e7bd4084dbe4fa04954084" type="folder">18-20</container></did><accessrestrict id="0e83e8dd8e86709df7f972ac81515598"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c6baca4f86fe997597684780a50afb04" level="file"><did><unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="de6e1b1a0bc8c7c4c0672ee3464b7583" label="mixed materials [A0000000075909]" type="box">67</container><container id="b8b0b61de7a78293c654d99e018387ae" parent="de6e1b1a0bc8c7c4c0672ee3464b7583" type="folder">1</container></did><accessrestrict id="a04d9293e94b60a9e39c9b4189abc925"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="21563c371ed6d15964e3cc6b122e8325" level="file"><did><unittitle>TML, 43-31 - Advair "Diskus" - A combination of fluticasone and salmeterol for asthma</unittitle><unitdate type="inclusive">2001 April 6</unitdate><container altrender="Record Storage Box (Paige)" id="0da1d973db9fb9ae23eb46de9b857613" label="mixed materials [A0000000075909]" type="box">67</container><container id="3912c4a8833ac9fbb4f8cc0513ce3d54" parent="0da1d973db9fb9ae23eb46de9b857613" type="folder">2-5</container></did><accessrestrict id="591f5ce0464ac805e58c930e1f206114"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a56fc8ba008f5ec96cb059f94525d216" level="file"><did><unittitle>TML, 43-5 - Fluoxetine (Sarafem) for premenstrual dysphoric disorder</unittitle><unitdate type="inclusive">2001 January 22</unitdate><container altrender="Record Storage Box (Paige)" id="54acb6f12047eb178749ec1a8f620017" label="mixed materials [A0000000075909]" type="box">67</container><container id="001867f77c1e0473bd87793516482319" parent="54acb6f12047eb178749ec1a8f620017" type="folder">6-8</container></did><accessrestrict id="516c40c3c42f23a1ef834fac3280423d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="29dd0d00d8ca1ffa9497a61ade7fcac7" level="file"><did><unittitle>TML, 43-57 - Levothyroxine</unittitle><unitdate type="inclusive">2001 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="9155107a827e7da4c427286fe3054c47" label="mixed materials [A0000000075909]" type="box">67</container><container id="df1d6043b2b2fe88b4477490aa37fbe3" parent="9155107a827e7da4c427286fe3054c47" type="folder">9-11</container></did><accessrestrict id="5e4d50d8e1cee2179d409a4d58ebfe39"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d2d95b76affb3a4c9b22a381ae08576d" level="file"><did><unittitle>TML, 43-28 - Detrol LA and Ditropan XL for overactive bladder</unittitle><unitdate type="inclusive">2001 April 2</unitdate><container altrender="Record Storage Box (Paige)" id="0bad6e505d7e1bf18edf00eddfd905b2" label="mixed materials [A0000000075909]" type="box">67</container><container id="880d956990735b46c33044d3cc9d136c" parent="0bad6e505d7e1bf18edf00eddfd905b2" type="folder">12-13</container></did><accessrestrict id="c2a600b167a1d8ec49922e49f096e4ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="bf76f78ab4a4977fe44b60003b8f05f2" level="file"><did><unittitle>TML, 43-27 - Prozac Weekly</unittitle><unitdate type="inclusive">2001 April 2</unitdate><container altrender="Record Storage Box (Paige)" id="12d4115f4f660884263c6df7e06d3f8c" label="mixed materials [A0000000075909]" type="box">67</container><container id="20d30936269738f43be200155658c090" parent="12d4115f4f660884263c6df7e06d3f8c" type="folder">14</container></did><accessrestrict id="154ff78d3302dfb71a0c20f63e7f510f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d6b0a2f70273ff0516f8b345cdc4f512" level="file"><did><unittitle>TML - Drugs for migraine</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="22465c15fd5dfdd223dee90c4285a077" label="mixed materials [A0000000075909]" type="box">67</container><container id="53e510df44408c1f8fa2bc36697ebe56" parent="22465c15fd5dfdd223dee90c4285a077" type="folder">15-17</container></did><accessrestrict id="81584269571599c2534c39747bee7f6e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ab3c9b20ba673d3a09626a2131dfbd70" level="file"><did><unittitle>TML - Drugs for migraine</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="eb76379e58bd6a9de2dedb8b5aea3490" label="mixed materials [A0000000075910]" type="box">68</container><container id="8599dfc9496082e29019f13bf775affb" parent="eb76379e58bd6a9de2dedb8b5aea3490" type="folder">1</container></did><accessrestrict id="33ca4d5589e42adbdeba4c14888b39e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ce9d0ae7e21eaea0c4687dae309cfee9" level="file"><did><unittitle>TML, 43-67 - Twinrix - A combination Hepatitis A and B vaccine</unittitle><unitdate type="inclusive">2001 August 6</unitdate><container altrender="Record Storage Box (Paige)" id="e59b8bb340ff04c6d0e54a561fad8228" label="mixed materials [A0000000075910]" type="box">68</container><container id="4430362ebad998836de7a05ba40be3ab" parent="e59b8bb340ff04c6d0e54a561fad8228" type="folder">2-4</container></did><accessrestrict id="c860c07bca67d0f682cba26ca6577767"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="50348bc86f79794dd7d3880f772dc9fb" level="file"><did><unittitle>TML, 43-81 - Influenza prevention 2001-2002</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="ea7304e3b713e7d5875c8c798cc754f7" label="mixed materials [A0000000075910]" type="box">68</container><container id="3fff1dbc6bb076079b254c7a494e4c00" parent="ea7304e3b713e7d5875c8c798cc754f7" type="folder">5-8</container></did><accessrestrict id="1bbd28b63a91d7783c47a3da12aa5197"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3b16d2ad8da51e66ff96ab39df1d0aac" level="file"><did><unittitle>TML, 43-33 - Topical tacrolimus treatment for atopic dermatitis</unittitle><unitdate type="inclusive">2001 April 16</unitdate><container altrender="Record Storage Box (Paige)" id="cdb84db231c2e4c707a7ce57ca86f443" label="mixed materials [A0000000075910]" type="box">68</container><container id="0415ac216fbd287b2d9f5977fcde7f0e" parent="cdb84db231c2e4c707a7ce57ca86f443" type="folder">9-12</container></did><accessrestrict id="524857adc52fa0f183b069d3ae7050b5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="41122ea5a6e7981f0132dc387c47d526" level="file"><did><unittitle>TML, 43-42 - Glucowatch Biographer - A noninvasive glucose monitoring device</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="273818c821f427d62ea3b83278d135aa" label="mixed materials [A0000000075910]" type="box">68</container><container id="2aa7c6c6dfd33250d302b7b135a77b14" parent="273818c821f427d62ea3b83278d135aa" type="folder">13-14</container></did><accessrestrict id="8a2f04b8e85fd19c93d31127f994912c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="1f33fb25dbc24b2e3a9cc4123daa4b4c" level="file"><did><unittitle>TML, 43-99 - Cardiovascular Safety of COX-2 Inhibitors</unittitle><unitdate type="inclusive">2001 November 12</unitdate><container altrender="Record Storage Box (Paige)" id="d2562096458d438abc5b6755c8dcf57b" label="mixed materials [A0000000075910]" type="box">68</container><container id="8b6b524c8209ccde5d8de3a11f15fef1" parent="d2562096458d438abc5b6755c8dcf57b" type="folder">15-17</container></did><accessrestrict id="ed26092ce8449e46cf63b80b2a291816"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9c5905505fca4831e512fb2648100be7" level="file"><did><unittitle>TML - Drugs of Choice - Hypertension and Heart Failure</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="a88e9e592c72321a4f58e9a7de926dea" label="mixed materials [A0000000075910]" type="box">68</container><container id="7fa449e11363d0fe70355ef088a7c0e8" parent="a88e9e592c72321a4f58e9a7de926dea" type="folder">18</container></did><accessrestrict id="75c6bb282a1bebd46a6a30af50403e35"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d83158c1d6d2339140e8e837daa705b4" level="file"><did><unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="f004fc5b91e459da5480caf5ed076031" label="mixed materials [A0000000075910]" type="box">68</container><container id="4ce7620109666a65251bac285a08d5a7" parent="f004fc5b91e459da5480caf5ed076031" type="folder">19-21</container></did><accessrestrict id="a70ce5ed30190ec1d7686f21b89b6372"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="45a1a372dc6189c488cbf6dbf95adb8d" level="file"><did><unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="f67563cafc24374b1c496c8d3e5c01cc" label="mixed materials [A0000000075911]" type="box">69</container><container id="a784f92f29e49df3fd96072ae8c3904d" parent="f67563cafc24374b1c496c8d3e5c01cc" type="folder">1</container></did><accessrestrict id="a1903924a041556ee7b26f4c2b26ac5e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="4cdec89511203afd4fe2dc98bb7107a3" level="file"><did><unittitle>TML, 43-3 - Drugs for Vulvovaginal Candidiasis</unittitle><unitdate type="inclusive">2001 January 8</unitdate><container altrender="Record Storage Box (Paige)" id="b4e3a7539aea56657ea982b4bf95b956" label="mixed materials [A0000000075911]" type="box">69</container><container id="791be6091378945d532bcf245ae3640c" parent="b4e3a7539aea56657ea982b4bf95b956" type="folder">2-4</container></did><accessrestrict id="721d15062edf16474f8c9615e7343c9b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9c93f14bdbe03244367dc9260f841c8a" level="file"><did><unittitle>TML, 43-40 - Epoetin - Erythropoietin (Procrit; Epogen) Revisited</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="484f63227327435b3027caea7e80fe41" label="mixed materials [A0000000075911]" type="box">69</container><container id="e2e7eed57be1ecb2ccf6813895265e63" parent="484f63227327435b3027caea7e80fe41" type="folder">5-8</container></did><accessrestrict id="0834865471315b83cd87445af0b5d964"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8c1db8b64ee78c1dea2315fd90476615" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="1e1b3b0b61d08456233adec4a3ce10b2" label="mixed materials [A0000000075911]" type="box">69</container><container id="1c8720708c31c3da9e8efda57e4b84a9" parent="1e1b3b0b61d08456233adec4a3ce10b2" type="folder">9-12</container></did><accessrestrict id="0b08c7f91d343d75d562eb65c74f54bc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="42c85fbc002a3352f01a11a7e4a6f54d" level="file"><did><unittitle>TML, 43-36 - Esomeprazole (Nexium)</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="a80f4dfa55beedaddbe07d58d4f7a134" label="mixed materials [A0000000075911]" type="box">69</container><container id="96436933aae5f23affb7a695c199220d" parent="a80f4dfa55beedaddbe07d58d4f7a134" type="folder">13-14</container></did><accessrestrict id="cc2db5a946dc97445662edf403135cfe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="dde7a8f4a1c15dd762a0160728804b73" level="file"><did><unittitle>TML, 43-111 - Update on glucosamine for osteoarthritis</unittitle><unitdate type="inclusive">2001 December 10</unitdate><container altrender="Record Storage Box (Paige)" id="c1790276212ccb1eb724ac3553318ecc" label="mixed materials [A0000000075911]" type="box">69</container><container id="41b9aad811f250df2243760472a31b9b" parent="c1790276212ccb1eb724ac3553318ecc" type="folder">15-17</container></did><accessrestrict id="5b2a4f2cbe109ddd0b02adec46206e8d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9666394f9b7e1594ab6d9d740833bf6d" level="file"><did><unittitle>TML, 43-53 - Galantamine (Reminyl) for Alzheimer's disease</unittitle><unitdate type="inclusive">2001 June 25</unitdate><container altrender="Record Storage Box (Paige)" id="734ac7588fea50f39807c8eb7cef1feb" label="mixed materials [A0000000075911]" type="box">69</container><container id="e1e17a46e91128645066f54a79499696" parent="734ac7588fea50f39807c8eb7cef1feb" type="folder">18-20</container></did><accessrestrict id="64351c947d34d22cef39ad4007296824"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9e514faa1eb026a69873e6b610137535" level="file"><did><unittitle>TML, 43-80 - Oxycodone and Oxycontin</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="7e17c63ac349ebe9f0ec2ba6259f35a9" label="mixed materials [A0000000075912]" type="box">70</container><container id="7c5c804b0090c43539c5565ed67c23da" parent="7e17c63ac349ebe9f0ec2ba6259f35a9" type="folder">1-4</container></did><accessrestrict id="71c26f172f9a9a3876c7b24d11cc0db1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9bf44e00458f50d0ecc17dc1d13c078a" level="file"><did><unittitle>TML - Drugs of Choice - Asthma - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="046782e7d4e4509f9565c9f26d79fac5" label="mixed materials [A0000000075912]" type="box">70</container><container id="c6edef6680cbf5ee4f51a9ca77cdf4fc" parent="046782e7d4e4509f9565c9f26d79fac5" type="folder">5-7</container></did><accessrestrict id="753a55d97a80d113ee2476718a3d1661"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="0dc13b68cd4edd9b7be7bd34aad97ff0" level="file"><did><unittitle>TML - Drugs of Choice - Hypertension - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="fee74e17686da20eedfff577c5b0fee7" label="mixed materials [A0000000075912]" type="box">70</container><container id="264812621ff4270bacfeb9cd13bf40d0" parent="fee74e17686da20eedfff577c5b0fee7" type="folder">8-10</container></did><accessrestrict id="d504ebc62c5421f5e1d907042650019a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="28985057e383ceb12ff871b5d26e61da" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="751dcf8849e17ffba865282604b98be8" label="mixed materials [A0000000075912]" type="box">70</container><container id="e89463ea06c9e2a1b6c09a8c7110ecaf" parent="751dcf8849e17ffba865282604b98be8" type="folder">11-13</container></did><accessrestrict id="22fbfc715602ec37fdf0114b7cb13cbe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="e9eaa9b717e217af3529d05e6f9fbd9e" level="file"><did><unittitle>TML - Drugs of Choice - Arthritis - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="cf5a03fb13c22868cc69350e36e520b7" label="mixed materials [A0000000075912]" type="box">70</container><container id="512f3bbf493297e3dcbed3adf01076c1" parent="cf5a03fb13c22868cc69350e36e520b7" type="folder">14-15</container></did><accessrestrict id="b5d06faa04330361ca1ca75b21c017fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a8579ee641a8d372e5b92c341780d2f0" level="file"><did><unittitle>TML - Drugs of Choice - Depression and Anxiety</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="3e72ae4015eb281dfd102223ed12bbb6" label="mixed materials [A0000000075912]" type="box">70</container><container id="0728255f01ccb59b432f79a2c774a7a1" parent="3e72ae4015eb281dfd102223ed12bbb6" type="folder">16-17</container></did><accessrestrict id="85e3914a93c77fea32c035bd079cdf38"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d1091da187ca03263e9fbe06a0c8e8b9" level="file"><did><unittitle>TML, 44-105 - Adefovir (Hespera) for chronic Hepatitis B infection</unittitle><unitdate type="inclusive">2002 December 9</unitdate><container altrender="Record Storage Box (Paige)" id="72aad6f58b3af2d637d4dc5b39a936c5" label="mixed materials [A0000000075913]" type="box">71</container><container id="bb447f6d64a184ef1ecf14a6939bb98c" parent="72aad6f58b3af2d637d4dc5b39a936c5" type="folder">1-4</container></did><accessrestrict id="5e9a358af553725b2b7a0e754e583db4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a52ad11ec1e3f4d9273267e959212194" level="file"><did><unittitle>TML, 44-67 - Alosetron (Lotronex) revisited</unittitle><unitdate type="inclusive">2002 August 5</unitdate><container altrender="Record Storage Box (Paige)" id="af04d950d90221ce0c0427b28007c11d" label="mixed materials [A0000000075913]" type="box">71</container><container id="6dc9220662af5efb6346e4120ae90799" parent="af04d950d90221ce0c0427b28007c11d" type="folder">5-8</container></did><accessrestrict id="44f937981b03e47fe5b48832e2bc3c06"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="524bcd1ef0983fc228db57fdceccbd8a" level="file"><did><unittitle>TML, 44-1 - Prevention and treatment of injury from chemical biological warfare</unittitle><unitdate type="inclusive">2002 January 7</unitdate><container altrender="Record Storage Box (Paige)" id="04a84d493e455152a9d8ffa88a691260" label="mixed materials [A0000000075913]" type="box">71</container><container id="a5205929cd866dfa07f0c055b4e1930b" parent="04a84d493e455152a9d8ffa88a691260" type="folder">9-11</container></did><accessrestrict id="41a008738c8b0cf8972cf6b24432d838"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="bad1e6f9e4ec0f760e77c31253787c34" level="file"><did><unittitle>TML, 44-18 - Anakinra (Kineret) for rheumatoid arthritis</unittitle><unitdate type="inclusive">2002 February 18</unitdate><container altrender="Record Storage Box (Paige)" id="7072466aa3a81bf4583758cc3b8b0de0" label="mixed materials [A0000000075913]" type="box">71</container><container id="2c82581c608aed01c6288e61c4315c24" parent="7072466aa3a81bf4583758cc3b8b0de0" type="folder">12-13</container></did><accessrestrict id="5283c1dbc9ae363bd049db90b8c9f8d8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="ba78803aaafb030f1962308400163490" level="file"><did><unittitle>TML, 44-19 - Almotriptan (Axert) and Frovatriptan (Friva) for migraine</unittitle><unitdate type="inclusive">2002 February 18</unitdate><container altrender="Record Storage Box (Paige)" id="0aea3f2116a7418c2168b525851cf50e" label="mixed materials [A0000000075913]" type="box">71</container><container id="684cc5213c49040c417db2319a197d0d" parent="0aea3f2116a7418c2168b525851cf50e" type="folder">14-16</container></did><accessrestrict id="261eac7e701cc4253a133eadd4895b0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="bb6077375b3a6ffeb4bb53556a4f4c3c" level="file"><did><unittitle>TML, 44-110 - Hemolysis from Ceftriaxone</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="72a6333761a2d4f644ec380f78355d8b" label="mixed materials [A0000000075913]" type="box">71</container><container id="6f14526823830f43d19144be2e814d39" parent="72a6333761a2d4f644ec380f78355d8b" type="folder">17-19</container></did><accessrestrict id="06663a53b51c9f32469146874e6a53fd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a4e45a144c74f16ab14378047e5576f1" level="file"><did><unittitle>TML, 44-6 - Budesonide (Entocort EC) for Crohn's disease</unittitle><unitdate type="inclusive">2002 January 21</unitdate><container altrender="Record Storage Box (Paige)" id="d193a841cc6512e2aabca7bc96304002" label="mixed materials [A0000000075913]" type="box">71</container><container id="be73e4a7d66f16b5b8b63016ff27a0d9" parent="d193a841cc6512e2aabca7bc96304002" type="folder">20-21</container></did><accessrestrict id="344623fd522ad204005bd4713a3a7eaa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9f13d0adec34e41920a5e68ddd64292c" level="file"><did><unittitle>TML, 44-109 - Dustateride (Avodart) for benign prostatic hyperplasia</unittitle><unitdate type="inclusive">2002 December 23</unitdate><container altrender="Record Storage Box (Paige)" id="c5b0a55a63cbd917e07ed3d334b0678d" label="mixed materials [A0000000075914]" type="box">72</container><container id="5053b242f7d239887e79f5ac2a8326b6" parent="c5b0a55a63cbd917e07ed3d334b0678d" type="folder">1</container></did><accessrestrict id="867284bb3e82161ed3ce13cf85bb50cf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9263ee3a396996d1f6c92f91c990e8b4" level="file"><did><unittitle>TML, 44-55 - Yasmin - an oral contraceptive with a new progestin</unittitle><unitdate type="inclusive">2002 June 24</unitdate><container altrender="Record Storage Box (Paige)" id="d95fe32c128335a6a79ac1d38954e08c" label="mixed materials [A0000000075914]" type="box">72</container><container id="73b8e1117e962b3621593cf53f234b1f" parent="d95fe32c128335a6a79ac1d38954e08c" type="folder">2-7</container></did><accessrestrict id="c400e4bb55cfe7ea165cfb2d2dc99c6b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="fec2a29720e66cc581b066877ffa632d" level="file"><did><unittitle>TML, 44-8 - Othro Evra - A contraceptive patch</unittitle><unitdate type="inclusive">2002 January 21</unitdate><container altrender="Record Storage Box (Paige)" id="48396c884d29ccf6877446cde5c1a71a" label="mixed materials [A0000000075914]" type="box">72</container><container id="96061adb901538ea27f2abb12a595d8c" parent="48396c884d29ccf6877446cde5c1a71a" type="folder">8-9</container></did><accessrestrict id="f89be5a42a6e7c9142c05161a1bb4330"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="ea19cfea9c41aa789e87a27139849cc9" level="file"><did><unittitle>TML, 44-42 - Copyright violations</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="b6c9f30328e8c087bb072cd49c86a2f7" label="mixed materials [A0000000075914]" type="box">72</container><container id="f7e0003b9be77e6ca7bfa20cea723d8d" parent="b6c9f30328e8c087bb072cd49c86a2f7" type="folder">10</container></did><accessrestrict id="ec1aa5a5bbffa7071d0ee4e1725ec096"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="573b9aa7949c2b6064549d58f22d1ef4" level="file"><did><unittitle>TML, 44-89 - Generic drugs</unittitle><unitdate type="inclusive">2002 October 14</unitdate><container altrender="Record Storage Box (Paige)" id="18f03f3bd80c704e607488cad1ad008d" label="mixed materials [A0000000075914]" type="box">72</container><container id="b97628ff7c48ba79c4a10d3709ec766a" parent="18f03f3bd80c704e607488cad1ad008d" type="folder">11-13</container></did><accessrestrict id="5b1243a2f3ac837601682945b4ad6a9e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="eca6e6e8880da77ade266c114c4c3ef8" level="file"><did><unittitle>TML, 44-77 - Gefitinib (Iressa) for advanced non-small cell lung cancer</unittitle><unitdate type="inclusive">2002 September 2</unitdate><container altrender="Record Storage Box (Paige)" id="087271db60461f69296537faaa16d8f0" label="mixed materials [A0000000075914]" type="box">72</container><container id="2e1b9b3f47216a60b66da6d29fb76d44" parent="087271db60461f69296537faaa16d8f0" type="folder">14-16</container></did><accessrestrict id="e52979497dde6f1c31a59d9d3764a403"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a5125bf7e9b481c9cf3b474c751ee55e" level="file"><did><unittitle>TML, 44-103 - GHB for nacolepsy</unittitle><unitdate type="inclusive">2002 December 9</unitdate><container altrender="Record Storage Box (Paige)" id="f79281aec090ce5d45652c3d13d6636e" label="mixed materials [A0000000075914]" type="box">72</container><container id="56c43d4e3655aec496e8608379e214e2" parent="f79281aec090ce5d45652c3d13d6636e" type="folder">17-19</container></did><accessrestrict id="0fce222a44f0f4d669d6446bfe4d0948"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="5f1f43a60e3a918e61f1524dd78e1670" level="file"><did><unittitle>TML - Fungal Infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="f1fd5d1ea39a5e55a1b8a5562f98c9ea" label="mixed materials [A0000000075914]" type="box">72</container><container id="da3035b545a63b8b1a5e1c2247afd81e" parent="f1fd5d1ea39a5e55a1b8a5562f98c9ea" type="folder">20</container></did><accessrestrict id="43b31e9dd0e56b4393c587638541da8a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="d0277fd8830f2d769496c88f15bb859c" level="file"><did><unittitle>TML - Fungal Infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="0847f8e9af0223a4847188ea6b961525" label="mixed materials [A0000000075915]" type="box">73</container><container id="d0aacd5d9c1e6f4b2438827bc24bf0c3" parent="0847f8e9af0223a4847188ea6b961525" type="folder">1</container></did><accessrestrict id="0374c695f899676ae2f0f4ab46c32079"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="38f15317a1ab04ccab7ddf87c59865ca" level="file"><did><unittitle>TML, 44-65 - Fulvestrant (Faslodex) for advanced breast cancer</unittitle><unitdate type="inclusive">2002 July 22</unitdate><container altrender="Record Storage Box (Paige)" id="57bccb3ceab1c6b72c8cd5cccd852d3a" label="mixed materials [A0000000075915]" type="box">73</container><container id="61efa08beea1ab4796dfa6ca5d2865e3" parent="57bccb3ceab1c6b72c8cd5cccd852d3a" type="folder">2-4</container></did><accessrestrict id="ce879f9aa1fe59c4646fb8a958d249d1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="c2dd44962d67176662e4db78dd0a66d1" level="file"><did><unittitle>TML, 44-5 - Cefditoren (Spectracef) - A new oral cephalosporin</unittitle><unitdate type="inclusive">2002 January 21</unitdate><container altrender="Record Storage Box (Paige)" id="9c1f4aa1642c471490fc4cee4dd74fa5" label="mixed materials [A0000000075915]" type="box">73</container><container id="f97dd1018ae828aea4c1ac9e74e36be7" parent="9c1f4aa1642c471490fc4cee4dd74fa5" type="folder">5-7</container></did><accessrestrict id="a137a040fd97e7017313ae9a82d2fe86"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="70993f6f906adca6d28b7cec87c5cbab" level="file"><did><unittitle>TML, 44-93 - Drugs past their expiration date</unittitle><unitdate type="inclusive">2002 October 28</unitdate><container altrender="Record Storage Box (Paige)" id="108e6dcd72aeb842a0302a4f5729e6bc" label="mixed materials [A0000000075915]" type="box">73</container><container id="744521ea60472f56bb7f77e08b113cf6" parent="108e6dcd72aeb842a0302a4f5729e6bc" type="folder">8-10</container></did><accessrestrict id="e06690c5813977cdcc6c8a5a7653718f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f9bc602671296cc3d2de922401f1986e" level="file"><did><unittitle>TML, 44-83 - Escitalopram (Lexapro) for depression</unittitle><unitdate type="inclusive">2002 September 30</unitdate><container altrender="Record Storage Box (Paige)" id="e991050636e30ec636434879648eb0c3" label="mixed materials [A0000000075915]" type="box">73</container><container id="b1feb388e62149e931a576f4a2ef9388" parent="e991050636e30ec636434879648eb0c3" type="folder">11-12</container></did><accessrestrict id="fdb13be24c2193fa8c3289e7d5ad654a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="88bf2c423e244a87d79645badbf2e9f3" level="file"><did><unittitle>TML, 44-43 - Fondaparinux (Arixtra) - a new anticoagulant</unittitle><unitdate type="inclusive">2002 May 13</unitdate><container altrender="Record Storage Box (Paige)" id="3d07df26341faacb833dd7405d70cda7" label="mixed materials [A0000000075915]" type="box">73</container><container id="a4998ad4cdeae3ad5af39d87aadb734d" parent="3d07df26341faacb833dd7405d70cda7" type="folder">13-15</container></did><accessrestrict id="bbbdd53df2b8ebd0612902a21d46a748"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="05b64e3022467a23598c9201bc74dfdf" level="file"><did><unittitle>TML - Cefepime</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="3d41f3ea4797ef52d9bcb72aab0d88bb" label="mixed materials [A0000000075915]" type="box">73</container><container id="caaf4ab7d26a92761232d7b90211661b" parent="3d41f3ea4797ef52d9bcb72aab0d88bb" type="folder">16-18</container></did><accessrestrict id="394b3115bcff39760eac5c39dc81bdb6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0b79a2b45ac5a48beb03988b3255f34c" level="file"><did><unittitle>TML, 44-126 - Eratapenem - a new parenteral carbapenem</unittitle><unitdate type="inclusive">2002 March 18</unitdate><container altrender="Record Storage Box (Paige)" id="15577b5e6bb9935519c10afb96649446" label="mixed materials [A0000000075915]" type="box">73</container><container id="4732df715264bdadbc88e7823930c21c" parent="15577b5e6bb9935519c10afb96649446" type="folder">19-21</container></did><accessrestrict id="556a688586b09ef7523a269879e4d606"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2ab8dcb85ae9ce0ddd2d1fdc51a02ee6" level="file"><did><unittitle>TML - Echinacea</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="b806ffd366c2ad71fa9a48b61d9795cd" label="mixed materials [A0000000075916]" type="box">74</container><container id="f97d052220661bb66a369870f91ef81a" parent="b806ffd366c2ad71fa9a48b61d9795cd" type="folder">1-3</container></did><accessrestrict id="dc18fb2ef4fb05f2fdaba6355d199ff6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="af85bd11efe07fd729751c8c218f32d2" level="file"><did><unittitle>TML, 44-47 - Botulinum Toxin (Botox Cosmetic) for frown lines</unittitle><unitdate type="inclusive">2002 May 27</unitdate><container altrender="Record Storage Box (Paige)" id="f922506ab230d47655ff6ed48a711f4f" label="mixed materials [A0000000075916]" type="box">74</container><container id="6dc718cffba5fbd30f16524339a75e62" parent="f922506ab230d47655ff6ed48a711f4f" type="folder">4-6</container></did><accessrestrict id="e67c688500af00baeca0146003fa4b6f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="45aa8fe42fd0ddc4536be77350df4b57" level="file"><did><unittitle>TML - Fungal Infections - Reprints</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="b77e9e65599b4e749aeb43b28482f8e7" label="mixed materials [A0000000075916]" type="box">74</container><container id="21247212c5d33a9b0b97be7fdf795618" parent="b77e9e65599b4e749aeb43b28482f8e7" type="folder">7</container></did><accessrestrict id="1f1099e38699970b363bae0c6975a70b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2e47b4ee1607009a90bcdea23b07a404" level="file"><did><unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="3e39b862bc5dce6736dc6b515ec2166b" label="mixed materials [A0000000075916]" type="box">74</container><container id="8ee6d909a38f68c10bfa041b73437e2e" parent="3e39b862bc5dce6736dc6b515ec2166b" type="folder">8-19</container></did><accessrestrict id="831283e78ef78563e6f6b9e3060a60fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f41b47c09c3e11ca72cf6fe9fcfca8b2" level="file"><did><unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="89995d9b980d28fff00b203bbe649f91" label="mixed materials [A0000000075917]" type="box">75</container><container id="ca87da702bf95b5f0cb0405dbfe0595d" parent="89995d9b980d28fff00b203bbe649f91" type="folder">1-2</container></did><accessrestrict id="37075cc131616efa32d821ddec70e19a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0785dbde88fe25acb019e68e53796851" level="file"><did><unittitle>TML, 44-73 - Neotame - a new artificial sweetner</unittitle><unitdate type="inclusive">2002 August 19</unitdate><container altrender="Record Storage Box (Paige)" id="19cb2927501f1b762c1c02cc58fb5f38" label="mixed materials [A0000000075917]" type="box">75</container><container id="b4fd4ff1b2179742ec839de3743a6aef" parent="19cb2927501f1b762c1c02cc58fb5f38" type="folder">3-4</container></did><accessrestrict id="423a699022dfc41e5a19356b8ede358f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="daec721a5877ed667e3be025c5b3972b" level="file"><did><unittitle>TML, 44-95 - Valacyclovir (Valtrex) for herpes labialis</unittitle><unitdate type="inclusive">2002 November 11</unitdate><container altrender="Record Storage Box (Paige)" id="a0996dcfee59aaf31eb2a5b169445b32" label="mixed materials [A0000000075917]" type="box">75</container><container id="b8d32fbd3167549b3a84663c126ed586" parent="a0996dcfee59aaf31eb2a5b169445b32" type="folder">5-6</container></did><accessrestrict id="65275a0edfafc2779f6f3b12b167613d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="daaa98dacc14a33f7dd8c3607f43fabe" level="file"><did><unittitle>TML - Drugs for prevention and treatment of postmenopausal osteoporosis - Treatment Guidelines</unittitle><unitdate type="inclusive">2002 November 1</unitdate><container altrender="Record Storage Box (Paige)" id="67b5dd25cc1f94cf005cc696d003c4ba" label="mixed materials [A0000000075917]" type="box">75</container><container id="2b4431c03a1618701c9ea4ebb881a6e8" parent="67b5dd25cc1f94cf005cc696d003c4ba" type="folder">7-10</container></did><accessrestrict id="66fca14cfc643877b243d938549ef683"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="6c5c80d095e7afd1c721854326e0f8cc" level="file"><did><unittitle>TML, 44-9 - Drugs for Non-HIV viral infections</unittitle><unitdate type="inclusive">2002 February 4</unitdate><container altrender="Record Storage Box (Paige)" id="af8df25c29d13b095a19b8104e4ea14d" label="mixed materials [A0000000075917]" type="box">75</container><container id="08ce5933c77a5fc72d8bcb13f09b9d43" parent="af8df25c29d13b095a19b8104e4ea14d" type="folder">11-17</container></did><accessrestrict id="bdf05fc38d86db9b72f37658b33c4730"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="bcfed60146a9353c15a7810e066eb562" level="file"><did><unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="208e0d6bea05ef954e8c76c7ef1bde23" label="mixed materials [A0000000075917]" type="box">75</container><container id="4113e18b204d8c00b84f5e5695b44826" parent="208e0d6bea05ef954e8c76c7ef1bde23" type="folder">18-19</container></did><accessrestrict id="3f36d4c0ac7dd42dca225464d90a4a7b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="26f9f680797154013e700d36b1ee02cc" level="file"><did><unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="80b4217c5e5941af80d7a4d22f57a5bd" label="mixed materials [A0000000075918]" type="box">76</container><container id="44bcc05417273d2629ed0dd5acb53ba2" parent="80b4217c5e5941af80d7a4d22f57a5bd" type="folder">1-2</container></did><accessrestrict id="538e6db36155fc336b5cd7453b267830"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="87edb03339d8ce2c8587c9b08fa0c33c" level="file"><did><unittitle>TML, 44-52 - Tazarotene (Tazorac) for acne</unittitle><unitdate type="inclusive">2002 June 10</unitdate><container altrender="Record Storage Box (Paige)" id="51f86f87ad5a1b51ea8783bc113a1129" label="mixed materials [A0000000075918]" type="box">76</container><container id="ecd6c69d74282abb6faf76663805ed76" parent="51f86f87ad5a1b51ea8783bc113a1129" type="folder">3-5</container></did><accessrestrict id="009827e7a43d5b337cbe6459416c7913"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="4e2f11c3afbd278cc01889db51cc3594" level="file"><did><unittitle>TML - Safety of antimicrobials in pregnancy</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="d7806f1cbe739ac1ffa3bd9cfbfd783f" label="mixed materials [A0000000075918]" type="box">76</container><container id="f563a4e6b0a686a5f60b140e4b42f8b8" parent="d7806f1cbe739ac1ffa3bd9cfbfd783f" type="folder">6-9</container></did><accessrestrict id="4077280e1fc84a55fa2f33342e312820"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="d9af5da201c75753edd17152b98006c9" level="file"><did><unittitle>TML, 44-63 - Voriconazole</unittitle><unitdate type="inclusive">2002 July 22</unitdate><container altrender="Record Storage Box (Paige)" id="a15e744c050212b0ecf2340784b98d8e" label="mixed materials [A0000000075918]" type="box">76</container><container id="879c3c7b7bdc4c1cb43f194edbe14881" parent="a15e744c050212b0ecf2340784b98d8e" type="folder">10-14</container></did><accessrestrict id="7f7313cf1c86daf164b8b5b1d2c47390"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f449d0ea0cb02a16dc4bb161afd0e8e1" level="file"><did><unittitle>TML - Cardiovascular drugs in the ICU - Treatment Guidelines</unittitle><unitdate type="inclusive">2002 December</unitdate><container altrender="Record Storage Box (Paige)" id="60c34ca89ea3c2cf11df9a1d4ef91d3a" label="mixed materials [A0000000075918]" type="box">76</container><container id="67b4e5be5353b8cf6f2e6d862a3d1815" parent="60c34ca89ea3c2cf11df9a1d4ef91d3a" type="folder">15-20</container></did><accessrestrict id="d78727a12815fb45316cee4c1bb66369"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="4536f53d88709a34f9764f238002f522" level="file"><did><unittitle>TML, 44-51 - Triptorelin Pamoate (Trelstar)</unittitle><unitdate type="inclusive">2002 June 10</unitdate><container altrender="Record Storage Box (Paige)" id="deade891cd3130a7cd28caf1944315fa" label="mixed materials [A0000000075919]" type="box">77</container><container id="bc6a36d9fec63548cf22cc7cd9a954b5" parent="deade891cd3130a7cd28caf1944315fa" type="folder">1-4</container></did><accessrestrict id="3f564956f49faf84f827624973a86572"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="8319ac1e74f3772c55f953d49d1fe802" level="file"><did><unittitle>TML - Drugs for Tuberculosis</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="b6e9c0aaa6098c5d96d2b5e202b216c2" label="mixed materials [A0000000075919]" type="box">77</container><container id="69691f63c84c8ca5bfd5fffe23a84ea3" parent="b6e9c0aaa6098c5d96d2b5e202b216c2" type="folder">5-8</container></did><accessrestrict id="6e3e6b2b8bab0f3a6559d5327bba741c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="c61123a9a767eb2a2f0665b7e710f056" level="file"><did><unittitle>TML, 44-80 - Tepostinil (Remodulin) for pulmonary arterial hypertension</unittitle><unitdate type="inclusive">2002 September 16</unitdate><container altrender="Record Storage Box (Paige)" id="2ef7bc379216ed8960392e40f9ddc5dd" label="mixed materials [A0000000075919]" type="box">77</container><container id="70b5958efe2e317c464c7145d63d80c4" parent="2ef7bc379216ed8960392e40f9ddc5dd" type="folder">9-11</container></did><accessrestrict id="96d0a14409c624606417824206c572f4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9c1edb72ecb57f4a5cf544ab8a33f1ca" level="file"><did><unittitle>TML, 44-59 - Drugs that may cause psychiatric symptoms</unittitle><unitdate type="inclusive">2002 July 8</unitdate><container altrender="Record Storage Box (Paige)" id="83c28c029a5556d07907f8a07aed58f3" label="mixed materials [A0000000075919]" type="box">77</container><container id="9e7597e36ef27ded01149fa05de3646c" parent="83c28c029a5556d07907f8a07aed58f3" type="folder">12-16</container></did><accessrestrict id="049b266831555277c80bf92411b09f0b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="83c1e0a1fb9e3488cec1e298480b45b9" level="file"><did><unittitle>TML, 44-79 - Tegaserod Maleate (Zelnom) for IBS with constipation</unittitle><unitdate type="inclusive">2002 September 16</unitdate><container altrender="Record Storage Box (Paige)" id="7c32e64159885b36eabb42e79a33b825" label="mixed materials [A0000000075919]" type="box">77</container><container id="0cca6bc0f26b75b9d809d3e7bc447275" parent="7c32e64159885b36eabb42e79a33b825" type="folder">17-19</container></did><accessrestrict id="6b6e7ca2998642d620f912e4ae273e58"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="702df7b3933e28f25249b7010b1efc23" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="e10ea91ae430023005718ede63966d48" label="mixed materials [A0000000075919]" type="box">77</container><container id="7958ebc8e5b0bce42e20c40a10b352af" parent="e10ea91ae430023005718ede63966d48" type="folder">20</container></did><accessrestrict id="21f8d786633e1a74c8baaec02b6e69c6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="fbd9f3d2b393e963f637e86d90ca6f0c" level="file"><did><unittitle>TML - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="66efc9552c09661cc9bf7b2c37b53397" label="mixed materials [A0000000075919]" type="box">77</container><container id="90db1e0440c3004138e0fe14a3fc13ce" parent="66efc9552c09661cc9bf7b2c37b53397" type="folder">21</container></did><accessrestrict id="8c19ab74e7734be86d15ccfc2ffd8632"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="3238875c71befee0c843bfb578b0af6f" level="file"><did><unittitle>TML - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="27ffd01cd6f17470da1ccbc4a8a4c363" label="mixed materials [A0000000075920]" type="box">78</container><container id="71459c9a4cb459181e231c5395512266" parent="27ffd01cd6f17470da1ccbc4a8a4c363" type="folder">1-3</container></did><accessrestrict id="f07baa851539686de763d2f786c2177e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0f73f901dbd4ead91b01d80ceed67c30" level="file"><did><unittitle>TML, 44-75 - Influenza prevention 2002-2003</unittitle><unitdate type="inclusive">2002 September 2</unitdate><container altrender="Record Storage Box (Paige)" id="89bf545e318ef841beffab9f2a729652" label="mixed materials [A0000000075920]" type="box">78</container><container id="d1713e48d5d3e17bf60b50a89256d0ac" parent="89bf545e318ef841beffab9f2a729652" type="folder">4-6</container></did><accessrestrict id="f979eb1f784b0838d5a64de4d9ac9da1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="23ee674858aa228c8597cb11a5363b5d" level="file"><did><unittitle>TML, 44-33 - Advice for travelers</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="e931ba65961e3450b884873e4694c312" label="mixed materials [A0000000075920]" type="box">78</container><container id="e757f82ae083f4b131ae66d42d5d5e75" parent="e931ba65961e3450b884873e4694c312" type="folder">7-9</container></did><accessrestrict id="687d9c16855007cc90b89408873e9116"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="c3ff86733b644974c019ea29b403f49f" level="file"><did><unittitle>TML, 44-97 - Potassium Iodine for thyroid protection in a nuclear accident or attack</unittitle><unitdate type="inclusive">2002 November 11</unitdate><container altrender="Record Storage Box (Paige)" id="84c91ebf94d47d591723533e1f44ae46" label="mixed materials [A0000000075920]" type="box">78</container><container id="dff99d3a100ad893b268c595fba43194" parent="84c91ebf94d47d591723533e1f44ae46" type="folder">10-11</container></did><accessrestrict id="ae3d1b9904d63ec7a442b7bf1ecd8dc5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="24af9a9128ef19b87942303f71c93a4b" level="file"><did><unittitle>TML, 44-91 - Acetaminophen safety</unittitle><unitdate type="inclusive">2002 October 28</unitdate><container altrender="Record Storage Box (Paige)" id="127aec378d9f5e9507b700246e1456ea" label="mixed materials [A0000000075920]" type="box">78</container><container id="555c115cdece7fb4261cfcd853fc2b05" parent="127aec378d9f5e9507b700246e1456ea" type="folder">12-16</container></did><accessrestrict id="7768a5d75ddf57469eb3bbdfec0f20af"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="b3aae1ba9f482e9eeee3c33251fd33f7" level="file"><did><unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle><unitdate type="inclusive">2002 June 24</unitdate><container altrender="Record Storage Box (Paige)" id="001d8da94bb2e0f7d1ab49ac077e50b0" label="mixed materials [A0000000075920]" type="box">78</container><container id="1bfe5750481623287dc83d66fb06cce2" parent="001d8da94bb2e0f7d1ab49ac077e50b0" type="folder">17-19</container></did><accessrestrict id="afa4af3e07bce4f2fa04d79ed2a8e09b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="8104e8da1a3aff8455ce0008f38fee5a" level="file"><did><unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle><unitdate type="inclusive">2002 June 24</unitdate><container altrender="Record Storage Box (Paige)" id="18231e68086c6348e5b58a878b811087" label="mixed materials [A0000000075921]" type="box">79</container><container id="bd92ff45be4a2e15b1ae0e11d35fdb82" parent="18231e68086c6348e5b58a878b811087" type="folder">1-2</container></did><accessrestrict id="aca0e4a78b7223c626fd6a43994f5d31"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="02479e2c1173076c05f34aa17007ba49" level="file"><did><unittitle>TML, 44-21 - Acute reactions of drug abuse</unittitle><unitdate type="inclusive">2002 March 4</unitdate><container altrender="Record Storage Box (Paige)" id="6e1318cc23e6166b4b6a5d49084a3115" label="mixed materials [A0000000075921]" type="box">79</container><container id="e0473b533397a90ad0d302acf5bac3fe" parent="6e1318cc23e6166b4b6a5d49084a3115" type="folder">3-6</container></did><accessrestrict id="c95f7f827b4be73752d104280c14ae0c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="d1098818233489d81f3ee9a35c491fda" level="file"><did><unittitle>TML, 44-71 - Tests for drug abuse</unittitle><unitdate type="inclusive">2002 August 19</unitdate><container altrender="Record Storage Box (Paige)" id="07459cfc3f0e7dd9314da778f692b557" label="mixed materials [A0000000075921]" type="box">79</container><container id="dde382213d9d01cce07a3273f36a3ffd" parent="07459cfc3f0e7dd9314da778f692b557" type="folder">7-10</container></did><accessrestrict id="6b5deed194656d7a78e4584eaf23da1c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a2d97df9926c22348169dc85fc2da466" level="file"><did><unittitle>TML, 44-82 - Accutane</unittitle><unitdate type="inclusive">2002 September</unitdate><container altrender="Record Storage Box (Paige)" id="742bd9c7360805f366ac762694ae53eb" label="mixed materials [A0000000075921]" type="box">79</container><container id="8c48dd225b06ef268925e69b6e726fde" parent="742bd9c7360805f366ac762694ae53eb" type="folder">11-12</container></did><accessrestrict id="811a73112a0f3db0c61460c6f50c3a83"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="77f6dda8f57e4d024c751d9255cb8084" level="file"><did><unittitle>TML, 44-50 - Spinal Manipulation</unittitle><unitdate type="inclusive">2002 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="4d054d3fc7f16f18f240ca7e94ec959e" label="mixed materials [A0000000075921]" type="box">79</container><container id="22bd9195dd51988247ff275bcaf0ee6f" parent="4d054d3fc7f16f18f240ca7e94ec959e" type="folder">13-15</container></did><accessrestrict id="c6a5678b6a97ed4390bd98a720535a47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="09411c4ec2cd0e10526be529fdbb7c1d" level="file"><did><unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="721f7696b9c48469e2966fed42b437d1" label="mixed materials [A0000000075921]" type="box">79</container><container id="bb1bb1766d094f4b20aa4112d341cc3c" parent="721f7696b9c48469e2966fed42b437d1" type="folder">16-17</container></did><accessrestrict id="1fde5116b8525bf37872775d4c998b9e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2af7784d4333e1386ceb5387b0141573" level="file"><did><unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="63f5b272ddb01882e435a331f9d7689b" label="mixed materials [A0000000075922]" type="box">80</container><container id="53411827eb033d9611d2ce209b9d4c98" parent="63f5b272ddb01882e435a331f9d7689b" type="folder">1-2</container></did><accessrestrict id="b2d240752dac7c5d6b161365b06fbe2d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="45b86f5c46903225f479639e02061c91" level="file"><did><unittitle>TML, 44-17 - Drotecogin - Activated Protein C (Xigris) for Severe Sepsis</unittitle><unitdate type="inclusive">2002 February 18</unitdate><container altrender="Record Storage Box (Paige)" id="5502dc308bb45fad91ecd537df54a67a" label="mixed materials [A0000000075922]" type="box">80</container><container id="7f091aba79c48c5021f8074e144e5055" parent="5502dc308bb45fad91ecd537df54a67a" type="folder">3-7</container></did><accessrestrict id="c6644b7dd17dbfbedd1d1af2963340f4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2df9fa1b1dadedbd80d056c6d1eb7e1b" level="file"><did><unittitle>TML, 44-78 - Hormone replacement therapy</unittitle><unitdate type="inclusive">2002 September 2</unitdate><container altrender="Record Storage Box (Paige)" id="4c76d1ae0f267161224d427b58672578" label="mixed materials [A0000000075922]" type="box">80</container><container id="d7d0b566b07bbe41280721552a13232b" parent="4c76d1ae0f267161224d427b58672578" type="folder">8-9</container></did><accessrestrict id="25fbac45d92806e8263c700a8600b817"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="79ecc959704f5a99033f6383c71d5e2b" level="file"><did><unittitle>TML, 44-30 -Bosentan (Tracleer) for pulmonary arterial hypertension</unittitle><unitdate type="inclusive">2002 April 11</unitdate><container altrender="Record Storage Box (Paige)" id="78c051484c2a92bce6e8d3c5d157bb2d" label="mixed materials [A0000000075922]" type="box">80</container><container id="664cc1f91ea09c757ad6762239d0cd54" parent="78c051484c2a92bce6e8d3c5d157bb2d" type="folder">10-12</container></did><accessrestrict id="c218a513a6535a5ceb72241f53f1083c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="ebeb0b87fb29433a1b670b6a4d5aa5fc" level="file"><did><unittitle>TML, 44-45 - Dexmethylphenidate (Focalin) for ADHD</unittitle><unitdate type="inclusive">2002 May 13</unitdate><container altrender="Record Storage Box (Paige)" id="c1ae778017ec3ae6b3aca64411d18286" label="mixed materials [A0000000075922]" type="box">80</container><container id="183e2cb71997dd2b6ed393f27aaaba31" parent="c1ae778017ec3ae6b3aca64411d18286" type="folder">13-14</container></did><accessrestrict id="daa9fc43588271721e9668e6387b1ecc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9cf28c7502d38a3253794dc0aff81d12" level="file"><did><unittitle>TML, 44-53 - Droperidol Risk - Arrhythmias</unittitle><unitdate type="inclusive">2002 June 10</unitdate><container altrender="Record Storage Box (Paige)" id="f53ee9ea6f2bf42adedd71a6e41db96b" label="mixed materials [A0000000075922]" type="box">80</container><container id="517d2c25f23e7ac6e7d093518221aa93" parent="f53ee9ea6f2bf42adedd71a6e41db96b" type="folder">15-16</container></did><accessrestrict id="9343665bbaab14cdc391de9fbda39aab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="037a4523e063f09b403c4b86b056b0b9" level="file"><did><unittitle>TML, 44-84 - Herbal Products - Problems with dietary supplements</unittitle><unitdate type="inclusive">2002 September 30</unitdate><container altrender="Record Storage Box (Paige)" id="5472ebb8b8365fe3c3e3eb2417507a14" label="mixed materials [A0000000075922]" type="box">80</container><container id="51569dfbebf3fa31c6132b715dd0f98f" parent="5472ebb8b8365fe3c3e3eb2417507a14" type="folder">17-19</container></did><accessrestrict id="2fdc328774c9f82ce8ebb61aee7387a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="606c2c7591fb4c21ba3d38fc6c7462b0" level="file"><did><unittitle>TML, 44-96 - Rasburicase</unittitle><unitdate type="inclusive">2002 November 11</unitdate><container altrender="Record Storage Box (Paige)" id="437cbc5c591cab06d697f87d537b94fa" label="mixed materials [A0000000075923]" type="box">81</container><container id="d5480a74381fdaa9b668f3c61d40f540" parent="437cbc5c591cab06d697f87d537b94fa" type="folder">1-2</container></did><accessrestrict id="6dd42fdac95221294c398b8dad4d3a7e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="b3d8e525fd2c6ceabdefb1c16c80e100" level="file"><did><unittitle>TML, 44-88 - Three beta-interferons for MS</unittitle><unitdate type="inclusive">2002 October 14</unitdate><container altrender="Record Storage Box (Paige)" id="869e9850740b7d607b3304f587f2ebac" label="mixed materials [A0000000075923]" type="box">81</container><container id="fbf0d7c5d685671724731ebcfb89ffea" parent="869e9850740b7d607b3304f587f2ebac" type="folder">3-6</container></did><accessrestrict id="de5073ebce08ff223cdc3bac4b44096d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="cd35b74adb66fbee3caa77d502914319" level="file"><did><unittitle>TML, 44-99 - Indications for an implantable cardioverter defibrillator</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="5815425424d87852e7888bb9e3bcd114" label="mixed materials [A0000000075923]" type="box">81</container><container id="4222b32d4cb2240010631d1226f13e69" parent="5815425424d87852e7888bb9e3bcd114" type="folder">7-9</container></did><accessrestrict id="44a756d7626a6484624c170f3c9fe601"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="caba3d20cbb6ac2bcf0fffb6486cd172" level="file"><did><unittitle>TML - Drugs for Diabetes - Treatment Guidelines</unittitle><unitdate type="inclusive">2002 September</unitdate><container altrender="Record Storage Box (Paige)" id="53fafa3f0fec67175cbda4cc839226d2" label="mixed materials [A0000000075923]" type="box">81</container><container id="0db8d52df25fd2a5656f373d8f948431" parent="53fafa3f0fec67175cbda4cc839226d2" type="folder">10-13</container></did><accessrestrict id="27fb92f6dcd523eaebbcb18be6a423a5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0cdc8024ee854934a00a2e6cc658127c" level="file"><did><unittitle>TML, 44-87 - Once-a-Week risedronate (Actonel)</unittitle><unitdate type="inclusive">2002 October 14</unitdate><container altrender="Record Storage Box (Paige)" id="fd0f0c654f9b8556c1abb2419b33e05e" label="mixed materials [A0000000075923]" type="box">81</container><container id="1c7bb4f3f7acad97144283486af734c6" parent="fd0f0c654f9b8556c1abb2419b33e05e" type="folder">14-15</container></did><accessrestrict id="3c69c2eda4cf5e33f151894a6dae98fa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="6373e1ea574b03380381b604f8f317ea" level="file"><did><unittitle>TML, 44-48 - Topical Primecrolimus (Elidel) for treatment of atopic dermatitis</unittitle><unitdate type="inclusive">2002 May 27</unitdate><container altrender="Record Storage Box (Paige)" id="3f091014a5ed5719d946ef97bfda2958" label="mixed materials [A0000000075923]" type="box">81</container><container id="164b699599447ea009bdc7fca85e3d5a" parent="3f091014a5ed5719d946ef97bfda2958" type="folder">16-17</container></did><accessrestrict id="c8982cc8907e5273994dc146b1a74168"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0a43de1bea99678d0bd3f43b5c8e3aab" level="file"><did><unittitle>TML, 44-107 - Metaglip and Avandamet for type 2 diabetes</unittitle><unitdate type="inclusive">2002 December 23</unitdate><container altrender="Record Storage Box (Paige)" id="0d2f9762d5eaaa6cc732a6670ce16bbc" label="mixed materials [A0000000075924]" type="box">82</container><container id="9c1ee05cc0017eb3d9eeb0508b24b18c" parent="0d2f9762d5eaaa6cc732a6670ce16bbc" type="folder">1-3</container></did><accessrestrict id="77f5cb2d5690ac4fb8b1401da5ce42c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0ad024dbe91f78abe8bfbef002c6b1ff" level="file"><did><unittitle>TML, 44-27 - Desloratadine</unittitle><unitdate type="inclusive">2002 March 18</unitdate><container altrender="Record Storage Box (Paige)" id="77ba8f8ed368b0b590a4cab05120c8f9" label="mixed materials [A0000000075924]" type="box">82</container><container id="2e6349fc6274bf3f279a40c459265caa" parent="77ba8f8ed368b0b590a4cab05120c8f9" type="folder">4-6</container></did><accessrestrict id="36a5c8671473d8ebde644f9ea2a482bc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="b7991b9a56fe105d30e6587c04553698" level="file"><did><unittitle>TML, 44-41 - Pantoprazole (Protonix IV)</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="515a174695a2e7793d4ded0c1e7bb1b9" label="mixed materials [A0000000075924]" type="box">82</container><container id="21dcc11de4869dc8984964b734b69075" parent="515a174695a2e7793d4ded0c1e7bb1b9" type="folder">7-8</container></did><accessrestrict id="ecf59515bb41f3b93d8d69d9976e28b0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="e886d7140f04a51e798f5685595d8a64" level="file"><did><unittitle>TML, 44-69 - Olmesartan (Benicar) for hypertension</unittitle><unitdate type="inclusive">2002 August 5</unitdate><container altrender="Record Storage Box (Paige)" id="c21f817eca51647cf29b0eef04f59d56" label="mixed materials [A0000000075924]" type="box">82</container><container id="6dff528137a2bc63f79a52f52b096708" parent="c21f817eca51647cf29b0eef04f59d56" type="folder">9-12</container></did><accessrestrict id="74dedc4bdd750d18fabe19b677cbe4fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a62ab234ffcd38be2c7ecb1b5105a478" level="file"><did><unittitle>TML - Drugs for Parasitic Infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="8c6cf635b2598e1d12308aef0a5eabb7" label="mixed materials [A0000000075924]" type="box">82</container><container id="6fe88489f064b5512cf1aa90a996cbfd" parent="8c6cf635b2598e1d12308aef0a5eabb7" type="folder">13-16</container></did><accessrestrict id="a1761f494a6aadd735240b5f6234da0c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="334f7d2fdf7bebf0df4dbded68f76c8d" level="file"><did><unittitle>TML, 44-44 - Pegfilgrastin (Neulasta) for prevention of febrile neutropenia</unittitle><unitdate type="inclusive">2002 May 13</unitdate><container altrender="Record Storage Box (Paige)" id="ac10b5cd6d415a4303187462df36aa3d" label="mixed materials [A0000000075924]" type="box">82</container><container id="ac1822afdbcf65162256c1bcb585f598" parent="ac10b5cd6d415a4303187462df36aa3d" type="folder">17-19</container></did><accessrestrict id="a69e5af2889f08c295264781d0dc1080"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f777550cceb72905734014265970ba2d" level="file"><did><unittitle>TML, 45-25 - Adalimumab (Humira) for rheumatoid arthritis</unittitle><unitdate type="inclusive">2003 March 31</unitdate><container altrender="Record Storage Box (Paige)" id="bda943386a4a795dcb9b3b67bdc56cb1" label="mixed materials [A0000000075925]" type="box">83</container><container id="dd22188a7cd9c56a7c31af534593e1de" parent="bda943386a4a795dcb9b3b67bdc56cb1" type="folder">1-3</container></did><accessrestrict id="843488d272c7cd2629b6cfaf3ea233ef"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="755a5cb278c5674c278d62217583d0dc" level="file"><did><unittitle>TML, 45-31 - Alefacept (Amevive) for treatment of psoriasis</unittitle><unitdate type="inclusive">2003 April 14</unitdate><container altrender="Record Storage Box (Paige)" id="de964eaae1435483e70b4562998d0ba2" label="mixed materials [A0000000075925]" type="box">83</container><container id="af530150ac5c88e56a8742ba21aeafef" parent="de964eaae1435483e70b4562998d0ba2" type="folder">4-6</container></did><accessrestrict id="a72cbce0a6c64d80126a119167b5dc50"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9a2ad2a43a1bd9b6c3ff840aca327639" level="file"><did><unittitle>TML, 45-43 - Alprazolam XR for panic disorder</unittitle><unitdate type="inclusive">2003 May 26</unitdate><container altrender="Record Storage Box (Paige)" id="10d2383dfd0c7baece4d25e1d0ebd627" label="mixed materials [A0000000075925]" type="box">83</container><container id="3924377a5867d1d43640be8488816592" parent="10d2383dfd0c7baece4d25e1d0ebd627" type="folder">7</container></did><accessrestrict id="7facc30ebfc92bd3e698021dbdeb21fe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="32827b05df08c432fb2cbb3d952c316a" level="file"><did><unittitle>TML, 45-15 - Aripiprazole (Abilify) for schizophrenia</unittitle><unitdate type="inclusive">2003 February 17</unitdate><container altrender="Record Storage Box (Paige)" id="9ad5a93ddbb3b7c5536ada407bd41f38" label="mixed materials [A0000000075925]" type="box">83</container><container id="9ea24a7b4bbec51c0cd71ac1173f3596" parent="9ad5a93ddbb3b7c5536ada407bd41f38" type="folder">8-10</container></did><accessrestrict id="e9db4aba5feb72c13178e46e3f2599e5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="2dcb5260bf184933786c79514811276a" level="file"><did><unittitle>TML, 45-5 - Augmentin XR</unittitle><unitdate type="inclusive">2003 January 20</unitdate><container altrender="Record Storage Box (Paige)" id="7f7c48b3c7db1638a3704bd98692d021" label="mixed materials [A0000000075925]" type="box">83</container><container id="c0454ea105eccb6d589702f1d6b0842f" parent="7f7c48b3c7db1638a3704bd98692d021" type="folder">11-13</container></did><accessrestrict id="352c7f8bef5faa523d50be8830568d03"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="6719542efa0dd7e6ff2199fb0fc45784" level="file"><did><unittitle>TML, 45-50 - Blue Light (Clearlight) for acne vulgaris</unittitle><unitdate type="inclusive">2003 June 23</unitdate><container altrender="Record Storage Box (Paige)" id="62c39a84b1b7bd2c4da88dc6a472bad2" label="mixed materials [A0000000075925]" type="box">83</container><container id="5a6fea0d43be0d0d253d2904755b2c9a" parent="62c39a84b1b7bd2c4da88dc6a472bad2" type="folder">14-15</container></did><accessrestrict id="dd3798d0577bb9e1fc29332ed3c1ed16"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="face99254c656f96b64bf580e5f85bcf" level="file"><did><unittitle>TML, 45-57 - Bortezomib for multiple myeloma</unittitle><unitdate type="inclusive">2003 July 21</unitdate><container altrender="Record Storage Box (Paige)" id="9cd8b6acc7859926c8e36f3addca3d57" label="mixed materials [A0000000075925]" type="box">83</container><container id="20cd66d413960e7d8a5a85dbcc7e6be3" parent="9cd8b6acc7859926c8e36f3addca3d57" type="folder">16-18</container></did><accessrestrict id="5b737b9395121e3828a6f6fa407666da"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9ec231ed3611900061caae3128c95513" level="file"><did><unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle><unitdate type="inclusive">2003 December 22</unitdate><container altrender="Record Storage Box (Paige)" id="97625ec42563766094223d158aab2266" label="mixed materials [A0000000075925]" type="box">83</container><container id="568428ffe64f0d09e152a168a7495eb7" parent="97625ec42563766094223d158aab2266" type="folder">19</container></did><accessrestrict id="e0dca88a43ebdabbfbf835cde2da0a4f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c6404194bb02ecf2496bacd146a0cc60" level="file"><did><unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle><unitdate type="inclusive">2003 December 22</unitdate><container altrender="Record Storage Box (Paige)" id="c632fd7f6ef54ca2284cd8e011ec5c37" label="mixed materials [A0000000075926]" type="box">84</container><container id="3d0e1441a64a534181fc2b65e16e3f7b" parent="c632fd7f6ef54ca2284cd8e011ec5c37" type="folder">1-3</container></did><accessrestrict id="ff3d2237bfc8f29c4712b54bf885e9be"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="2ddbc741772355d7dce54b4b63ef6749" level="file"><did><unittitle>TML, 45-97 - Efalizumabe (Raptiva) for treatment of psoriasis</unittitle><unitdate type="inclusive">2003 December 8</unitdate><container altrender="Record Storage Box (Paige)" id="cb4efdb811dc0ba2a6a3f93b77a6b666" label="mixed materials [A0000000075926]" type="box">84</container><container id="0bcb9e907a5618eb659a3d99ee083efc" parent="cb4efdb811dc0ba2a6a3f93b77a6b666" type="folder">4-5</container></did><accessrestrict id="6eb237f5b70a5174ed44b4dc845e1439"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0f45b082b3a08c7cce74229a00644b02" level="file"><did><unittitle>TML, 45-97 (45-333) - Eletriptan (Replax) for migraine</unittitle><unitdate type="inclusive">2003 April 28</unitdate><container altrender="Record Storage Box (Paige)" id="69d5e1feaaf099e682ebb4807ae550d6" label="mixed materials [A0000000075926]" type="box">84</container><container id="0582b6693f3264ca604d79433827689f" parent="69d5e1feaaf099e682ebb4807ae550d6" type="folder">6-8</container></did><accessrestrict id="f517a35e209156fcce5cddbc43b68b14"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="94948e6e42424f89ec840de91511a768" level="file"><did><unittitle>TML, 45-49 - Enfuvirtide (Fuzeon) for HIV infection</unittitle><unitdate type="inclusive">2003 June 23</unitdate><container altrender="Record Storage Box (Paige)" id="33c2fe4da73637bfa10c7ad28ac6b885" label="mixed materials [A0000000075926]" type="box">84</container><container id="45d8a970ee2601013518233e40fc994d" parent="33c2fe4da73637bfa10c7ad28ac6b885" type="folder">9-11</container></did><accessrestrict id="a3551a188d335a0b903727fcd2a48fa4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="48f4b3c522fa705a3ae202735e45ac3b" level="file"><did><unittitle>TML, 45-89 - Growth hormone for normal short children</unittitle><unitdate type="inclusive">2003 November 10</unitdate><container altrender="Record Storage Box (Paige)" id="be8bf22cee068aaf3f4148c310465ea2" label="mixed materials [A0000000075926]" type="box">84</container><container id="b445ab030c90c30e6fb44073b5a65d6a" parent="be8bf22cee068aaf3f4148c310465ea2" type="folder">12-14</container></did><accessrestrict id="3229644ce53e8795f97a65d5d61f18e8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="780d425bdbd53ceafd83133223d279a7" level="file"><did><unittitle>TML, 45-67 - Omalizumab (Xolair) for Asthma</unittitle><unitdate type="inclusive">2003 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="b687bf22b878e7cee7bb754295486423" label="mixed materials [A0000000075926]" type="box">84</container><container id="9be5353bdb84f25a8839aa6380a5275f" parent="b687bf22b878e7cee7bb754295486423" type="folder">15-18</container></did><accessrestrict id="12994eea68e1f09108df54e255ae8cff"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3e27a4c127b0269848618ade1805962f" level="file"><did><unittitle>TML, 45-7 - Oxalipatin</unittitle><unitdate type="inclusive">2003 January 20</unitdate><container altrender="Record Storage Box (Paige)" id="4f9a51866781ff0c4e77b5210ceaca8b" label="mixed materials [A0000000075926]" type="box">84</container><container id="d4003622176d0d1647756e5f2877b63b" parent="4f9a51866781ff0c4e77b5210ceaca8b" type="folder">19</container></did><accessrestrict id="319e1cb1c4d5a539efc2e6af94af005a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="732aaf61ce82ace45c4354ea0038b752" level="file"><did><unittitle>TML, 45-7 - Oxalipatin</unittitle><unitdate type="inclusive">2003 January 20</unitdate><container altrender="Record Storage Box (Paige)" id="defe28ea25b89d8c7bb30341e9354bf2" label="mixed materials [A0000000075927]" type="box">85</container><container id="00d7a550306c54d4fd141ab586a7ca01" parent="defe28ea25b89d8c7bb30341e9354bf2" type="folder">1-2</container></did><accessrestrict id="c716c8d0ab4facf419cf7e7c4082202e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c4617feb74a721aa21a7112babed977f" level="file"><did><unittitle>TML, 45-38 - Oxbutynin trandermal (Oxytrol) for overactive bladder</unittitle><unitdate type="inclusive">2003 May 12</unitdate><container altrender="Record Storage Box (Paige)" id="bbd77cac180718c08a3fc001b6e53654" label="mixed materials [A0000000075927]" type="box">85</container><container id="eeed3bfc6b1e86acdb74b5d4bbe218f1" parent="bbd77cac180718c08a3fc001b6e53654" type="folder">3-4</container></did><accessrestrict id="09ded828b852ae6c86297bc23c88adc0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="8486f3e9d9968bc9f1dce0df7483cd4b" level="file"><did><unittitle>TML, 45-54 - Rapid tests for HIV infection</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="ab84f20756a0a05627fc1e07cc3aa432" label="mixed materials [A0000000075927]" type="box">85</container><container id="d13f3664cbe83fd0158b1324d8b533ca" parent="ab84f20756a0a05627fc1e07cc3aa432" type="folder">5-8</container></did><accessrestrict id="9d74192e21e6502b4dff990dec4cbb50"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="e54b07dbb6cb8e75aad0e568c11cae0a" level="file"><did><unittitle>TML, 45-77 - Vardenafil (Levitra) for erectile dysfunction</unittitle><unitdate type="inclusive">2003 September 29</unitdate><container altrender="Record Storage Box (Paige)" id="68008fd8264dfba9c9ad5115716b0166" label="mixed materials [A0000000075927]" type="box">85</container><container id="d125cc1f289d03daa690f3705a5debce" parent="68008fd8264dfba9c9ad5115716b0166" type="folder">9-12</container></did><accessrestrict id="f6350ccd6ef35a9adb3c39e7c7bf3a3c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="fdd62d893c6f422fd7c183e65efa7835" level="file"><did><unittitle>TML, 45-11 - Atomoxetine (Strattera)</unittitle><unitdate type="inclusive">2003 February 3</unitdate><container altrender="Record Storage Box (Paige)" id="0cc269aa5a13123cfe58b83adb965b1f" label="mixed materials [A0000000075927]" type="box">85</container><container id="fcf60785461eace807128408a8dd86fe" parent="0cc269aa5a13123cfe58b83adb965b1f" type="folder">13-15</container></did><accessrestrict id="36610a7149adbc1f92cfdc7751128db1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="35402d0a4356ba61f6f491a96f89217a" level="file"><did><unittitle>TML, 45-15 - Buprenorphine - an alternative to methadone</unittitle><unitdate type="inclusive">2013 February 17</unitdate><container altrender="Record Storage Box (Paige)" id="9793c62f360d31d77507d5b6cea92b34" label="mixed materials [A0000000075927]" type="box">85</container><container id="0d89516899806a7ed955aa4bf4cb63b1" parent="9793c62f360d31d77507d5b6cea92b34" type="folder">16-20</container></did><accessrestrict id="136a1315a2303fa111e5d01cb0517e7d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3fc7a0238f453d851bcf8a694afaf2ab" level="file"><did><unittitle>TML, 45-74 - Agalsidase beta (Fabrazyme) for Fabry disease</unittitle><unitdate type="inclusive">2003 September 15</unitdate><container altrender="Record Storage Box (Paige)" id="d66aa470891d8018ceb04f082a7b6c2e" label="mixed materials [A0000000075928]" type="box">86</container><container id="c23904260a2bb7b5963fa1fc4c06cd04" parent="d66aa470891d8018ceb04f082a7b6c2e" type="folder">1-3</container></did><accessrestrict id="aab1089a7327f8fc78a2fc319190599a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="5569c52b23e7d7eeddf53f7c2b84a996" level="file"><did><unittitle>TML, 45-39 - Eplerenone (Inspra)</unittitle><unitdate type="inclusive">2003 May 12</unitdate><container altrender="Record Storage Box (Paige)" id="1c09ea1c111f5934a9a3386a860cf91c" label="mixed materials [A0000000075928]" type="box">86</container><container id="c549f5f6724e60129f2e28d377617cce" parent="1c09ea1c111f5934a9a3386a860cf91c" type="folder">4-6</container></did><accessrestrict id="4fc1e68dd96cabb133f171a2e6a52471"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="19fc064c09e3806caaddbb51b70e4090" level="file"><did><unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle><unitdate type="inclusive">2003 December 8</unitdate><container altrender="Record Storage Box (Paige)" id="0ab82dd127df43cf2e1f7554646e89ab" label="mixed materials [A0000000075928]" type="box">86</container><container id="6aaa96f9a4a1b170dd3f64d154dffaf7" parent="0ab82dd127df43cf2e1f7554646e89ab" type="folder">5A-6A</container></did><accessrestrict id="60b6213d43e89633056c4a067f8c54e8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="f0a8b264973dfe8db5fe8da9b49f6e58" level="file"><did><unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle><unitdate type="inclusive">2003 December 8</unitdate><container altrender="Record Storage Box (Paige)" id="12dd50e714feb69c7e419dfab6c8a179" label="mixed materials [A0000000075928]" type="box">86</container><container id="80b66c87cbad0db1294f1c58a74be8c1" parent="12dd50e714feb69c7e419dfab6c8a179" type="folder">7-9</container></did><accessrestrict id="7a45da012d9d8375ab9c62d057d20b13"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="d1e93fdc68ebf64e073b0d53c908f073" level="file"><did><unittitle>TML, 45-101 - Tadalafil (Cialis) for Erectile dysfunction</unittitle><unitdate type="inclusive">2003 December 22</unitdate><container altrender="Record Storage Box (Paige)" id="973311c307f79126cd3b57a5faeceecf" label="mixed materials [A0000000075928]" type="box">86</container><container id="9eecba878567bf4ca62872b6b06fa760" parent="973311c307f79126cd3b57a5faeceecf" type="folder">10-11</container></did><accessrestrict id="a187e298156d35ecb24bf62acbaa2162"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="bf6ed6095bb9e6efdcac9a21b49e00e9" level="file"><did><unittitle>TML, 45-95 - Tattoo Removal</unittitle><unitdate type="inclusive">2003 November 24</unitdate><container altrender="Record Storage Box (Paige)" id="0c50342117ee0a7f3ec0653ef09eb5b2" label="mixed materials [A0000000075928]" type="box">86</container><container id="5ec2f7ba7850ec8309e2d2356fea938a" parent="0c50342117ee0a7f3ec0653ef09eb5b2" type="folder">12-13</container></did><accessrestrict id="1cb8774dfbec0195c1be0234b77205c6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="a857cbd537b23d5351b0c89499d70d8e" level="file"><did><unittitle>TML, 45-51 - Priloscec, Nexium and stereoisomers</unittitle><unitdate type="inclusive">2003 June 23</unitdate><container altrender="Record Storage Box (Paige)" id="660ffabbfc27a2373797a85d6c5fd5e7" label="mixed materials [A0000000075928]" type="box">86</container><container id="369e20e548a1633e4f1175bff84f9d49" parent="660ffabbfc27a2373797a85d6c5fd5e7" type="folder">14</container></did><accessrestrict id="4b2308536bb701384ee28edb8995985a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="1ed11b7c73752bdb0689383a30c1baf5" level="file"><did><unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle><unitdate type="inclusive">2003 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="9290c9f66735df3b84f90ea5ff54d075" label="mixed materials [A0000000075928]" type="box">86</container><container id="9cb2458ce245f28ac71722ec41b012e4" parent="9290c9f66735df3b84f90ea5ff54d075" type="folder">15-16</container></did><accessrestrict id="4ae7a8a3386cf59e0586622b1db28e61"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c48f05a528d95bdfee4855de30cb54e2" level="file"><did><unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle><unitdate type="inclusive">2003 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="1f502b69212b799c1e910dbf9ff74bfd" label="mixed materials [A0000000075929]" type="box">87</container><container id="cf3463e3f93478812f645ffee2d11769" parent="1f502b69212b799c1e910dbf9ff74bfd" type="folder">1</container></did><accessrestrict id="d1a19b29c41ed450efa6dd0a35b030ad"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3e6aff84359c7cdd06669d9d72f8c12a" level="file"><did><unittitle>TML, 45-21 - Montelukast (Singulair) for allergic rhinitis</unittitle><unitdate type="inclusive">2003 March 17</unitdate><container altrender="Record Storage Box (Paige)" id="680ba5316b992408e997940ba30e056b" label="mixed materials [A0000000075929]" type="box">87</container><container id="b985d127ba105c93a4dd79a66282c139" parent="680ba5316b992408e997940ba30e056b" type="folder">2-4</container></did><accessrestrict id="2b573db89b3a7e7ffb7bbe4571d64e85"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="7d40fbe976113721e79b64dd1d00e27d" level="file"><did><unittitle>TML, 45-3 - OTC Loratadine</unittitle><unitdate type="inclusive">2003 January 6</unitdate><container altrender="Record Storage Box (Paige)" id="12c85ae7ea233f8b04ff7205c17c56e2" label="mixed materials [A0000000075929]" type="box">87</container><container id="f05937d5659749aae3fbb81dd046054c" parent="12c85ae7ea233f8b04ff7205c17c56e2" type="folder">5</container></did><accessrestrict id="68d83db5324a44659c1dd3f51c2e2864"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="1823eedc9d0074c8a4265ac61efdfda5" level="file"><did><unittitle>TML, 45-41 - Insect repellents</unittitle><unitdate type="inclusive">2003 May 26</unitdate><container altrender="Record Storage Box (Paige)" id="cda501eca2751118190b05bf381b1d5b" label="mixed materials [A0000000075929]" type="box">87</container><container id="5fd8e0a397ce0e93a2397129cf42e478" parent="cda501eca2751118190b05bf381b1d5b" type="folder">6-8</container></did><accessrestrict id="fd9f974ca565c85df29a51348d8fb4a7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="2f3bcea3a484b983f63233e648e58d71" level="file"><did><unittitle>TML, 45-81 - Rosuvastatin - a new lipid-lowering drug</unittitle><unitdate type="inclusive">2003 October 13</unitdate><container altrender="Record Storage Box (Paige)" id="d88b0c6399340c544a7052f26f9184b0" label="mixed materials [A0000000075929]" type="box">87</container><container id="7387149e92b89146ea5294def02f58c5" parent="d88b0c6399340c544a7052f26f9184b0" type="folder">9-12</container></did><accessrestrict id="43bf4f6f81d3fbdf04c68bbc454e9040"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="ba56ad48c3bef0d702fff7fdda72fa22" level="file"><did><unittitle>TML, 45-35 - Insulin-sensitizing drugs for polycystic ovary syndrome</unittitle><unitdate type="inclusive">2003 April 28</unitdate><container altrender="Record Storage Box (Paige)" id="d5f02bf28da04e57e8e3a8efa390bcfe" label="mixed materials [A0000000075929]" type="box">87</container><container id="6cd5590935dd941e9b0be2ba5449dba6" parent="d5f02bf28da04e57e8e3a8efa390bcfe" type="folder">13-15</container></did><accessrestrict id="68c074ca5c7b85d99e37109be8f03f26"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3d9fbb15ae7446c6c645d70bd47fbf3b" level="file"><did><unittitle>TML, 45-73 - Memantine for Alzheimer's disease</unittitle><unitdate type="inclusive">2003 September 15</unitdate><container altrender="Record Storage Box (Paige)" id="0016356521af0f43d4afabf73fec0aca" label="mixed materials [A0000000075929]" type="box">87</container><container id="95052071af1161abd9420b50665b7212" parent="0016356521af0f43d4afabf73fec0aca" type="folder">16-18</container></did><accessrestrict id="349dea74056b705fe12a6e58b6be4a61"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="11bdec471c430a38763f1ea9a86eab38" level="file"><did><unittitle>TML, 45-58 - Treatment of heat injury</unittitle><unitdate type="inclusive">2003 July 21</unitdate><container altrender="Record Storage Box (Paige)" id="6f98671c07fb8864a1f3ebf629eb8586" label="mixed materials [A0000000075930]" type="box">88</container><container id="b93217dd94ac57cea037def84d225889" parent="6f98671c07fb8864a1f3ebf629eb8586" type="folder">1-2</container></did><accessrestrict id="b32e89185eafe8ec72db09448de5ce28"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="806d8942533d66de734e65e88b3304ee" level="file"><did><unittitle>TML, 45-90 - Atazanavir (Reyataz) and Emtricitabine (Emtriva) for HIV infection</unittitle><unitdate type="inclusive">2003 November 10</unitdate><container altrender="Record Storage Box (Paige)" id="48e79715570e2007695f029a6de95659" label="mixed materials [A0000000075930]" type="box">88</container><container id="70fea6ba62908ed5e2d51010c3b46223" parent="48e79715570e2007695f029a6de95659" type="folder">3-6</container></did><accessrestrict id="d90cbf0a7351c28f0b2d1347edc27949"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="04dee614a81cacb32c43ef5b0a88af03" level="file"><did><unittitle>TML, 45-88 - Aldurazyme (Laronidase)</unittitle><unitdate type="inclusive">2003 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="3ea28829ca3b5f51eac6f3d94af69c61" label="mixed materials [A0000000075930]" type="box">88</container><container id="80bef3a549fa5883daaa54869693e395" parent="3ea28829ca3b5f51eac6f3d94af69c61" type="folder">7-8</container></did><accessrestrict id="b53a56596e6cd54c520d93ec764edd68"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9233509af152396c7a0be4f4a4690cec" level="file"><did><unittitle>TML, 45-46 - Drug Interactions</unittitle><unitdate type="inclusive">2003 June 9</unitdate><container altrender="Record Storage Box (Paige)" id="4244a1e3fc0c84968a46adc228dd097e" label="mixed materials [A0000000075930]" type="box">88</container><container id="c1912a6e6e903f9fa2ef77358018bae9" parent="4244a1e3fc0c84968a46adc228dd097e" type="folder">9-12</container></did><accessrestrict id="7b355cfd23bf5faae7008b6d8dfcd613"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="95a2b9eb73be12648888070a03ead474" level="file"><did><unittitle>TML, 45-85 - Lowering Plasma Homocystein</unittitle><unitdate type="inclusive">2003 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="f18e7ac79cfcda23c2f73c4488567240" label="mixed materials [A0000000075930]" type="box">88</container><container id="d53fec879cb3e041fead8ed8fe6a62aa" parent="f18e7ac79cfcda23c2f73c4488567240" type="folder">13-17</container></did><accessrestrict id="150bc9e4636bdbb6ef444d31120758f6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="dad27947e40b662edd3cc5a90a0be625" level="file"><did><unittitle>TML, 45-83 - Lp-Pla2 - A new marker of Vasular Risk</unittitle><unitdate type="inclusive">2003 October 13</unitdate><container altrender="Record Storage Box (Paige)" id="285855a1140625a9043a98ebfb247b8d" label="mixed materials [A0000000075930]" type="box">88</container><container id="00b787195b09d313e5810bf9be7597ad" parent="285855a1140625a9043a98ebfb247b8d" type="folder">18-19</container></did><accessrestrict id="7bacb749d5cace7b77c6d20686088469"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="e617e6eea5f9996628c705dd200e1ffa" level="file"><did><unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle><unitdate type="inclusive">2003 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="0ea412a915e437b94f4994e26864be11" label="mixed materials [A0000000075930]" type="box">88</container><container id="ad0bbc64d755ad49d597a356d12fce2d" parent="0ea412a915e437b94f4994e26864be11" type="folder">20</container></did><accessrestrict id="8c291adc86b1ece8d63fe68ecf028b3e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9fd8a0d9db61f711e261afe6ec4c49ea" level="file"><did><unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle><unitdate type="inclusive">2003 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="a0d2a3fa2b26e4adc8017aaa67b5a651" label="mixed materials [A0000000075931]" type="box">89</container><container id="4152dd5b526075909b35ab1625de9740" parent="a0d2a3fa2b26e4adc8017aaa67b5a651" type="folder">1-4</container></did><accessrestrict id="bce92c80f15ffaccbaa401c6170b83ed"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="edaf8bc319227fe95dce9ce1973f3621" level="file"><did><unittitle>TML, 45-86 - Iodine-131 - Tositumomab (Bexxar) for treatment of Lymphoma</unittitle><unitdate type="inclusive">2003 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="3f9a88e1cb171e20bb606312268a4adf" label="mixed materials [A0000000075931]" type="box">89</container><container id="5191309ec007edccef2ed0a80654de76" parent="3f9a88e1cb171e20bb606312268a4adf" type="folder">5-9</container></did><accessrestrict id="a9e5f083314a82f3692a841eac51a5ca"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="f8dc69e4bf109c9986cc722051633070" level="file"><did><unittitle>TML, 45-27 - Pneumococcal Conjugate Vaccine</unittitle><unitdate type="inclusive">2003 March 31</unitdate><container altrender="Record Storage Box (Paige)" id="d23897384d3d11d5bd268d700b8172ea" label="mixed materials [A0000000075931]" type="box">89</container><container id="d0f3dea88c58b13cdf0c8f8192023e82" parent="d23897384d3d11d5bd268d700b8172ea" type="folder">10-11</container></did><accessrestrict id="e59f218612780c21cd1831f3c38ec08e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="cc9f06be346fedef1f6102477bee9cb2" level="file"><did><unittitle>TML, 45-78 - Influenza Prevention</unittitle><unitdate type="inclusive">2003 September 29</unitdate><container altrender="Record Storage Box (Paige)" id="417d305f7bc88a3bde36966489c56387" label="mixed materials [A0000000075931]" type="box">89</container><container id="4440ad7a8b523279123bccb2652ba74e" parent="417d305f7bc88a3bde36966489c56387" type="folder">12-14</container></did><accessrestrict id="cc6daf505d9a0ea7ee4c3ea324aa8478"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="39d9d76dedec7d6057d3eb65d8744ded" level="file"><did><unittitle>TML, 45-19 - Peginterferon alfa (Pegasys) for Chronic Hepatitis C</unittitle><unitdate type="inclusive">2003 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="bb93630ef34d7bc2cd8cb08ff92266ee" label="mixed materials [A0000000075931]" type="box">89</container><container id="215df6f9a63294b6ae0d42df3483699d" parent="bb93630ef34d7bc2cd8cb08ff92266ee" type="folder">15-16</container></did><accessrestrict id="4cfe15ffe7bdd2742771ed54d3c1d07c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="efd0e7eb3789a0bc30a68f63ca9b430c" level="file"><did><unittitle>TML, 45-55 - Pegvisomant (Somavert) for Acromegly</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="732d0434413805357a41a3fb0a08ed5a" label="mixed materials [A0000000075931]" type="box">89</container><container id="cc23b27a33c57e38023fabc68c4d9e4b" parent="732d0434413805357a41a3fb0a08ed5a" type="folder">17-20</container></did><accessrestrict id="565dbbbdc9cf527d50ca1536a406a58f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="e809ce901af88811ad1fd0cb5bc5882c" level="file"><did><unittitle>TML, 45-9 - Teriparatide for Osteoporosis</unittitle><unitdate type="inclusive">2003 February 3</unitdate><container altrender="Record Storage Box (Paige)" id="ce94d252d039e685affe0b9dfe44352a" label="mixed materials [A0000000075932]" type="box">90</container><container id="63bae26e7d7c80bdad6e4796e6357be3" parent="ce94d252d039e685affe0b9dfe44352a" type="folder">1-4</container></did><accessrestrict id="662bdc9f7dbb54b08b4950ea34c176c4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="acd944256fa6e191f50b1c636b7b7bf4" level="file"><did><unittitle>TML, 45-70 - Testim and Striant - two new testosterone products</unittitle><unitdate type="inclusive">2003 September 1</unitdate><container altrender="Record Storage Box (Paige)" id="2dbb900e122e6c05e010a46689e30435" label="mixed materials [A0000000075932]" type="box">90</container><container id="d2e538b3064d9e1b48554951b61c0fcd" parent="2dbb900e122e6c05e010a46689e30435" type="folder">5-8</container></did><accessrestrict id="56655a641344d4055a005097ec27c5cb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="fbdf4b7f30d77eaf33b84599e0a5e6e6" level="file"><did><unittitle>TML, 45-1 - Smallpox vaccine</unittitle><unitdate type="inclusive">2003 January 6</unitdate><container altrender="Record Storage Box (Paige)" id="712a3218ede55d724f4886f4e4c0c18e" label="mixed materials [A0000000075932]" type="box">90</container><container id="51ca74a7bd06e1994c45754dbe9072d8" parent="712a3218ede55d724f4886f4e4c0c18e" type="folder">9-12</container></did><accessrestrict id="df814d1bfcebe53223f1d57c2a6776e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="d9642438ec124cd82d8e135b0198ede7" level="file"><did><unittitle>TML, 45-69 - Minimal surgery for treatment of GERD</unittitle><unitdate type="inclusive">2003 September 1</unitdate><container altrender="Record Storage Box (Paige)" id="23ac367e1d52ca6fd269f4a5b296c608" label="mixed materials [A0000000075932]" type="box">90</container><container id="a7d21b83aac5aba7409360b42d6bca5d" parent="23ac367e1d52ca6fd269f4a5b296c608" type="folder">13-16</container></did><accessrestrict id="572b2a0e74e3c89c9169b31576cc0b55"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0e7f3c8cc41ff780e30caa2e1cd3c245" level="file"><did><unittitle>TML, 45-23 - Drug-eluting Stents</unittitle><unitdate type="inclusive">2003 March 17</unitdate><container altrender="Record Storage Box (Paige)" id="026c45948a2baa4d6f67dd4a41babbee" label="mixed materials [A0000000075932]" type="box">90</container><container id="168495bc17361accd017f22159bf0ce3" parent="026c45948a2baa4d6f67dd4a41babbee" type="folder">17-19</container></did><accessrestrict id="91472bcb765db5980f76960bca69f7bb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="4cbcc7808efc65afe1e68d84b33f1bea" level="file"><did><unittitle>TML, 45-23 - Drug-eluting Stents</unittitle><unitdate type="inclusive">2003 March 17</unitdate><container altrender="Record Storage Box (Paige)" id="ce295ae66b48310dce310ad5316fbd7a" label="mixed materials [A0000000075933]" type="box">91</container><container id="38afc6e022c14b3c9290757a06e9ee1e" parent="ce295ae66b48310dce310ad5316fbd7a" type="folder">1</container></did><accessrestrict id="ad37cdcd99a2044624e749e1cd39779d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="f9a9c4fc1896553a888be142b1758016" level="file"><did><unittitle>TML, 45-61 - Omeprazole (Prilosec) (OTC)</unittitle><unitdate type="inclusive">2003 August 4</unitdate><container altrender="Record Storage Box (Paige)" id="904f61aa297b8d22eda880836689df94" label="mixed materials [A0000000075933]" type="box">91</container><container id="8fc293b9020383b9d538f6da400182b8" parent="904f61aa297b8d22eda880836689df94" type="folder">2-3</container></did><accessrestrict id="d9a5d8493c3334bb1cda4ff7afb8a52c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="839fb8691411f959bd1aac5c4ebf7d26" level="file"><did><unittitle>TML, 45-29 - Nitazoxanide (Alina) - a new anti-protozoal agent</unittitle><unitdate type="inclusive">2003 April 14</unitdate><container altrender="Record Storage Box (Paige)" id="179ac64a52814b1b1337fa19dad5aa98" label="mixed materials [A0000000075933]" type="box">91</container><container id="faec4caa99cffd5fcbbd3cc976197dbf" parent="179ac64a52814b1b1337fa19dad5aa98" type="folder">4-5</container></did><accessrestrict id="ba825ee552c2bf91acd8b458e0a15d2d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="55365ce4b3ea2d58db64e9416965cb4e" level="file"><did><unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="8c58a1d668a569fee20412038f77ec61" label="mixed materials [A0000000075933]" type="box">91</container><container id="5036fe00ebb6cbe1f5baf7df60912182" parent="8c58a1d668a569fee20412038f77ec61" type="folder">6-17</container></did><accessrestrict id="0ed20f41fac45d1a638a3740752cb703"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="668d7e7e07b5750eb2c823e11c095964" level="file"><did><unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="6f3a5d44708a54b1ffd1d3b378bbb6fb" label="mixed materials [A0000000075934]" type="box">92</container><container id="f5e59eb752b378247674be0c3ea0b915" parent="6f3a5d44708a54b1ffd1d3b378bbb6fb" type="folder">1-4</container></did><accessrestrict id="c2b71f78c735a86ad9547e6e3d24546c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c171f13c04b5ef1cf3b3fe5e96a9ef03" level="file"><did><unittitle>TML - Weight Loss - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 December</unitdate><container altrender="Record Storage Box (Paige)" id="1d0711b8db6784580f4b41ddb18491d7" label="mixed materials [A0000000075934]" type="box">92</container><container id="4ab8501aa8f714b769f09c70bc6c1d9b" parent="1d0711b8db6784580f4b41ddb18491d7" type="folder">5-13</container></did><accessrestrict id="6dd9eece4a3c89e40bca2442781a600d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="ee60c4bf66a25475983425024da14c39" level="file"><did><unittitle>TML - Heart Failure - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 April</unitdate><container altrender="Record Storage Box (Paige)" id="f190e71691a75ec1dafc17376635a64e" label="mixed materials [A0000000075934]" type="box">92</container><container id="2a9d2b604150ea57746fdc61c6ab2c26" parent="f190e71691a75ec1dafc17376635a64e" type="folder">14-18</container></did><accessrestrict id="957488be5b6a3b3f5fb3aca8638e23b6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0be1e684fc9e69b20bc9867cc0b7288f" level="file"><did><unittitle>TML - Drugs for rheumatoid arthritis - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 January</unitdate><container altrender="Record Storage Box (Paige)" id="f8a71134f45057678b78438296f44a5a" label="mixed materials [A0000000075935]" type="box">93</container><container id="a28f3aef416e463e10fd0b855d508131" parent="f8a71134f45057678b78438296f44a5a" type="folder">1-7</container></did><accessrestrict id="fea0a477360238ce0c79c9e79ad6d39a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c0978c508033828e366f1d55950a308e" level="file"><did><unittitle>TML - Drugs for Psychiatric Disorders</unittitle><unitdate type="inclusive">2003 July</unitdate><container altrender="Record Storage Box (Paige)" id="254b7080a352a40135e518b26f4c30bd" label="mixed materials [A0000000075935]" type="box">93</container><container id="b6e4eaebf4b4631e4160b49e4801e2d6" parent="254b7080a352a40135e518b26f4c30bd" type="folder">8-18</container></did><accessrestrict id="03781a219ff982acf63e0290b3b87f0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="a9906d72f32382fa1bb39c1ccd388091" level="file"><did><unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle><unitdate type="inclusive">2003 January</unitdate><container altrender="Record Storage Box (Paige)" id="b1b6a4c6c3effbdf56f5009b79ddff03" label="mixed materials [A0000000075935]" type="box">93</container><container id="19e35ea1ede51b12b69e9a1bd256d6ad" parent="b1b6a4c6c3effbdf56f5009b79ddff03" type="folder">19</container></did><accessrestrict id="a19ba7012ef7e238dc26e208ad0c53df"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9d1257d4a4ba512b1aa0bb0a4c07fdcd" level="file"><did><unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle><unitdate type="inclusive">2003 January</unitdate><container altrender="Record Storage Box (Paige)" id="2f8c30c37c5c5dfaa6ff82b6186a01ca" label="mixed materials [A0000000075936]" type="box">94</container><container id="ff2d8cf354ce15173e88e04d29559d3e" parent="2f8c30c37c5c5dfaa6ff82b6186a01ca" type="folder">1-4</container></did><accessrestrict id="2097ee7f9bd39cd5ea6f974d3df6ff1f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="380c664090534851fbc806e0558fde2f" level="file"><did><unittitle>TML - Assisted Reproduction - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 October</unitdate><container altrender="Record Storage Box (Paige)" id="8c8380db148fab874b4f83310d4a8e72" label="mixed materials [A0000000075936]" type="box">94</container><container id="2b4b99bc15ecab485fb72a833812855b" parent="8c8380db148fab874b4f83310d4a8e72" type="folder">5-13</container></did><accessrestrict id="69fb416fcc934ed0c8b1f96140cd08e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="dfe820ca0d9eb165533f652cbc41ee32" level="file"><did><unittitle>TML - Drugs for Hypertension - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 February</unitdate><container altrender="Record Storage Box (Paige)" id="abb23f8d2329e84c250ecfa7e8f171f5" label="mixed materials [A0000000075936]" type="box">94</container><container id="4e5dd3b6cfa58eb0cc8e6c17031e3934" parent="abb23f8d2329e84c250ecfa7e8f171f5" type="folder">14-17</container></did><accessrestrict id="5a63fa0917343ef8eb141521fcb9e24e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3ce9ce08c457fba44042e2deea5066f7" level="file"><did><unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="9cede1258eadafd574cdb020c486ac7b" label="mixed materials [A0000000075936]" type="box">94</container><container id="368120a84cf0479fa9e05537f2d98e91" parent="9cede1258eadafd574cdb020c486ac7b" type="folder">18</container></did><accessrestrict id="43bc17de19e0d00f4e7031362b3b3efc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="d475b54c5095880adce7b8263966fe2d" level="file"><did><unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="5621779ad6310c2aa2e2f18dd58b6bb4" label="mixed materials [A0000000075937]" type="box">95</container><container id="6c2e48a9fb36ae131c404797c2159c2b" parent="5621779ad6310c2aa2e2f18dd58b6bb4" type="folder">1-8</container></did><accessrestrict id="d727ecc0d3636f553591f418559bc721"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="a6efb00d5c63c6a2ccedf6563ae43110" level="file"><did><unittitle>TML - Drugs for Epilepsy - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 May</unitdate><container altrender="Record Storage Box (Paige)" id="1bd3410f25f6d8c391fd0795345189ae" label="mixed materials [A0000000075937]" type="box">95</container><container id="819b5c9a88efb5c223c35a16ee3d87f3" parent="1bd3410f25f6d8c391fd0795345189ae" type="folder">9-14</container></did><accessrestrict id="ae7bd45c44b6a19a25f101af3b5a211a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="5a5ba60bec4d0b97fddcd00799fd7626" level="file"><did><unittitle>TML - Drugs for Lipid Disorders - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 August</unitdate><container altrender="Record Storage Box (Paige)" id="78901f09cbf1c58497e90b943678ba82" label="mixed materials [A0000000075937]" type="box">95</container><container id="b4fdbfb9b4cb05c52098115a71dafad8" parent="78901f09cbf1c58497e90b943678ba82" type="folder">15-18</container></did><accessrestrict id="334e64660b4fc298f4d1c26e9a76a343"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3c1aea5febbafdf8b5e437a8e97b9218" level="file"><did><unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="7c00feb5cdf9d4e553e71b70e2a937ea" label="mixed materials [A0000000075937]" type="box">95</container><container id="d4cf61f47fbff9187f971680470068fb" parent="7c00feb5cdf9d4e553e71b70e2a937ea" type="folder">19</container></did><accessrestrict id="7cdf942787e0cbed8326189a2020f299"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="ddf6b73987ce0637989f66584610c6ea" level="file"><did><unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="9026a47a46442a4ae0d1e1ef7a5cfdf0" label="mixed materials [A0000000075938]" type="box">96</container><container id="695039d118b98722fd4ce364b6ece38c" parent="9026a47a46442a4ae0d1e1ef7a5cfdf0" type="folder">1</container></did><accessrestrict id="2b960cecbba771988110df8a9cd33742"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0ca468433bcdc6006e7fb9b0ef21814e" level="file"><did><unittitle>TML, 45-93 - Which SSRI</unittitle><unitdate type="inclusive">2003 November 24</unitdate><container altrender="Record Storage Box (Paige)" id="e7edab28ffd06d394403e346c4310907" label="mixed materials [A0000000075938]" type="box">96</container><container id="6a6f762f4b5af0a584fecaef7b0d2d43" parent="e7edab28ffd06d394403e346c4310907" type="folder">2-5</container></did><accessrestrict id="72e10bfbf01df945876de61f8480a08b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="1e5a72f232d4e116685aff32e9ed9f87" level="file"><did><unittitle>TML - Drugs for Allergic Disorders - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 November</unitdate><container altrender="Record Storage Box (Paige)" id="954cca6cc3d76f18ef3d43f796dc0d0f" label="mixed materials [A0000000075938]" type="box">96</container><container id="c4bfd6b9c445c97b5fa3cd665da04063" parent="954cca6cc3d76f18ef3d43f796dc0d0f" type="folder">6-9</container></did><accessrestrict id="ce922dcf8bde445758a34a54106e0ec6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="7621ca9e85272fb03e367f6102650bf9" level="file"><did><unittitle>TML - Drugs for Pneumonia - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 September</unitdate><container altrender="Record Storage Box (Paige)" id="878cfe0c76e1361723d0969c43f274dd" label="mixed materials [A0000000075938]" type="box">96</container><container id="c75b394c608d765078c5744cabff3208" parent="878cfe0c76e1361723d0969c43f274dd" type="folder">10-17</container></did><accessrestrict id="429d1928e15342d8a9639e6b6a92e6d4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="68e729c691bb49c8be35f332fbb1e32b" level="file"><did><unittitle>TML - Antimicrobial Prophylaxis for Surgery - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="629914efaa5866ac5a38aad4ad0aba1b" label="mixed materials [A0000000075939]" type="box">97</container><container id="1db1d3dfb3733ebbb98c0f528fd08382" parent="629914efaa5866ac5a38aad4ad0aba1b" type="folder">1-10</container></did><accessrestrict id="084a4278da0f4581918db07f8eb825b4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="07f19737b5f6d3009e9e85a8b0528533" level="file"><did><unittitle>TML - Drugs for Cardiac Arrhythmias - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="ddc2c8bd933089ed35d09934b37b534b" label="mixed materials [A0000000075939]" type="box">97</container><container id="4b5f9949151e1c3592f330b605e79676" parent="ddc2c8bd933089ed35d09934b37b534b" type="folder">11-18</container></did><accessrestrict id="8f26a61c71898392ee05f246c39c61b0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="c099bb967206188345dcdbf9c2975e6d" level="file"><did><unittitle>TML - Advice for Travelers - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="221b3f7a4294ae77986a96b6a0ed5e42" label="mixed materials [A0000000075940]" type="box">98</container><container id="62a326b816fe031f226d896a580ce795" parent="221b3f7a4294ae77986a96b6a0ed5e42" type="folder">1-9</container></did><accessrestrict id="e0b7814bc924716eb27275e9522cf9ae"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="237497500e700200226282634e319af9" level="file"><did><unittitle>TML - Drugs for Migraine - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="66e86cffcaeede382137e51e7f5866c3" label="mixed materials [A0000000075940]" type="box">98</container><container id="7d77c58a7ceb2ccfd850ea33dcae3707" parent="66e86cffcaeede382137e51e7f5866c3" type="folder">10-15</container></did><accessrestrict id="00d75b64dab2398628516bc88ce53406"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="423b8c383be805c9a485a8fecfe9ddb1" level="file"><did><unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 December</unitdate><container altrender="Record Storage Box (Paige)" id="c680704af97f8da7d6db5167e1997404" label="mixed materials [A0000000075940]" type="box">98</container><container id="8979260da9bdfe965a452fdf969bd306" parent="c680704af97f8da7d6db5167e1997404" type="folder">16</container></did><accessrestrict id="98f8b37e529ccb193a51c645e7d19af9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="26700edc7d4dff9bb83e29c005e8dedd" level="file"><did><unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 December</unitdate><container altrender="Record Storage Box (Paige)" id="46ed3757132c404c42d01272d47ce00e" label="mixed materials [A0000000075941]" type="box">99</container><container id="481ac0d2f82415d3890c20bef700ab9b" parent="46ed3757132c404c42d01272d47ce00e" type="folder">1-5</container></did><accessrestrict id="ff906c4305f7b289ec47141f34c41d10"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="bef1ef630d26c3d4f70cc63b2da9dbfa" level="file"><did><unittitle>TML - Drugs for Sexually transmitted infections - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 October</unitdate><container altrender="Record Storage Box (Paige)" id="fec6b569a3e308d0d48f7e14932b1617" label="mixed materials [A0000000075941]" type="box">99</container><container id="809c3d0324cfe11f9de25e9bb1f856e3" parent="fec6b569a3e308d0d48f7e14932b1617" type="folder">6-12</container></did><accessrestrict id="6db6900a0738aa418a1db1239ba995f3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="ef8b77a4a9168df66dbaa1d35328f051" level="file"><did><unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 June</unitdate><container altrender="Record Storage Box (Paige)" id="f755d59ca73b2efc8bc02bc55fb0e255" label="mixed materials [A0000000075941]" type="box">99</container><container id="9fffba21be7612e68c0949e135932c3e" parent="f755d59ca73b2efc8bc02bc55fb0e255" type="folder">13-18</container></did><accessrestrict id="d4257f7e3e2891eb7db697e7bd0a7fc7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="4122c98e47eb1d53ed958233e91ca5d6" level="file"><did><unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 June</unitdate><container altrender="Record Storage Box (Paige)" id="e13da1ce28571563412463517afdd2d1" label="mixed materials [A0000000075942]" type="box">100</container><container id="b1c197207ea343ad572099f9a7a1f34f" parent="e13da1ce28571563412463517afdd2d1" type="folder">1-3</container></did><accessrestrict id="4ac25a41ad51ce40a2b44624b0c6f458"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="1db0c21858cc9e616d5906c203e6860d" level="file"><did><unittitle>TML, 46-22 - Abarelix (Plenaxis) for advanced prostrate cancer</unittitle><unitdate type="inclusive">2004 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="06a1161927bda04cca24e7141adcb601" label="mixed materials [A0000000075942]" type="box">100</container><container id="aaed641beca454968b1366faeb5fd8db" parent="06a1161927bda04cca24e7141adcb601" type="folder">4-5</container></did><accessrestrict id="d7dfc37db7d6c404c6134b6250ab6400"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="7f8aea6a2a9125acc397a2b721ccebdb" level="file"><did><unittitle>TML, 46-9 - Daptomycin (Cubicin) for skin and soft tissue infections</unittitle><unitdate type="inclusive">2004 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="edbf2a13553ca54956bb6d69407a1aa1" label="mixed materials [A0000000075942]" type="box">100</container><container id="76de34bd5959c667fa7c7cd8b79c1916" parent="edbf2a13553ca54956bb6d69407a1aa1" type="folder">6-8</container></did><accessrestrict id="8b64bb10092754b7b8a4c90c8deb7337"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="08fbdaa8a0871e1576f4bafb794f57f9" level="file"><did><unittitle>TML, 46-10 - Emergency Contraception OTC</unittitle><unitdate type="inclusive">2004 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="e921450aa829fac7106da46f2cb1ea19" label="mixed materials [A0000000075942]" type="box">100</container><container id="619d3fffa4d65199abddfaad73387301" parent="e921450aa829fac7106da46f2cb1ea19" type="folder">9-10</container></did><accessrestrict id="00f05ef1f3a72bb3da4ce317cb793c27"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="9ea3892837eec8429d01fe1dc14e6b41" level="file"><did><unittitle>TML, 46-5 - Lasik and its alternatives - an update</unittitle><unitdate type="inclusive">2004 January 19</unitdate><container altrender="Record Storage Box (Paige)" id="a0e3aff84f9a7b3720f98e6a74984108" label="mixed materials [A0000000075942]" type="box">100</container><container id="ec7b4169c5cb27eacb85393f0575c45a" parent="a0e3aff84f9a7b3720f98e6a74984108" type="folder">11-14</container></did><accessrestrict id="7815c3c9e1b402b4a02ed5022e168609"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="f1703fc66140060139d86d70ac0c3846" level="file"><did><unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle><unitdate type="inclusive">2004 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="1e36c9eeb9ce9e96c37b9b9cf76f991c" label="mixed materials [A0000000075942]" type="box">100</container><container id="4c6e082bca5acadb49ea2c51745ec4d9" parent="1e36c9eeb9ce9e96c37b9b9cf76f991c" type="folder">15-18</container></did><accessrestrict id="dc0cf1e8ca62aefc4f65bdca678ea19e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="e8f33c13c32daa15598a2e144e9f900f" level="file"><did><unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle><unitdate type="inclusive">2004 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="4e1f8ebaf9a8c74f6b5597054bf3ee46" label="mixed materials [A0000000075943]" type="box">101</container><container id="4c75ec595ce39d6b5a72a200b1be0805" parent="4e1f8ebaf9a8c74f6b5597054bf3ee46" type="folder">1</container></did><accessrestrict id="81a1621d7a2a2452c30a530869fc9bea"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="f1258ee39d7e2cce0fa124be57ed0634" level="file"><did><unittitle>TML - Choice of Antibacterial Drugs - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 March</unitdate><container altrender="Record Storage Box (Paige)" id="7fb627a2d41bf4fea69e5e3d514a9a76" label="mixed materials [A0000000075943]" type="box">101</container><container id="e0f7a731bc0a7f2a073a9b5893f0f6eb" parent="7fb627a2d41bf4fea69e5e3d514a9a76" type="folder">2-8</container></did><accessrestrict id="d14f31516858f5ff1d6ab38316a1acdf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="dcf6c003359f1d37afb6b89504a47763" level="file"><did><unittitle>TML - Drugs for Peptic Ulcers - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 February</unitdate><container altrender="Record Storage Box (Paige)" id="5706bbb5fd5dfb72976d0926d6869968" label="mixed materials [A0000000075943]" type="box">101</container><container id="0bada5ec39c6324f607323472b08dafc" parent="5706bbb5fd5dfb72976d0926d6869968" type="folder">9-17</container></did><accessrestrict id="ee022307e7bb1d19942f259293477255"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="0ba4f3a6cf74e6af72c13dc1e491dbd6" level="file"><did><unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 January</unitdate><container altrender="Record Storage Box (Paige)" id="4598986bd131baa5a68f8581f6277301" label="mixed materials [A0000000075943]" type="box">101</container><container id="f692f221f51261cc6caec9cc4a198d76" parent="4598986bd131baa5a68f8581f6277301" type="folder">18-19</container></did><accessrestrict id="cae76792326d54b966f74999980f0522"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="499346d5020cece037a74d774986c858" level="file"><did><unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 January</unitdate><container altrender="Record Storage Box (Paige)" id="32634f96a2dc4ffeb81908cecbd54713" label="mixed materials [A0000000075944]" type="box">102</container><container id="24902d12c2132d44b54dfca1024e508c" parent="32634f96a2dc4ffeb81908cecbd54713" type="folder">1-4</container></did><accessrestrict id="78b76f282a6087796d952eea7ca3851b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="e2ff3268992aa759f09a842e60822ffb" level="file"><did><unittitle>TML - Drugs for Pain - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 July</unitdate><container altrender="Record Storage Box (Paige)" id="a5ab38c539134ca6d8a22490db33133c" label="mixed materials [A0000000075944]" type="box">102</container><container id="286cc273d8e760dd61595dc66ce9cc75" parent="a5ab38c539134ca6d8a22490db33133c" type="folder">5-14</container></did><accessrestrict id="04e11af6b467a1e7c10d7574675c44fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c></dsc>
</archdesc>
</ead>
